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Abstract 
Actin is a highly abundant structural protein in eukaryotes that is critical for 
several cellular processes. In the apicomplexan parasite Toxoplasma gondii, 
actin is critical for the completion of the lytic cycle and, thus, parasite survival. 
Only recently, actin structures were visualised in Toxoplasma by exploiting 
actin-chromobodies, revealing an extensive actin network within the 
parasitophorous vacuole (PV) (Periz et al. 2017). This network consists of 
intravacuolar filamentous structures that connect individual parasites within the 
PV. In addition, parasites possess a cytosolic actin centre (cAC) anterior to the 
nucleus.  
The study presented here aimed at exploiting actin visualisation to investigate 
actin dynamics in unprecedented detail in vivo. For this purpose, I established a 
conditional CRISPR/Cas9 that allows for rapid and efficient gene disruption in 
Toxoplasma. Combining this system with the actin-chromobody technology 
granted detailed insights into the actin dynamics in intracellular parasites. I 
identified the actin depolymerisation factor (TgADF) as an important factor in 
the disassembly of the intravacuolar F-actin filaments prior to parasite egress 
from the host cell. Furthermore, this study revealed TgFormin2 to be critical for 
maintaining the cAC. Since cAC loss severely impaired actin distribution and 
peripheral actin flow in intracellular parasites, I concluded that TgFormin2 
represents a major key player in mediating proper actin dynamics. TgFormin2 
also appeared to be important for apicoplast inheritance and positioning. 
In summary, data presented in this thesis significantly contribute to the 
understanding of actin dynamics in Toxoplasma. Further insights into 
apicomplexan actin dynamics will be gained by exploiting the conditional 
CRISPR/Cas9 technology for phenotypic screening approaches. 
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Definitions/abbreviations 
Aa Amino acid 
ACT1 or act1 Actin1 
ADF or adf Actin depolymerisation factor 
ADP Adenosine diphosphate 
AID Auxin-inducible degron 
AMA1 Apical membrane antigen 1 
Amp Ampicillin 
Arg Arginine 
At Arabidopsis thaliana 
ATP Adenosine triphosphate 
a.u. arbitrary units 
αTAT1 alpha-tubulin acetyltransferase 1  
BLAST Basic Local Alignment Search Tool 
BIPPO 5-Benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 
bp Base pair 
BSA Bovine serum albumin 
°C Degree Celsius 
Ca2+ Calcium 
cAC Cytosolic actin centre 
Cas9 CRISPR associated protein 9 
CAT Chloramphenicol acetyltransferase 
cDNA Complementary deoxyribonucleic acid 
Cb Chromobody 
Cb-Em Chromobody Emerald 
CDPK Calcium-dependent protein kinase 
CIP Calf intestinal phosphatase 
C-terminal Carboxyl terminal 
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats 
DD Destabilisation domain 
DHFR Dihydrofolate reductase 
DiCre Dimerisable Cre 
Dm Drosophila melanogaster 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO Dimethyl sulfoxide 
DN Dominant negative 
DNA Deoxyribonucleic acid 
ds Double-strand 
DSB double-strand break 
dNTP Deoxynucleotide 5’-triphosphate 
E. coli Escherichia coli 
EDTA Ethylene diamine tetraacetic acid 
Em Emerald fluorescent protein 
ER Endoplasmic reticulum 
EtOH Ethanol 
FBS Fetal bovine serum 
fw Forward 
FRM or frm Formin or formin 
g Gram or Gravity (context dependent) 
GAP Glideosome associated protein 
gDNA Genomic deoxyribonucleic acid 
GFP Green fluorescent protein 
GOI Gene of interest 
GED GTPase Effector Domain 
GFP Green Fluorescent Protein 
GPI Glycophosphatidylinositol 
gRNA Guide RNA 
GTP Guanosine triphosphate 
h Hour 
H2O Water 
HEPES 4-(2-Hydroxyethyl)-piperazineethanesulphonic acid 
HFF Human foreskin fibroblast 
Hs Homo sapiens 
Hx or hxgprt Hypoxanthine-xanthine-guanine phosphoribosyl transferase 
IAA indole-3-acetic acid 
IFA Immunofluorescence analysis 
IMC Inner membrane complex 
IPP isopentenyl pyrophosphate 
K Lysine 
kbp Kilo base pair 
KD Knockdown 
kDa Kilo Dalton 
KO Knockout 
LB Luria-Bertani 
LoxP Locus crossover in P1 
Lys Lysine 
M Molar or Methionine (amino acid) 
MCS Multiple cloning site 
mg Milligram 
MIC Micronemal protein 
min Minute 
MJ Moving Junction 
ml Millilitre 
mM Milimolar 
MTOC Microtubule organisation centre 
MPA Mycophenolic acid 
mRNA Messenger ribonucleic acid 
MT Microtubule 
Myo Myosin 
NCBI National Center for Biotechnology Information 
NHEJ Non-homologous end joining 
ng Nanogram 
nm Nanometer 
N-terminal Amino terminal 
ORF Open reading frame 
P. falciparum or 
Pf 
Plasmodium falciparum 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
Pi Inorganic phosphate 
PM Plasma membrane 
POI Protein of interest 
PV Parasitophorous vacuole 
PVM Parasitophorous vacuole membrane 
r Resistant 
RB Residual body 
rev Reverse 
RFP Red Fluorescent Protein 
RNA Ribonucleic acid 
RON Rhoptry neck protein 
rpm revolutions per min 
RT Room temperature 
s Second 
SAG1 Surface antigen 1 
sCas9 Split-Cas9 
SD Standard deviation 
sgRNA Single-guide RNA 
SOC Super optimal broth with catabolite repression 
ss Single-strand 
SSR Site specific recombination 
t Time 
T. gondii or Tg Toxoplasma gondii 
TAE Tris-acetate-EDTA 
TEMED N,N,N’,N’-tetramethylethylenediamine 
term terminus 
TM Transmembrane 
Tris Tris [hydroxymethyl] aminomethane 
U Unit 
UTR Untranslated region 
UV Ultraviolet 
V Volts 
v/v Volume/volume percentage 
w/v Weight/volume percentage 
WHO World health organisation 
wt Wild-type 
Xan Xanthosine monophosphate 
X-Gal 5-bromo-4-chloro-3-indoyl-â-D-Galactopyranoside 
YFP Yellow fluorescent protein 
µg Microgram 
µl Microliter 
µm Micrometer 
µM Micromolar 
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1 Introduction 
The single cell organism Toxoplasma gondii is an obligate intracellular parasite 
that can infect any nucleated cell in any warm-blooded animal, including 
humans. In this chapter, I will provide an introduction to the overall biology of 
this parasite. I will specifically highlight the function of the structural protein 
actin within the asexual lytic cycle of Toxoplasma. Furthermore, the recently 
developed molecular tool CRISPR/Cas9 will be reviewed.   
 
1.1 Taxonomie 
Toxoplasma gondii is the only species in the genus Toxoplasma and, therefore, 
will be simply referred to as Toxoplasma during this thesis. Toxoplasma is placed 
in the (Infra)Phylum of the Apicomplexa within the Coccidia subclass. 
Apicomplexans are characterised by the presence of an apical complex and a 
parasitic life style  (LEVINE et al. 1980). It is important to note that Plasmodium 
species, the causative agent of malaria, also belong to the  apicomplexan 
(infra)phylum (LEVINE et al. 1980). The (Infra)Phylum Apciomplexa contains 
about 6000 species, but a potential number of up to 10 million is estimated (Adl 
et al. 2007). Although all apicomplexan organisms are parasitic, there is 
evidence suggesting that their ancestor was living in a symbiotic relationship 
with corals (Moore et al. 2008; van Dooren and Striepen 2013). 
The (infra)phylum Apicomplexa belongs to the superphylum of the Alveolata (Adl 
et al. 2012; Ruggiero et al. 2015; Adl et al. 2019). A common feature in 
Alveolata is a peripheral alveolar membrane system. This system contains of 
membrane sacs that are located directly underneath and outline the plasma 
membrane (Adl et al. 2019). This peripheral alveolar membrane system is 
referred to as IMC (Inner Membrane Complex) in Apicomplexa (Blader et al. 
2015). Alveolata belong to the taxon “SAR” (Burki et al. 2007; Adl et al. 2012).  
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1.2 Health Impact of apicomplexan parasites 
In total, Plasmodium was responsible for an estimated 219 million malaria cases 
globally, with an estimated 435,000 deaths in 2017 worldwide. Children under 
the age of 5 were most affected (World Health Organization: World Malaria 
Report 2018).  
One third of the human population is infected with Toxoplasma (Blader et al. 
2015). Most post-natal infections remain asymptomatic in healthy individuals. 
However, there are two situations when Toxoplasma infection can result in 
clinical disease: (1) When infected individuals become immunocompromised and 
(2) when an acute infection occurs in pregnant individuals since congenital 
infection can happen in the fetus (Blader et al. 2015). Effect of Toxoplasma 
infection on the unborn child can be dramatic, including spontaneous abortion, 
mental retardation (Black and Boothroyd 2000), deafness and retinal damage 
(Torrey and Yolken 2013). Toxoplasmic encephalitis was reported to be one of 
the most common AIDS-associated diseases of the central nervous system (Luft 
and Remington 1992). It shall also be mentioned that Toxoplasma infections can 
cause ocular disease (Torrey and Yolken 2013) and that the effect of Toxoplasma 
infection on host behaviour and mental health is under investigation (Tyebji et 
al. 2019).  
 
1.3  The life cycle of Toxoplasma 
The Toxoplasma life cycle (Figure 1-1) was first postulated by Frenkel and 
colleagues in 1970 (Frenkel, Dubey, and Miller 1970). The life cycle can be 
separated into three different stages: the sexual stage and the asexual stage, 
also known as lytic cycle. In between, there is an environmental stage when the 
parasite is transferred from its definitive host (sexual replication) to the 
intermediate host (asexual replication) (Robert-Gangneux and Dardé 2012). 
Noteworthy, Toxoplasma can be transmitted between different intermediate 
hosts orally, i.e. without having to complete the sexual cycle in cats. This 
remarkable feature of Toxoplasma biology was reported to be the driving force 
behind the clonal global expansion of Toxoplasma (Su et al. 2003). Throughout 
its life cycle Toxoplasma can occur in three infectious stages: rapidly dividing 
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tachyzoites, slow growing bradyzoites that can form tissue cysts and sporozoites 
which occur in oocysts that are shed by cat faeces (Torrey and Yolken 2013).   
 
Figure 1-1: The life cycle of Toxoplasma gondii 
The Toxoplasma life cycle is separated into the sexual, asexual and environmental stage. 
Sexual replication happens exclusively in feline species. Cats shed infective oocysts 
which are ingested by the intermediate host where asexual replication occurs. Asexual 
replication can occur in any warm-blooded animal (here depicted as mice, sheep or pig). 
Consumption of infected prey by the cat re-introduces Toxoplasma to its definite host. 
Humans can be infected with Toxoplasma when ingesting contaminated food or water. 
Toxoplasma poses a threat to immunocompromised individuals and embryos. Reprinted 
by permission from Springer Nature Customer Service Centre GmbH: Springer Nature, 
Nature Reviews Microbiology (Hunter and Sibley 2012) ©2012, License number: 
4638711134319.  
 
1.3.1 Definitive host – sexual replication  
Sexual replication happens exclusively in feline species. The cat-exclusive 
occurrence of sexual replication was recently linked to a systemic excess of 
linoleic acid in felines (Di Genova et al. 2019). The excess of linoleic acid is 
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believed to be caused by the absence of delta-6-desaturase activity in cats 
(Rivers, Sinclair, and Crawford 1975; Sinclair, McLean, and Monger 1979). When 
the murine delta-6-desaturase was inhibited in mice that were fed a diet 
supplemented with linoleic acid, Toxoplasma was able to undergo sexual 
replication in mice (Di Genova et al. 2019).  Cats can be infected by tachyzoites 
and bradyzoites (Dubey and Frenkel 1976; Dubey 2006). They can also be 
infected by oocysts (Dubey 2006). However, a higher number of oocysts than 
bradyzoites is required for establishing an infection that results in the cat 
shedding oocysts.  
Upon oral uptake of a bradyzoite cyst by a cat, the cyst wall is destroyed by 
digestive enzymes. Free parasites enter epithelial cells of the small intestine 
(enterocytes) and replicate asexually. Eventually, merozoites are formed in 
schizonts, a process called schizogony. Schizogony is followed by sexual 
development, i.e. the formation of male and female gametocytes (gametogony). 
After fertilisation, an oocyst forms within an enterocyte. The oocyst is 
eventually released into the environment within the cat faeces (Robert-
Gangneux and Dardé 2012).  
 
1.3.2 Environmental stage 
Outside the cat, sporozoites are formed within the oocyst. These sporulated 
oocysts can be taken up by the intermediate host through ingestion of 
contaminated food or water. Importantly, Toxoplasma undergoes meiotic 
reduction during sporozoite formation resulting in a haploid genome (Robert-
Gangneux and Dardé 2012). 
The oocyst wall consists of multiple layers (Ferguson, Hutchison, and Siim 1975; 
Speer, Clark, and Dubey 1998) and protects the sporozoites from the outer 
environment (Belli, Smith, and Ferguson 2006). It was reported that oocyst wall 
has similar properties to common plastic material, making it resistant to the 
outer environment and disinfectants (Dumetre et al. 2013). In the laboratory, 
oocysts can survive harsh conditions maintaining their infectiveness for hundreds 
of days, if not years  (Dubey 1998; Yilmaz and Hopkins 1972). In the 
environment, oocysts were reported to remain infectious for over a year (Yilmaz 
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and Hopkins 1972; Frenkel, Ruiz, and Chinchilla 1975). Contamination of water 
supply with cat faeces can cause Toxoplasmosis outbreaks in the human 
population, as shown by a case study from Brazil (De Moura et al. 2006). 
 
1.3.3 Intermediate host – asexual lytic cycle  
Within the intermediate host, Toxoplasma replicates asexually. After oocyst 
uptake, the sporzoites break free and invade intestinal epithelial cells. Here, 
they differentiate into tachyzoites that can spread throughout the body (Robert-
Gangneux and Dardé 2012). Tachyzoites can convert into bradyzoites. This stage 
forms cysts that can remain in the intermediate host for life (Robert-Gangneux 
and Dardé 2012). Upon transmission from one intermediate host to another or to 
the cat, bradyzoites break free from the cysts and establish a new infection 
(Robert-Gangneux and Dardé 2012).  
 
1.4 The asexual lytic cycle of Toxoplasma tachyzoites: a 
closer look  
The lytic cycle can be divided into several phases: gliding, host cell invasion, 
asexual replication and egress (Figure 1-2).  In short, after gliding towards and 
invasion of a host cell, the parasite replicates within that cell and, eventually, 
egresses to infect another cell. Since experiments during this study were 
exclusively performed on asexually replicating tachyzoites, these steps will be 
described in more detail in the following sections. Also, the tachyzoite 
ultrastructure shall be introduced. 
 
1.4.1 Tachyzoite structure  
Tachyzoites show a crescent shape and are usually about 2µm in width and 6-
8µm in length (Dubey, Lindsay, and Speer 1998; Joiner and Roos 2002). They 
possess many organelles typically found in eukaryotes, including a nucleus, a 
single interconnected endoplasmatic reticulum (ER) network, a single 
mitochondrion and a single Golgi apparatus (Figure 1-3) (Joiner and Roos 2002). 
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In addition, three distinct types of secretory organelles are present in 
Toxoplasma. These organelles are micronemes, rhoptries and dense granuoles 
(Dubey, Lindsay, and Speer 1998; Joiner and Roos 2002). Micronemes and 
rhoptries play important roles in gliding motility and, thus, host cell invasion and 
egress (please refer to sections 1.4.2., 1.4.3. and 1.4.5). The microneme 
secretion process is introduced in the context of parasite egress in section 1.4.5. 
 
Figure 1-2: The Lytic cycle of Toxoplasma 
Completion of the lytic cycle depends on several steps: gliding, host cell invasion, asexual 
replication and egress. After gliding towards and invasion of a host cell, the parasite 
replicates within that cell and, eventually, egresses to infect another cell. Republished with 
permission of Annual Reviews (Annual Reviews of Microbiology), from (Blader et al. 2015) 
© 2015; permission conveyed through Copyright Clearance Center, Inc. License number: 
4638721038758. 
 
Dense granules were found to be involved in the maturation of the 
parasitophorous vacuole (PV) (Mercier and Cesbron-Delauw 2015).  For instance, 
the dense granule proteins GRA17 and 23 were suggested to mediate traffic of 
small molecules between the PV and the host cell (Gold et al. 2015). 
Additionally, dense granule proteins were reported to localise to the host cell 
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nucleus where they can impact host gene expression levels (Bougdour et al. 
2013; Braun et al. 2013). Micronemes and rhoptries are localised to the apical 
tip of the tachyzoite and are part of the apical complex, together with the 
apical polar ring (APR) and the conoid (Morrissette and Sibley 2002).  
 
Figure 1-3: Schematic of the Toxoplasma tachyzoite ultrastructure 
Tachyzoites possess a crescent shape and many organelles typically found in eukaryotes 
including a nucleus, a single interconnected endoplasmatic reticulum (ER) network, a 
single mitochondrion and a single Golgi apparatus. The tachyzoite body is outlined by the 
inner membrane complex (IMC) that sits just beneath the plasma membrane and on top of 
the subpellicular microtubules (not depicted). The conoid is located to the apical tip of the 
parasite together with micronemes, rhoptries and dense granuoles, the three types of 
secretory organelles found in tachyzoites. The apicoplast is a non-photosynthetic plastid 
organelle and crucial for parasite survival. Abbreviations: EC - endosome compartment; 
PLV - plant-like vacuole. Republished with permission of Annual Reviews (Annual 
Reviews of Microbiology), from (Blader et al. 2015) © 2015; permission conveyed through 
Copyright Clearance Center, Inc. License number: 4638721038758. 
 
Together with microtubules, the conoid is part of the tachyzoite cytoskeleton. 
The conoid is a cone-like structure at the apical tip of tachyzoites and consists 
of tubulin (Nichols and Chiappino 1987; Hu, Roos, and Murray 2002). Notably, the 
28 
 
tubulins forming the conoid arrange into a polymer different from typical 
microtubules (Hu, Roos, and Murray 2002). Conoid extrusion is part of the host 
cell invasion process (Nichols, Chiappino, and O’Connor 1983; Werk 1985) and 
was reported to depend on calcium (Mondragon and Frixione 1996). Recently, 
the conoid protein hub 1 (CPH1) was identified (Long, Anthony, et al. 2017). This 
protein localises to the conoid and is critical for conoid integrity in extracellular 
parasites. CPH1 also appeared to be critical for parasite motility and invasion. In 
addition, three calmodulin (CaM)-like proteins localise to the conoid (Long, 
Brown, et al. 2017). Interestingly, these proteins appear to be involved in 
parasite invasion, egress and motility. However, CaMs 1-3 are dispensable for 
conoid extrusion.  CaM 1 and 2 were originally localised to the conoid by Hu and 
co-workers (Hu et al. 2006). 
Two constituents of the APR are known: RNG1 and RNG2 (Morrissette 2015). 
RNG1 localises to the APR (Tran et al. 2010). Since attempts to knock-out RNG1 
failed, Tran and co-workers suggested RNG1 to be critical for parasite survival. 
Depletion of RNG2, which also localises to the APR, inhibits host cell invasion, 
motility and microneme secretion (Katris et al. 2014). Interestingly, Katris and 
colleagues could restore microneme secretion by stimulating RNG2 depleted 
parasites with calcium. This finding was interpreted as implication for a function 
of the apical complex in the regulatory pathways for microneme secretion. The 
APR also functions as a microtubule organisation centre (MTOC) from which 22 
subpellicular microtubules originate (Nichols and Chiappino 1987). These 
microtubules span about two-thirds of the tachyzoite body and form a spiralled 
cage.  In addition to the subpellicular microtubules, two intraconoid 
microtubules can be found spanning the inner lumen of the conoid (Nichols and 
Chiappino 1987; Hu, Roos, and Murray 2002; Morrissette 2015). 
The tachyzoite body is outlined by the inner membrane complex (IMC) that sits 
just beneath the plasma membrane and on top of the subpellicular microtubules 
(Harding and Meissner 2014). The IMC is composed of flattened membrane sacs 
(alveoli) that lie directly underneath the plasma membrane. The alveoli are 
supported by the subpellicular network (SPN) (Harding and Meissner 2014). The 
SPN was initially characterised as an interwoven network of filaments that spans 
the whole tachyzoite body (Mann and Beckers 2001). The network is believed to 
be a membrane skeleton that confers cell shape and stability.  The first SPN 
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components to be discovered were the intermediate filament-like proteins IMC1 
and 2 (Mann and Beckers 2001). Since then, a large number of additional IMC 
proteins  (e.g. IMC3-15, IMC17-24) has been described  (Gubbels, Wieffer, and 
Striepen 2004; Hu et al. 2006; Anderson-White et al. 2011; Chen et al. 2015). It 
was reported that the IMC proteins show distinct spatiotemporal distribution 
patterns during the tachyzoite development (Anderson-White et al. 2011). For 
instance, IMC15 represents a marker for early daughter cell budding (Anderson-
White et al. 2011). Loss of IMC15 can cause additional daughter buds to form 
within the mother cell (Dubey et al. 2017).  
IMC suture components (ISCs) were identified to localise to the transverse and 
longitudinal alveolar sutures of the IMC (Chen et al. 2015). ISCs were proposed 
to be involved in the establishment and/or maintenance of the tachyzoite shape, 
as parasites lacking ISC3 display aberrant morphology (Chen et al. 2017). Also, 
disruption of ISC3 caused a loss of virulence in mice (Chen et al. 2017). 
 
1.4.1.1 The apicoplast 
The apicoplast, a non-photosynthetic plastid organelle, represents a crucial 
organelle in Toxoplasma tachyzoites. The understanding of apicoplast biology is 
crucial for the data presented in this thesis. Therefore, this organelle shall be 
introduced in more detail in this section.   
The apicoplast was independently described in Toxoplasma in 1996 and 1997 
(McFadden et al. 1996; Kohler et al. 1997). Both studies localised DNA from a 
35kb extrachromosomal DNA circle, originally believed to represent 
mitochondrial DNA (McFadden and Yeh 2017), to a distinct organelle that was 
identified as the apicoplast. The complete sequence of the plastid-DNA in P. 
falciparum showed that the apicoplast lacks genes required for photosynthesis 
(Wilson et al. 1996).  
The apicoplast is believed to be derived from a red algae by secondary 
endosymbiosis (Janouskovec et al. 2010). It was, however, controversially 
debated in the past whether the apicoplast originated from a red or a green 
algae (Wilson 1993; Williamson et al. 1994; Kohler et al. 1997; Funes et al. 2002; 
Cai et al. 2003; Waller et al. 2003; Coppin et al. 2005; Waller and Keeling 2006). 
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The puzzle was solved by the discovery of Chromera velia, a photosynthetic 
relative of the apicomplexan parasite lineage (Moore et al. 2008). C.velia is a 
single cell organism that lives in scleractinian corals. The plastid of C. velia is 
bound by four membranes and shares an origin with the apicoplast. Examination 
of the plastids in C. velia and CCMP3155, another photosynthetic alveolate 
closely related to apicomplexans, revealed that the apicoplast in apicomplexans 
is derived from a red algae (Janouskovec et al. 2010).  
Apicoplast division is coordinated with nucleus replication (Striepen et al. 2000). 
Dividing and non-dividing apicoplasts are associated with the centrosome 
throughout the parasite life cycle (Striepen et al. 2000). It was reported that 
disruption of microtubule formation impacts apicoplast replication (Striepen et 
al. 2000). Proper actin dyncamics are also critical for apicoplast replication and 
segregation  (Andenmatten et al. 2013; Jacot, Daher, and Soldati-Favre 2013; 
Haase et al. 2015; Whitelaw et al. 2017). Disruption of actin dynamics results in 
vacuoles containing parasites devoid of the apicoplast. TgMyoF and TgDrpA 
represent additional key players in apicoplast division. TgMyoF was reported to 
be involved in centrosome positioning and apicoplast inheritance (Jacot, Daher, 
and Soldati-Favre 2013). The dynamin-related protein TgDrpA is critical for 
acpicoplast fission (van Dooren et al. 2009). The enzyme ensures the cutting of 
the dividing apicoplast so that both daughter cells receive one single apicoplast.  
The apicoplast is essential for parasite survival (Roos and Fichera 1997; He et al. 
2001). It is important to note, however, that apicoplast loss does not 
immediately abolish Toxoplasma growth. Parasites usually die within the 2nd lytic 
cycle after apicoplast loss, a phenomenon referred to as the “delayed death 
phenotype” (Roos and Fichera 1997; He et al. 2001). Intriguingly, as long as one 
parasite within the vacuole possesses an apicoplast, the vacuole as a whole 
shows almost normal growth even in the 2nd lytic cycle (He et al. 2001). This 
shows that one single apicoplast can keep a whole vacuole of parasites alive.  
The apicoplast hosts fatty acid synthesis via the FASII pathway (Waller et al. 
1998; Ramakrishnan et al. 2012) and synthesis of isopentenyl pyrophosphate 
(IPP) which is a precursor of isoprenoids (Jomaa et al. 1999; Nair et al. 2011). It 
is further believed that the apicoplast is involved in the synthesis of iron sulphur 
clusters (Kumar et al. 2011; Gisselberg et al. 2013; Geoffrey Ian McFadden and 
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Yeh 2017) and haem synthesis (Sato et al. 2004; Dhanasekaran et al. 2004; 
Nagaraj et al. 2008, 2009; Goldberg and Sigala 2017). In Plasmodium, asexual 
blood stage parasites that are lacking the apicoplast can survive indefinitely 
when supplemented with exogenous IPP (Yeh and DeRisi 2011). This makes IPP 
synthesis the only essential apicoplast function in malaria blood stages. Lack of 
isoprenoid precursors was suggested to interfere with protein prenylation and 
cellular vesicle trafficking, resulting in the fragmentation of the digestive 
vacuole in parasites experiencing delayed death (Kennedy et al. 2019). 
 
1.4.2 Gliding motility 
Experiments with tachyzoites in 2D identified three distinct types of movement: 
circular gliding, upright twirling and helical rotation (Hakansson et al. 1999). 
More recently, tachyzoite gliding was analysed in a more biologically relevant 3D 
environment (Leung et al. 2014). These experiments revealed that tachyzoites 
move in irregular corkscrew-like trajectories. It was suggested that the different 
gliding styles that were observed in 2D reflect the different types of movement 
that are necessary to perform corkscrew-like trajectories in 3D (Leung et al. 
2014; Frénal, Dubremetz, et al. 2017). 
The key concept of apicomplexan motility is the gliding on a surface which 
requires cell-cell contact between gliding parasite and substrate (Figure 1-4). 
This presents a remarkable feature as parasites do not utilise ciliary or flagellar 
propulsion as is often the case in unicellular organisms. The exact mechanisms 
by which this type of forward movement is achieved are currently under 
investigation. One of the proposed models is the so-called actomyosin motor 
complex. This complex consists, among other factors, of the structural protein 
actin and MyosinA (MyoA). Another key player are the micronemes, a set of 
secretory organelles (Frénal, Dubremetz, et al. 2017). 
In brief, the proposed mode of action of the actomyosin motor complex is 
depicted in the following (Frénal, Dubremetz, et al. 2017): The MyoA tail domain 
is linked to the IMC via MLC1 while the MyoA head interacts with actin filaments 
between the IMC and the parasite plasma membrane. This complex is kept in 
place by the gliding-associated proteins (GAPs), GAP40, GAP45 and GAP50. When 
32 
 
gliding is initiated, micronemes are exocytosed at the apical tip of the 
tachyzoite and adhesion molecules are integrated into the parasite plasma 
membrane. These adhesins span the plasma membrane and interact with 
receptor molecules on the substrate surface outside the parasite.  The actin 
filaments are connected to adhesins via a glideosome-associated connector 
(GAC). Overall, this molecular set up anchors the actin-myosin motor to the IMC 
and, at the same time, the outside surface of the substrate. This allows MyoA- 
mediated force generation by translocation of actin filaments alongside the 
tachyzoite periphery towards the basal end of the parasite. 
 
Figure 1-4: Gliding motility in Toxoplasma tachyzoites 
Tachyzoite movement on a host cell plasma membrane (hPM) requires contact between 
the gliding parasite and the substrate. Forward movement is achieved by the actomyosin 
motor complex. This complex consists, among other factors, of the structural protein actin 
and MyosinA (MyoA). Another key player are the micronemes, a set of secretory 
organelles. MyoA is linked to the IMC and interacts with actin filaments between the IMC 
33 
 
and the parasite plasma membrane (pPM). When gliding is initiated, micronemes are 
exocytosed at the apical tip of the tachyzoite and adhesion molecules are integrated into 
the pPM. These adhesins span the pPM and interact with receptor molecules on the hPM. 
Forward movement is achieved by MyoA-mediated translocation of actin filaments 
alongside the tachyzoite periphery towards the basal end of the parasite. Abbreviations: 
IMC - inner membrane complex; pPM - parasite plasma membrane; hPM - host plasma 
membrane. Reprinted by permission from Springer Nature Customer Service Centre 
GmbH: Springer Nature, Nature Reviews Microbiology (Frénal, Dubremetz, et al. 2017) 
©2017, License number: 4638730100889.  
 
Numerous studies were conducted to support the current view of the actomyosin 
system and its components.  Myosin A was reported to possess kinetic properties 
similar to myosins in muscle cells, thus explaining its capacity in generating 
force together with actin (Herm-Götz et al. 2002). The same study identified 
myosin light chain (MLC1) to bind MyoA (Herm-Götz et al. 2002). In addition, 
Myosin A was  found to be essential for parasite gliding and invasion (Meissner, 
Schlüter, and Soldati 2002).  
The gliding associated proteins GAP45 and 50 were identified and localised to 
the IMC (Gaskins et al. 2004). Subsequently, GAP40 was identified and GAP45 
was further characterised to be essential for motility, egress and invasion 
(Frénal et al. 2010). Recently, GAC was proposed to connect the actomyosin 
complex with micronemal adhesins (Jacot et al. 2016). GAC appears to be 
critical for gliding, egress and invasion. Interestingly, experimental data suggest 
actin stabilising properties for GAC (Jacot et al. 2016). Noteworthy, experiments 
were performed on Plasmodium falciparum actin, not Toxoplasma actin.  
Several adhesion molecules are known to function in Toxoplasma (Paing and 
Tolia 2014; Frénal, Dubremetz, et al. 2017). For instance, loss of the microneme 
protein MIC2 negatively impacted tachyzoite attachment to the host cell surface 
and reduced helical gliding movements in 2D assays (Huynh and Carruthers 
2006). 
In summary, these studies highlight the importance of this complex for the lytic 
cycle and overall parasite morphology. Nevertheless, it is still debated whether 
the actomyosin system is exclusively responsible for parasite gliding and 
invasion. Some of the proposed actomyosin motor complex components were 
suggested to be dispensable as clonal tachyzoite lines lacking the myoA or mic2 
gene were able to survive (Andenmatten et al. 2013). Although lack of MIC2 
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impacted overall motility, clonal mic2 knock-out parasites were still able to 
perform gliding at the same maximum speed as wild-type parasites (Gras et al. 
2017). Taken together, these observations could suggest an alternative gliding 
and invasion mechanism. Conditional depletions of other components of the 
actomyosin system support the existence of such an alternative system (Egarter 
et al. 2014; Whitelaw et al. 2017).  Whitelaw and co-workers suggested a role 
for the actomyosin complex in surface attachment, rather than force generation 
during parasite gliding (Whitelaw et al. 2017). A recent study suggested 
retrograde membrane flow as a driving force for tachyzoite gliding motility (Gras 
et al. 2019). Gras and colleagues reported that extracellular parasites are 
capable of taking up exogenous material such as labelled lipids. After uptake, 
these lipids appear to be secreted again upon activation of gliding motility 
during attachment and invasion (Gras et al. 2019). Based on these findings, the 
authors proposed the existence of an endocytosis-secretion cycle in Toxoplasma. 
Furthermore, fluorescent microscopy and transmission electron microscopy 
(TEM) provide evidence that extracellular parasites are capable of endocytosing 
surface proteins (e.g. SAG1) (Gras et al. 2019). This observation indicates that 
membrane recycling occurs in Toxoplasma. Based on these findings, a retrograde 
membrane flow (fountain flow model) was suggested to be involved in 
movement generation in Toxoplasma (Figure 1-5). Bead translocation 
experiments indicated that the retrograde membrane flow occurs independently 
from the actomyosin motor complex (Whitelaw et al. 2017; Gras et al. 2019). It 
was further hypothesized that the membrane flow and the actomyosin motor 
complex might work together to enable parasite movement (Gras et al. 2019).  
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Figure 1-5: Cartoon depicting the involvement of the retrograde membrane 
flow (fountain-flow model) in Toxoplasma motility 
The endocytic-secretory cycle (1-5) generates retrograde membrane flow and maintains 
membrane volume. Several steps occur during the endocytic-secretory cycle: (1) 
Secretion of secretory organelles, (2) retrograde membrane flow, (3) membrane recycling 
or (3`) trail deposition and (4,5) trafficking of recycled lipids and secretory organelles back 
to the secretory organelles. Reprinted from PLOS Biology (Gras et al. 2019) under the  
Creative Commons Attribution 4.0 International License. 
 
1.4.3 Invasion 
Successful host cell invasion relies on (1) attachment to the host cell, (2) 
secretion of microneme content, (3) reorientation so that apical tip of 
tachyzoite faces the host cell, (4) rhoptry secretion and finally (5) motility-
driven propulsion of the parasite into the host cell (Frénal, Dubremetz, et al. 
2017). 
It is important to note that the invasion process relies on parasite motility. To 
exploit the actomyosin system for host cell invasion, the parasite has to be 
firmly anchored to the host cell membrane. Tachyzoites achieve this by 
establishing a structure referred to as the moving junction (MJ). In brief, the MJ 
is formed by exocytosis of the micronemal protein AMA1 to the parasites 
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surface. In addition, rhoptry proteins including RON2 are secreted and inserted 
into the host cell surface, acting as a receptor for AMA1. AMA1 is linked to the 
actomyoisn motor, thus allowing force transduction to propel the parasite into 
the host cell (Besteiro, Dubremetz, and Lebrun 2011; Frénal, Dubremetz, et al. 
2017). 
In Toxoplasma,  AMA1 was reported to localise to the micronemes and to be 
secreted by extracellular tachyzoites, with calcium strongly increasing secretion 
(Donahue et al. 2000). AMA1 was first linked to invasion by Hehl and co-workers 
based on the reduction of parasite invasion after treatment with antiserum 
against AMA1 (Hehl et al. 2000). In addition, this study confirmed that AMA1 
localises to the micronemes in intracellular parasites and that AMA1 is secreted 
by extracellular parasites. Conditional depletion of AMA1 strongly impaired 
tachyzoite invasion while overall motility appeared unaffected in a 2D gliding 
assay (Mital et al. 2005). This presented further evidence for AMA1 to be 
specifically involved in host cell invasion. AMA1 was also suggested to be 
involved in the rhoptry secretion process (Mital et al. 2005). 
The rhoptry proteins RON2, 4, 5 and 8 are present at the MJ (Besteiro et al. 
2009).  While RON4, 5 and 8 were suggested to be exposed to the host cell 
cytoplasm (Besteiro et al. 2009), RON2 was proposed to be a transmembrane 
protein with parts of the protein being present on both sides of the host cell 
membrane (Lamarque et al. 2011). An interaction between RON2 and AMA1 was 
suggested by metabolic labelling and immunoprecipitation (Besteiro et al. 2009). 
This interaction was later supported in vivo on the surface of extracellular 
parasites amongst other binding assays (Lamarque et al. 2011).  
Although the MJ junction model is based on numerous publications, the exact 
mechanism underlying Toxoplasma invasion is still controversially debated. For 
instance, AMA1 was suggested to play a critical role in attachment of the 
tachyzoite to the host cell surface, but to be dispensable for MJ formation 
(Giovannini et al. 2011; Bargieri et al. 2013). Strikingly, a clonal AMA1 null 
mutant was able to survive in culture displaying reduced host cell invasion 
(Bargieri et al. 2013). Although reduced in numbers, observed invasion events 
for this strain showed similar kinetics to wild-type parasites. Based on this, AMA1 
was proposed to be involved in host cell attachment, but not directly in the 
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invasion process. Another study offered redundancy in AMA and RON proteins as 
possible explanation for the residual invasion in AMA1 null mutants (Lamarque et 
al. 2014). Specifically, AMA2 and AMA4 (together with RON2L1) were suggested to 
functionally compensate in the absence of AMA1.  
All in all, it would appear that many details of the tachyzoite invasion process 
remain to be elucidated. This becomes apparent with the description of a novel 
RON protein, RON4L1 that appears to be a member of the 
AMA1/RON2/RON4/RON5/RON8 complex (Guérin et al. 2017). RON4L1 faces the 
host cytoplasm of the MJ. RON4L1 is not critical for parasite growth in culture. 
However, a slightly decreased virulence in mice was observed upon RON4L1 
depletion. 
When invading the host cell, tachyzoites engulf themselves in a parasitophorous 
vacuole (PV).  Once the parasite has fully entered the host, the PV is pinched off 
via a fission pore (Suss-Toby, Zimmerberg, and Ward 1996). This closes the PV 
and creates and extra compartment for the parasite to replicate. The PV is 
established by invagination of the host cell membrane so that most, if not all, of 
the PV membrane (PVM) is derived from the host (Suss-Toby, Zimmerberg, and 
Ward 1996). Importantly, host transmembrane proteins are excluded from the 
PVM at the MJ during invasion, rendering the PV nonfusogenic (Mordue et al. 
1999; Clough and Frickel 2017).  Thus, the PV avoids the host cell lysosomal 
system. 
The PV creates a closed compartment for the parasite by presenting a physical 
barrier to the host cell cytoplasm. Nevertheless, the PVM allows for small 
molecule exchange between the PV and the host cell cytoplasm (Schwab, 
Beckers, and Joiner 1994; Gold et al. 2015), granting the parasites access to 
essential nutrients from the host. Noteworthy, the PVM is the structure that is 
recognized by the host immune system.  This makes the PV a place of high host-
parasite interaction. While the host employs mechanisms to kill Toxoplasma, the 
parasite combats these efforts to guarantee its own survival (Clough and Frickel 
2017). 
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1.4.4 Asexual replication 
Asexual replication of Toxoplasma tachyzoites within the PV happens via 
endodyogeny (Goldman, Carver, and Sulzer 1958; Sheffield and Melton 1968). In 
this mode of replication, two daughter cells bud within the mother cell, which is 
destroyed at the end of this process. The budding daughter cells IMCs are formed 
on the apical side from the maternal nucleus. The daughter cells take up 
organelles through their open basal end (Goldman, Carver, and Sulzer 1958; 
Sheffield and Melton 1968; Hu et al. 2002).  
An extensive study by Nishi and colleagues provided a detailed timetable for 
daughter cell formation and organelle distribution (Nishi et al. 2008). When the 
daughter cells continue to grow, they first receive the divided Golgi and 
apicoplast. The nucleus, ER and the mitochondrion follow. Micronemes and 
rhoptries are synthesised de novo within the forming daughter cells. In total, this 
process takes about 6 hours to complete. Hence, every 6 hours, the parasite 
burden within a hot cell doubles. As the daughter cells continue to enlarge, they 
eventually fill out the entire mother cell.  At this point the maternal IMC 
disappears and the two daughter cells are engulfed by the maternal plasma 
membrane (Sheffield and Melton 1968). Photobleach and Photoactivation studies 
revealed that the daughter IMC is initially synthesised de novo and later 
supplemented with recycled maternal IMC (Ouologuem and Roos 2014). 
Noteworthy, Periz and co-workers recently reported that micronemes, in 
addition to being synthesized de novo, can also be recycled from the mother to 
the daughter cells (Periz et al. 2019). 
The centrosome was identified as platform for daughter cell budding in 
replicating tachyzoites (Chen and Gubbels 2013).  Together with the replication 
of the Golgi apparatus and the apicoplast,  centrosome division is among the 
first observable steps of endodyogeny in Toxoplasma (Hu et al. 2002; Hartmann 
et al. 2006; Nishi et al. 2008). Two centrosomes become visible near the nucleus 
before the start of the daughter IMC budding. Centrosome division starts with 
the re-localisation of the centrosome from the apical site of the nucleus to the 
basal site of the nucleus. After division, the two centrosomes migrate back to 
their apical position (Hartmann et al. 2006). More in depth analysis revealed that 
the centrosome is made up of two cores, the inner and the outer core (Suvorova 
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et al. 2015).  Interestingly, the two cores seem to fulfil independent functions 
during endodyogeny. The outer core is critical for daughter cell budding, while 
the inner core is involved in nuclear division. It was reported that cells that lack 
the outer core components do not show any daughter buds, but are still capable 
of dividing the nucleus (Suvorova et al. 2015). 
Within the PV, tachyzoites grow in a rosette-like organisation with individual 
parasites being attached  to a common residual body with their basal end 
(Dubey, Lindsay, and Speer 1998; Muniz-Hernández et al. 2011). The residual 
body was suggested to be involved in establishing the rosette formation (Muniz-
Hernández et al. 2011). Work published by Periz and co-workers suggested that 
vesicular trafficking occurs through the residual body between individual 
parasites  (Periz et al. 2017). This finding was subsequently supported by 
experimental data from Frénal and co-workers indicating that the residual body 
connects the cytoplasm of all parasites within a vacuole, allowing for molecule 
transport between individual parasites (Frénal, Jacot, et al. 2017). The residual 
body also harbours acidocalcisomes which contain calcium (Attias, Miranda, and 
De Souza 2019). This observation gave rise to hypothesis that the residual body 
might be involved in the egress process in which Calcium-signalling is involved as 
a requirement for microneme secretion (Blader et al. 2015) (see section 1.4.5). 
Together, these findings indicate that the residual body fulfils specific functions 
during the asexual life cycle. 
 
1.4.5 Egress 
There are several reasons for tachyzoites to initiate egress from their host cell 
(Blader et al. 2015).  For instance, the host cell immune response or damage to 
the host cell can trigger parasite egress. In the absence of abiotic factors 
impacting egress, a potential quorum sensing mechanism might initiate egress 
when a certain tachyzoite density is reached in the host cell (Blader et al. 2015).  
As egress from the host cell relies on parasite mobility (gliding),  microneme 
secretion is a critical requirement for this process (Blader et al. 2015).  A 
complex network of multiple factors is believed to be involved in the process of 
microneme secretion (Bullen, Bisio, and Soldati-Favre 2019). Roughly, the model 
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suggests that, prior to microneme secretion, the signalling molecule inositol 
1,4,5-triphosphate (IP3) mediates calcium release from the ER. Elevated calcium 
levels activate calcium-dependent protein kinases (CDPKs), which are critical for 
microneme secretion. At the same time, the phospholipid Phosphatidic Acid (PA) 
is integrated into the parasite plasma membrane. PA is recognised by the 
acylated pleckstrin homology (PH) domain-containing protein (APH). APH is 
anchored to the microneme and acts as PA sensor, allowing for microneme 
exocytosis.  
The critical role of calcium in Toxoplasma egress was first and described in 1982 
(Endo, Sethi, and Piekarski 1982). CDPK1 is essential for calcium dependent 
microneme secretion (Lourido et al. 2010). The kinase was shown to play a 
significant role in gliding motility, invasion and egress. Interestingly, CDPK3 is 
dispensable for invasion, but required for egress and gliding motility (Lourido, 
Tang, and Sibley 2012). Noteworthy, microneme secretion appeared only 
dependent on CDPK3 when calcium was used to initiate secretion.  In contrast to 
this, microneme exocytosis relies on CDPK1 regardless of the applied initiator 
substance (calcium or ethanol) (Lourido, Tang, and Sibley 2012). These data 
indicate that Toxoplasma utilises distinct signalling pathways for triggering 
microneme secretion. Another study confirmed the critical role for CDPK3 in 
calcium-mediated egress, but not invasion (McCoy et al. 2012). Interestingly, 
this study did not observe any impact of CDPK3 depletion on overall parasite 
motility. McCoy and colleagues further reported that CDPK3 depletion had no 
effect on microneme secretion in extracellular parasites (McCoy et al. 2012). 
This strengthens the view that CDPK3 is exclusively involved in egress of 
intracellular parasites. A forward screen also identified CDPK3 as important for 
rapid egress of intracellular parasites (Garrison et al. 2012). Gaji and colleagues 
reported phosphorylation of TgMyoA as function of TgCDPK3 during parasite 
egress (Gaji et al. 2015). TgCDPK3-dependent phosphorylation of TgMyoA 
appeared important for egress and motility as shown by 2D motility assays 
exploiting TgCDPK3 mutants and TgMyoA phosphorylation mutants.  
APH was recently identified by Bullen and co-workers (Bullen et al. 2016). APH 
was localised to the micronemes and its depletion impaired parasite egress. 
Experiments performed by Bullen and colleagues suggested APH binding to PA. It 
was further reported that APH is highly selective for PA (Darvill et al. 2018). 
41 
 
Darvill and colleagues identified two major PA binding sites within the APH 
domain. This causes APH to bind to more than one PA molecule.  
The involvement of IP3 in calcium release in Toxoplasma was suggested to be 
based on the negative impact of an IP3 receptor antagonist on microneme 
secretion, invasion and attachment (Lovett et al. 2002). Based on these findings 
the phosphoinositide-specific phospholipase (PLC) was suggested to be involved 
in IP3 synthesis. Indirect evidence for PLC involvement had previously been 
provided by a study showing that a PLC-inhibitor blocks parasite egress (Moudy, 
Manning, and Beckers 2001). PI-PLC was first characterised in Toxoplasma in 
2006 (Fang, Marchesini, and Moreno 2006) and later described as critical to the 
lytic cycle (Bullen et al. 2016). 
Calcium release does not only initiate motility for egress, but also the release of 
the perforin-like protein 1 (PLP1) (Kafsack et al. 2009). PLP1 was reported to be 
released from micronemes and to mediate pore formation in the PVM. Depletion 
of PLP1 heavily impaired the parasite ability to escape the PV.  The 
lecithin:cholesterol acyltransferase (LCAT) is also involved in enabling parasite 
egress (Pszenny et al. 2016). Upon secretion from intracellular parasites, this 
dense granule enzyme localises to the lumen of the PV. Pszenny and co-workers 
proposed that the membrane-remodelling properties of LCAT could benefit the 
egress process by supporting parasite escape from the host cell. LCAT depleted 
parasites also depicted a slower growth rate and reduced virulence in mice. A 
follow-up study confirmed the involvement of LCAT in parasite egress, but failed 
to reproduce its importance for growth in culture and virulence in mice (Schultz 
and Carruthers 2018). 
Overall, calcium-dependent motility plays a critical role in the completion of the 
lytic life cycle as it is crucial for invasion and egress. Distinct signalling pathways 
appear to exist in Toxoplasma for enabling calcium release in different 
scenarios.  
The final stage of the lytic cycle is the differentiation of tachyzoites into 
bradyzoites residing in tissue cysts (White, Radke, and Radke 2014). Bradyzoites 
are very similar to tachyzoites in structure and tissue cysts can persist in a host 
for life  (Dubey, Lindsay, and Speer 1998). It was proposed that bradyzoites are 
42 
 
non-replicative (Radke et al. 2003). However, more recent data suggested active 
endodyogeny to occur in bradyzoites (Watts et al. 2015).  
 
1.5 Molecular Tools to dissect Toxoplasma biology 
The haploid nature of the tachyzoite genome allows for genetically modification 
of genes with relative ease. Since the permanent loss of some genes is 
detrimental to the parasite, conditional systems are required to explore the 
function of these essential genes. In Toxoplasma, gene function can be 
conditionally controlled on the genomic level, the transcriptional level and the 
protein level (Meissner et al. 2007; Jiménez-Ruiz et al. 2014). 
Gene transcription can be regulated with the tetracycline inducible 
transactivator system which was first exploited to describe the function of MyoA 
in Toxoplasma (Meissner, Schlüter, and Soldati 2002). In this system the 
transactivator TATi is constitutively expressed in tachyzoite parasites. The 
parasites were modified to encode for an additional copy of myoA (myoA-i) 
under the control of a so-called Tet-promoter. After the introduction of the 
extra myoA-i copy, the endogenous myoA gene was deleted. The Tet-promoter 
remains active only in the presence of TATi. Gene translation can be suppressed 
by adding anhydrotetracycline (ATc) which sequesters TATi, thus preventing its 
binding to the Tet-promoter. Due to the inactivity of the Tet-promoter, the 
myoA-i gene is not translated resulting in a gene knock-down. Further 
adaptation of the system by Sheiner and colleagues allows for direct 
replacement of the endogenous promoter of the gene of interest (GOI) with the 
Tet-promoter (Sheiner et al. 2011).  This was achieved by generating a parental 
TATi-Δku80 line that allows for reliable promoter replacement by double 
homologous recombination. By exploiting the transactivator TRAD4, the 
transactivator system was also successfully used for studying essential 
Plasmodium genes (Pino et al. 2012).   
Protein stability can be regulated by fusing the protein of interest to a 
destabilisation (ddFKBP) domain. The ddFKBP domain was shown to cause rapid 
protein degradation in mammalian cells (Banaszynski et al. 2006). The authors 
were able to prevent ddFKBP-mediated protein degradation by culturing the 
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cells with Shld-1, the ligand for ddFKBP, in a reversible fashion. This technology 
was adapted for Toxoplasma (Herm-Götz et al. 2007) and Plasmodium 
(Armstrong and Goldberg 2007). Another system that enables conditional protein 
degradation in Toxoplasma is the auxin-inducible degron (AID) system (Brown, 
Long, and Sibley 2017; Brown, Long, and Sibley 2018). The system was first 
described in yeast, chicken and mammalian cells (Nishimura et al. 2009). It has 
also found application in Plasmodium falciparum (Kreidenweiss, Hopkins, and 
Mordmüller 2013) and Plasmodium berghei (Philip and Waters 2015). In brief, 
the protein of interest (POI) is tagged with the AID sequence. Addition of auxin 
promotes binding of the E3 ubiquitin ligase TIR to AID, resulting in POI 
degradation. Since the auxin-dependent degradation machinery, including TIR, is 
derived from plants (Teale, Paponov, and Palme 2006; Leyser 2018), the E3 
ubiquitin ligase TIR has to be expressed in the respective organism for the 
system to function (Kreidenweiss, Hopkins, and Mordmüller 2013; Philip and 
Waters 2015; K. M. Brown, Long, and Sibley 2017; K. Brown, Long, and Sibley 
2018).  
Conditional gene depletion (knock-out) via the DiCre system was made available 
in Toxoplasma in 2013 (Andenmatten et al. 2013). In this system, the Cre-
recombinase is split into two subunits which are fused to the rapamycin binding 
domains FKBP and FRB. Both subunits are expressed in the parasite. The GOI is 
flanked with two loxP sites. Upon rapamycin treatment, these two DiCre 
domains are brought together and the recombinase resumes activity, excising 
the DNA sequence between the loxP sites. The use of an YFP reporter gene 
downstream the loxP site indicates successful excision of the target gene. The 
DiCre system was originally described in mammalian cells (Jullien et al. 2003) 
and in mice (Jullien et al. 2007).   
 
1.5.1 The type II CRISPR/Cas9 system  
The CRISPR/Cas9 system (CRSIPR: clustered regularly interspaced short 
palindromic repeats) was recently introduced as a novel tool for genomic editing 
in various organisms. In this system, an endonuclease is guided by a guide RNA 
(gRNA) to the genomic DNA sequence complementary to the gRNA. The 
endonuclease then cleaves the double-stranded DNA (dsDNA) leading to gene 
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disruption by small insertions or deletions of nucleotides (Doudna and 
Charpentier 2014; Hartenian and Doench 2015; Jiang and Doudna 2017). The 
CRISPR-Cas9 system naturally occurs in prokaryotes where it acts as an adaptive 
immune system that protects the organism from foreign DNA, e.g. 
bacteriophages (Figure 1-6). DNA sequences encoding gRNAs are present in the 
prokaryotic genome as clustered regularly interspaced short palindromic repeats 
(CRISPRs) (Doudna and Charpentier 2014; Hartenian and Doench 2015; Jiang and 
Doudna 2017). 
 
Figure 1-6: The type II CRISPR/Cas9 system in prokaryotes 
The CRISPR-Cas9 system acts as an adaptive immune system that protects prokaryotes from 
foreign DNA, e.g. bacteriophages. The cas operon codes for the Cas9 endonuclease as well 
as additional Cas proteins. The CRISPR array contains the spacer sequences that are 
acquired from foreign DNA. Activity of the type II CRISPR/Cas9 system relies on the 
transcription of the CRISPR repeats.  The spacers mature into CRISPR RNAs (crRNAs) and 
hybridise with the trans-activating crRNA (tracrRNA). This RNA hybrid molecule associated 
with the Cas9 endonuclease. The crRNA then guides the complex to its complementary DNA 
sequence which will be cut by Cas9. Importantly, a protospacer adjacent motif (PAM) is critical 
for DNA cleavage to occur. Republished with permission of Annual Reviews (Annual Reviews 
of Biophysics), from (Jiang and Doudna 2017) © 2017; permission conveyed through 
Copyright Clearance Center, Inc. License number: 4638781404178. 
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CRISPRs were first described in E. coli in 1987 as repeats of unknown function 
(Ishino et al. 1987). Subsequently, the term CRISPR was proposed (Jansen et al. 
2002). Jansen and co-workers also reported the presence of CRISPR-associated 
(Cas) genes adjacent to the CRISPR loci. CRISPR systems are characterized based 
on, amongst other factors, their respective protein-coding Cas genes (Makarova 
et al. 2011; Makarova, Wolf, and Koonin 2018). They are categorized into two 
major classes consisting of six different types of CRISPR systems (types I - VI) 
(Makarova, Wolf, and Koonin 2018). 
Activity of the type II CRISPR/Cas9 system relies on the transcription of 
palindromic repeats which, subsequently, get cut into individual CRISPR RNAs 
(crRNAs) (Figure 1-6). The hybridization of a crRNA with a so-called trans-
activating crRNA (tracrRNA) is followed by the association of this RNA hybrid 
molecule to the Cas9 endonuclease. The crRNA then guides the complex to its 
complementary DNA sequence which will be cut by Cas9 (Doudna and 
Charpentier 2014; Hartenian and Doench 2015; Jiang and Doudna 2017). 
Although the CRISPR system type II encodes for additional proteins, the Cas9 
endonuclease was reported to be the only enzyme necessary for DNA cleavage 
(Sapranauskas et al. 2011). Two independent studies showed that Cas9 is an 
RNA-guided endonuclease (Gasiunas et al. 2012; Jinek et al. 2012). The RNA 
confers site-specific DNA cleavage as only DNA sequences complementary to the 
guide RNA are cleaved (Gasiunas et al. 2012; Jinek et al. 2012). Moreover, Jinek 
and co-workers succeeded in fusing the crRNA and tracrRNA to one chimeric RNA 
molecule (Jinek et al. 2012). This chimeric DNA together with Cas9 proved to be 
programmable for cleaving specific DNA sequences such as gfp (Jinek et al. 
2012). The Cas9 enzyme possesses two nuclease domains, HCH and RuvC-like 
(Sapranauskas et al. 2011; Gasiunas et al. 2012; Jinek et al. 2012). Each of the 
two nuclease domains cleaves one of the two opposite DNA strands (Figure 1-7) 
(Gasiunas et al. 2012; Jinek et al. 2012).  
Of relevance, the Streptococcus pyogenes type II Cas9 system requires a 
protospacer adjacent motif (PAM) for DNA cleavage to occur (Jinek et al. 2012). 
This PAM sequence is proximal to the target DNA sequence and its sequence is 
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NGG (Jinek et al. 2012). It was reported that Cas9 cleaves DNA three nucleotides 
upstream of the PAM sequence (Gasiunas et al. 2012; Jinek et al. 2012). 
 
Figure 1-7: Schematic of the sgRNA-mediated gene specificity of the type II 
CRISPR/Cas9 system 
Fusing of the crRNA and tracrRNA to one single guide RNA (sgRNA) via a linker 
sequence enables Cas9-mediated gene targeting. Each of the two Cas9 endonuclease 
domains, HCH and RuvC, cleaves one of the two opposite DNA strands. The protospacer 
adjacent motif (PAM) sequence is proximal to the target DNA sequence and, for the type 
II CRISPR/Cas9 system, its sequence is NGG. Cas9-mediated DNA cleavage occurs 
three nucleotides upstream of the PAM sequence. Reprinted by permission from John 
Wiley & Sons, Inc.: John Wiley and Sons, FEBS Journal (Hartenian and Doench 2015) 
©2015. License number: 4638770871847. 
 
Taken together, the type II CRISPR/Cas9 system presents a convenient 
application for gene modifications in other organisms. Only one recombinant 
enzyme together with one chimeric gRNA should be sufficient for gene 
disruption. Indeed, the type II CRISPR/Cas9 system was successfully applied for 
genome editing purposes in various organisms, including human cells (Jinek et 
al. 2013; Mali et al. 2013), woody plants (Fan et al. 2015), beetles (Gilles, 
Schinko, and Averof 2015) and rabbits (Yan et al. 2014). Furthermore, the 
CRISPR/Cas9 technology enables genome wide screens in mammalian cells 
(Shalem et al. 2014; Wang et al. 2014; Jiang et al. 2019; Korkmaz et al. 2019). In 
Toxoplasma, the CRISPR/Cas9 was shown to be effective for single target gene 
disruption and site-specific insertions (Shen et al. 2014; Sidik et al. 2014). In 
47 
 
2016, a genome-wide CRISPR/Cas9 screen identified novel fitness-conferring 
genes in Toxoplasma (Sidik et al. 2016; Sidik, Huet, and Lourido 2018).   
Various efforts have been made to exploit the CRISPR/Cas9 as conditional system 
(Zhou and Deiters 2016).  For instance, different approaches exploiting the split-
Cas9 concept have been reported in mammalian cells (Nihongaki et al. 2015; 
Truong et al. 2015; Wright et al. 2015; Zetsche, Volz, and Zhang 2015; Schmelas 
and Grimm 2018). For this concept, the Cas9 enzyme is split into its N- and C-
terminus which allows for different ways of promoting sub-unit reunion. In two 
independent studies, the sub-units were linked to fusion proteins which can be 
induced to promote reunion of the N- and C-terminus, resulting in Cas9 activity. 
Nihongaki and co-workers exploited photo-inducible dimerization domains that 
promote Cas9 activity in response to blue light (Nihongaki et al. 2015). Zetsche 
and colleagues used the rapamycin-binding domains FRB and FKBP12 to enable 
conditional Cas9 activity (Zetsche, Volz, and Zhang 2015). In Toxoplasma, a 
conditional nuclear Cas9 fused to ddFKBP was described and applied to identify 
factors involved in the nuclear export of RNA (Serpeloni et al. 2016). 
 
1.6 Actin in eukaryotes 
1.6.1 Structure of actin monomers and filaments 
The structural protein actin is highly abundant and conserved in eukaryotic cells 
(Baum et al. 2006; Pollard and Cooper 2009; Pollard 2016). Actin fulfils various 
critical functions within eukaryotic cells including cytokinesis, cargo trafficking 
and cellular motility (Pollard and Cooper 2009). In a eukaryotic cell, actin occurs 
in two different states, the globular (G-actin) and filamentous (F-actin) form 
(Baum et al. 2006; Pollard and Cooper 2009; Dominguez and Holmes 2011).  
The atomic structure of monomeric G-actin was first described in 1990, 
revealing that  the G-actin protein consists of 4 subdomains  (Kabsch et al. 
1990). G-actin binds ATP or ADP in the cleft between the subdomains 2 and 4 
(Kabsch et al. 1990; Otterbein, Graceffa, and Dominguez 2001). It was reported 
that G-actin-ATP and G-actin-ADP show conformational differences in subdomain 
2 (Otterbein, Graceffa, and Dominguez 2001; Graceffa and Dominguez 2003).  
48 
 
G-actin monomers can polymerise to form F-actin. Electron microscopy in 1963 
proposed that F-actin consists of two actin strands that intertwine to form a 
right-handed helical filament (Hanson and Lowy 1963). More recently, the F-
actin structure was described by cryo-electron microscopy (Fujii et al. 2010). 
Based on these data, it was suggested that the F-actin structure actually 
represents a single left-handed helix (Dominguez and Holmes 2011). Dominguez 
and Holmes argued that, since the twist per actin molecule is -166° (close to -
180°), the F-actin filament structure only appears like two strands that slowly 
turn in a right-handed fashion. Hence, the F-actin structure can either be 
described as a two-start right-handed helix or a single-start left-handed helix.   
One critical factor for the transition between G-actin and F-actin (actin 
treadmilling) is the hydrolysis of ATP (Figure 1-8) (Korn, Carlier, and Pantaloni 
1987; Baum et al. 2006). The actin treadmilling cycle starts with the addition of 
G-actin-ATP to “barbed” (plus) end of the F-actin filament. During this 
polymerisation step, ATP is hydrolysed to ADP and inorganic phosphate (Pi). 
Hydrolysis of ATP results in stable F-actin filaments with bound ADP+Pi (F-actin-
ADP-Pi). Slow release of Pi results in F-actin-ADP and destabilises the filament, 
resulting in the release of G-actin-ADP from the F-actin filament. In a growing F-
actin strand, F-actin-ADP accumulates at the “pointed” (minus) end where the 
depolymerisation of G-actin-ADP occurs.  Subsequently, ADP can be replaced 
with ATP, generating a new G-actin-ATP molecule. It was suggested that the 
addition of a new G-actin-ATP molecule to the F-actin barbed end causes a 
conformational change in the adjacent actin molecule (Murakami et al. 2010). 
Murakami and co-workers proposed this structural change to initiate ATP 
hydrolysis. 
Of relevance, the amount of monomeric G-actin has to be above a certain 
threshold for polymerisation to occur. This threshold is referred to as the critical 
concentration. All G-actin monomers above this concentration are available for 
polymerisation (Pollard and Borisy 2003). Importantly, the critical concentration 
for polymerisation to happen at the barbed end is lower than the concentration 
needed to allow for polymerisation at the pointed end (Pollard and Borisy 2003; 
Pollard 2016). It should also be mentioned that the critical concentration needed 
for G-actin-ATP to polymerise was reported to be lower than the concentration 
required for G-actin-ADP (Cooke 1975; Pollard 1984). This means that actin 
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polymerisation is more likely to happen at the barbed end of an F-actin strand 
by attaching G-actin-ATP monomers.  
 
Figure 1-8: Actin treadmilling in eukaryotes 
F-actin filaments are dynamic structures that can undergo growth and shrinkage by 
addition or disassociation of actin monomers, respectively. The actin treadmilling cycle 
starts with the addition of G-actin-ATP to “barbed” (+) end of the F-actin filament. During 
this polymerisation step, ATP is hydrolysed to ADP and inorganic phosphate (Pi). 
Hydrolysis of ATP results in stable F-actin filaments with bound ADP+Pi (Actin-ADP-Pi). 
Slow release of Pi results in Actin-ADP and destabilises the filament, resulting in the 
release of Actin-ADP from the F-actin filament. In a growing F-actin strand, Actin-ADP 
accumulates at the “pointed” (-) end where the depolymerisation occurs.  Subsequently, 
ADP can be replaced with ATP, generating a new Actin-ATP molecule. ADF/cofilin 
destabilizes F-actin filaments, thus increasing the amount of available G-actin monomers. 
ADF/cofilin binds to F-actin filaments and causes F-actin depolymerisation. While 
depolymerisation happens at the (-) end during the treadmilling process, F-actin filament 
elongation occurs at the (+) end. Profilin binds to Actin-ATP promoting actin 
polymerisation. Profilin also binds Actin-ADP increasing the exchange rate of actin-bound 
ADP for ATP (not depicted).  Abbreviations: ATP - adenosine triphosphate; ADP - 
adenosine diphosphate; P - monophosphate. This figure was inspired by  (Baum et al. 
2006). 
 
The first step of de novo F-actin filament formation is called actin nucleation. 
Actin nucleation refers to the formation of a new F-actin filament by the 
assembly of G-actin monomers (Pollard, Blanchoin, and Mullins 2000). Inevitably, 
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this process requires the formation of actin dimers and trimers, a process that is 
kinetically unfavourable (Sept and McCammon 2001; Deeks and Hussey 2005; 
Pollard 2016). From this point onwards however, G-actin monomer assembly to 
the actin trimer was proposed to occur with the same rate as G-actin 
polymerisation on existing F-actin filaments (Sept and McCammon 2001). It is 
therefore believed that the assembly of this trimer nucleus presents the critical 
step that has to be overcome for de novo F-actin formation (Sept and 
McCammon 2001; Deeks and Hussey 2005).  
To efficiently control many of the kinetically unfavourable steps of actin 
dynamics, eukaryotic cells exploit a vast number of actin binding proteins (APBs) 
(Pollard 2016). For instance, these ABPs are involved in facilitating the transition 
between G-actin and F-actin (actin treadmilling) and de novo filament synthesis. 
Some of the eukaryotic key players involved in this process shall be briefly 
described in the following section. 
 
1.6.2 Function of Actin binding proteins (ABPs)  
1.6.2.1 Actin treadmilling  
Several ABPs are involved in the actin treadmilling process, including the factors 
adf/cofilin and profilin (Figure 1-8).  Proteins belonging to the ADF/cofilin 
family destabilize F-actin filaments, thus increasing the amount of available G-
actin monomers (Moon and Drubin 1995). Initially, in vitro studies reported that 
cofilin binds to F-actin filaments (Nishida, Maekawa, and Sakai 1984) and causes 
F-actin depolymerisation (Yonezawa, Nishida, and Sakai 1985). The role of 
cofilin in F-actin turnover and depolymerisation was confirmed in vivo in yeast 
(Lappalainen and Drubin 1997). Cofilin mutants depicted increased numbers of 
actin patches within the cell indicating a role for cofilin in actin 
depolymerisation and turnover. In a comparative study, ADF was later shown to 
depolymerise F-actin filaments more potently than cofilin (Yeoh et al. 2002). 
Both proteins bind to F-actin with similar affinity and severe F-actin filaments 
with comparable potency. Cofilin and ADF have higher affinity to G-Actin-ADP 
than to G-Actin-ATP. Furthermore, ADF has a higher affinity to F-actin-ADP than 
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F-actin-ATP or F-actin-ADP-Pi and increases the depolymerisation rate from the 
pointed end (Carlier et al. 1997). 
Based on these results, a treadmilling model was proposed by Yeoh and co-
workers in which ADF/cofilin bind to F-actin-ADP causing filament fragmentation 
at the pointed end (Yeoh et al. 2002). Disassembly of F-actin at the pointed end 
is followed by nucleotide exchange (G-actin-ADP to G-actin-ATP) and new 
filament formation. Recently, it was suggested that ADF/cofilin-mediated 
filament depolymerisation might also occur at the barbed end (Wioland et al. 
2017). Maintaining actin treadmilling by F-actin severing and depolymerisation 
has physiological importance as cofilin is critical for proper embryonic 
development in mice (Gurniak, Perlas, and Witke 2005). Furthermore lack of ADF 
function causes corneal defects in mice (Ikeda et al. 2003; Bellenchi et al. 
2007). Co-depletion of cofilin and ADF in mammalian cells leads to stress fiber 
accumulation affecting nuclear integrity (Kanellos et al. 2015). 
While depolymerisation happens at the pointed end during the treadmilling 
process, F-actin filament elongation occurs at the barbed end. One of the 
proteins involved in mediating filament assembly is the polymerisation factor 
profilin which binds monomeric G-actin (Baum et al. 2006; Pollard 2016). A role 
for profilin in actin treadmilling was first suggested in 1977 (Carlsson et al. 
1977), while its ability to promote actin polymerisation was proposed in 1993 
(Pantaloni and Carlier 1993). It was further shown that profilin binds to G-actin-
ATP and G-actin-ADP with similar affinity while drastically increasing the 
exchange rate of actin-bound ADP for ATP (Selden et al. 1999). Based on these 
findings, Selden and co-workers suggested that rapid profilin-mediated 
regeneration of the G-actin-ATP pool depicts a key step in actin treadmilling.  
This is because the maintenance of the G-actin-pool at a level above the critical 
concentration is necessary for continued actin assembly.  
For F-actin elongation at the barbed end, profilin acts together with a protein 
called formin (see below). Together, profilin and formin can achieve a dramatic 
increase of F-actin elongation rates compared to the rates shown by actin alone 
or actin with only formin (Romero et al. 2004; Kovar et al. 2006). Another factor 
impacting F-actin filament dynamics are so-called capping proteins. These 
52 
 
proteins are able to bind to free barbed ends and prevent addition or removal of 
actin monomers (Edwards et al. 2014; Pollard 2016). 
 
1.6.2.2 Actin nucleation  
Since actin nucleation is kinetically unfavourable, eukaryotic cells exploit so-
called nucleation factors to overcome the initial steps of de novo filament 
formation. Three different types of actin nucleators have been described: the 
Arp2/3 complex, the formin protein family and spire (Figure 1-9) (Goode and 
Eck 2007). 
First described in 1994,  the Arp2/3 complex consists of seven sub-units 
including the actin related proteins Arp2 and Arp3 (Machesky et al. 1994). The 
complex was shown to associate with the sides of F-actin filaments (Mullins, 
Stafford, and Pollard 1997) and to promote actin polymerisation (Welch, 
Iwamatsu, and Mitchison 1997). In brief, further research revealed that Arp2/3 
causes the branching of novel daughter actin filaments from already existing 
mother filaments at an angle of 70° (Mullins, Heuser, and Pollard 1998). It was 
further proposed that the two actin related proteins of the complex (Arp2 and 3) 
act as the first subunits of the newly forming daughter filament (Volkmann et al. 
2001; Rouiller et al. 2008). As a consequence, the arp2/3 complex is associated 
with the pointed end of F-actin filaments. 
Due to the localisation of some of its components to the lamellipodia in 
stationary and motile cells, the Arp2/3 complex was suggested to be involved in 
lamellipodia protrusion (Welch et al. 1997). The function of Arp2/3-mediated 
actin network assembly in cell migration was confirmed in fibroblasts lacking a 
functional Arp2/3 complex (Suraneni et al. 2012). These cells were incapable of 
forming lamellipodia and showed a defect in performing directional migration.  
Another type of actin nucleator, Spire, was identified in the fly Drosophila in 
2005 (Quinlan et al. 2005). Quinlan and colleagues showed that spire is able to 
promote actin assembly in vitro. Spire possesses four WASP homology 2 (WH2) 
domains and all four domains are required for maximum nucleation potential 
(Quinlan et al. 2005). It was proposed that spire attracts four G-actin monomers 
(one to each WH2 domain) to create a nucleation complex (Quinlan et al. 2005). 
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Interestingly, it was suggested that spire and formins can interact with each 
other in a regulatory fashion during actin nucleation (Quinlan et al. 2007). A 
model was proposed in which spire recruits formin to the barbed end of F-actin 
causing fast formin-mediated filament growth (Montaville et al. 2014). 
 
Figure 1-9: The three types of actin nucleation factors in eukaryotes 
Since spontaneous actin nucleation is highly unfavourable, eukaryotic cells exploit 
nucleation factors to overcome the initial steps of de novo filament formation. The three 
different types of actin nucleators are the Arp2/3 complex, formins and spire. Formins 
form a dimer and stabilise actin dimers to initiate F-actin assembly. The formin dimer 
stays associated with the barbed end of the growing actin filament while promoting 
addition of G-actin. This mode of action is referred to as “processive capping”. A flexible 
linker between the two formin proteins enables repositioning of the dimer which is 
necessary when additional actin monomers are added to the barbed end. The Arp2/3 
complex (together with WASp) mediates de novo filament polymerisation on already 
existing filaments at an angle of 70°. Spire possesses four WH2 domains and all four 
domains are required for maximum nucleation potential. Spire attracts four G-actin 
monomers (one to each WH2 domain) to create a nucleation complex. Dotted line arrows 
indicate the barbed end of the respective actin filament. Republished with permission of 
Annual Reviews (Annual Reviews of Biochemistry), from (Goode and Eck 2007) © 2007; 
permission conveyed through Copyright Clearance Center, Inc. License number: 
4638780103258. 
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The actin nucleation mechanism of formins is of high importance for this thesis. 
Therefore, formin biology shall here be described in more detail. The first gene 
was introduced as a formin in 1990 (Woychik et al. 1990). Since then, many 
members of the formin family have been described in various organisms 
(Evangelista, Zigmond, and Boone 2003; Goode and Eck 2007). Members of the 
formin family were reported to nucleate actin and to mediate “processive 
capping” of F-actin filaments (Goode and Eck 2007; Courtemanche 2018).  
Formins share two domains, the formin homology domain 1 and 2 (FH1 and FH2) 
(Castrillon and Wasserman 1994; Wasserman 1998). The FH1 domain was 
reported to interact with profilin (Evangelista et al. 1997; Imamura et al. 1997), 
while the FH2 domain appeared critical for formin-mediated actin assembly 
(Sagot et al. 2002; Pruyne et al. 2002).  
It was shown that formin is required for the assembly of F-actin cables in yeast 
(Feierbach and Chang 2001; Evangelista et al. 2002; Sagot, Klee, and Pellman 
2002). This formin-mediated F-actin assembly requires profilin in vivo 
(Evangelista et al. 2002). In vitro experiments with a minimal form of the yeast 
formin Bni1 suggested that actin assembly can happen without profilin, but is 
enhanced in the presence of profilin (Sagot et al. 2002). Pring and colleagues 
proposed that Bni1 promotes actin nucleation by stabilising an actin dimer to 
allow for further actin assembly (Pring et al. 2003). 
Based on in vitro data, Sagot and co-workers proposed that yeast formin Bni1 
promotes formation of unbranched actin filaments, while Arp2/3 promotes the 
formation of branched actin filaments (Sagot et al. 2002). Interestingly, a 
minimal version of yeast Bni1 (Bni1pFH1FH2) localised to the barbed end of 
unbranched filaments in vitro as determined by electron microscopy (Pruyne et 
al. 2002). Association of the Bni1FH2 domain with the barbed end was further 
supported by its ability to promote actin filament assembly in the presence of 
capping proteins (Zigmond et al. 2003; Moseley et al. 2004). Barbed end 
protection from capping proteins was also reported for the FH1FH2 core of the 
mouse formin FRLα, indicating that barbed-end localisation is a universal formin 
trait (Harris, Li, and Higgs 2004). 
The barbed end localisation of formins, together with their proposed (FH2-
dependent) dimerization (Harris, Li, and Higgs 2004; Moseley et al. 2004; Xu et 
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al. 2004), gave rise to the “processive capping” model for formin-dependent 
actin nucleation and filament elongation. In this model, the formin dimer 
associates with the barbed end while promoting addition of G-actin to the 
growing F-actin strand. During filament elongation, formin repositions to 
maintain persistent association with the growing barbed end (Goode and Eck 
2007; Courtemanche 2018). It is important to note that the exact structural 
mechanism of formin-mediated processive filament elongation at the growing 
barbed end is still under investigation (Paul and Pollard 2009; Thompson et al. 
2013; Courtemanche 2018). 
The model is supported by structural analyses of the formin dimer. The formin 
dimer was described as a stable, but flexible structure (Xu et al. 2004).  Xu and 
colleagues proposed that a flexible link between the two formin proteins allows 
for repositioning of the dimer upon actin addition to the barbed end. Another 
study provided the crystal structure of the complex between the yeast BnipFH2 
domain with actin (Otomo et al. 2005). The study suggests that the formin dimer 
can switch between two states, either promoting actin monomer addition to or 
promoting actin disassociation from the F-actin filament. Structural analysis by 
Otomo and co-workers also supports the model of formin enabling actin 
nucleation by stabilising an actin dimer that acts as nucleus for further actin 
assembly. More recently, continuous association of the mouse formin mDia1 to 
the growing actin filament was made visible by single-molecule fluorescence 
microscopy in real time (Breitsprecher et al. 2012).  The same technology was 
later used to confirm the existence of a processive formin (AtFH14) in the plant 
Arabidopsis (Zhang et al. 2016). 
Several cellular functions have been proposed for formins in various organisms 
(Evangelista, Zigmond, and Boone 2003). For example, it was shown that formins 
are required for the formation of the cytokinetic actin ring and the completion 
of cytokinesis in yeast (Tolliday, VerPlank, and Li 2002). In addition, plants 
lacking the formin AtFH5 were compromised in cytokinesis in the seed 
endosperm (Ingouff et al. 2005). In mice, the formin family member Fhod3 is 
critical for heart development in embryos (Kan-o et al. 2012) and postnatal 
juveniles (Ushijima et al. 2018).  
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1.7  Actin in Toxoplasma 
Toxoplasma encodes actin on a single copy gene, Tgactin1 (Tgact1) 
(Dobrowolski, Niesman, and Sibley 1997).The TgACT1 protein shares 93% 
sequence similarity with Plasmodium falciparum actin, but only about 80% with 
other eukaryotic actins (Dobrowolski, Niesman, and Sibley 1997; Baum et al. 
2006). Initial studies assessing the physical state of actin in Toxoplasma used cell 
fractionation by centrifugation for separating F-actin from G-actin (Dobrowolski, 
Niesman, and Sibley 1997). This experimental set up failed to detect actin in the 
pellet fraction where F-actin is expected to accumulate. Dobrowolski and 
colleagues therefore suggested that actin is mainly present in its monomeric G-
actin state in Toxoplasma.  
In a comparative approach with recombinant actin in vitro, Toxoplasma actin 
formed shorter (ca. 0.1µm) and more unstable filaments than rabbit actin (ca. 
2µm) (Sahoo et al. 2006). It was proposed that amino acid residues on the 
Toxoplasma actin monomer surface differ from conventional actin and that 
these differences contribute to filament instability (Sahoo et al. 2006; Skillman 
et al. 2011). In vitro, the critical concentration required for Toxoplasma actin to 
polymerise was proposed to be lower than for conventional actins, resulting in 
the understanding that TgACT1 filaments possess a rapid assembly and turnover 
rate (Sahoo et al. 2006). Since stabilisation of TgACT1 affected parasite gliding, 
the general instability of TgACT1 filaments was suggested to be an adaptation 
that enables parasite motility (Skillman et al. 2011).  
The concept of rapid apicomplexan F-actin turnover was supported by findings in 
the related apicomplexan parasite Plasmodium falciparum (Schmitz et al. 2005). 
Plasmodium actin1 (PfACT1) also formed shorter filaments (ca 0.1µm) when 
compared to rabbit actin (ca 3.5µm) in vitro. Another study reported inefficient 
filament assembly by recombinant PfACT1 in vitro (Schüler, Mueller, and 
Matuschewski 2005). More recently, pyrene fluorescence assays suggested 
kinetics for PfACT1 similar to canonical actin (Kumpula et al. 2017). Of 
relevance, the depolymerisation rate for PfACT1 appeared faster than for 
canonical actins. Structural differences to canonical actins were proposed to 
cause the instability and, consequently, the short nature of Plasmodium F-actin 
(Vahokoski et al. 2014). Electron cryo-microscopy revealed differences in the 
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contact sites between PfACT1 molecules as reason for the filament instability 
(Pospich et al. 2017). Based on crystallography studies for PfACT1, it was 
reported that the conformation of the Arg178/Asp180-containing A-loop plays a 
key role in Plasmodium filament destabilisation (Kumpula et al. 2019). Within 
the PfACT1 molecule, for instance, the A-loop interacts with the Plasmodium-
specific residue Lys(K)270, enabling a conformational stage that promotes actin 
filament fragmentation (Kumpula et al. 2019). When PfACT1 was mutated to a 
K270M variant, reflecting canonical actin and blocking interaction with the A-
loop, longer actin filaments were formed in vitro (Kumpula et al. 2019). 
Noteworthy, Toxoplasma actin1-K270M mutants were found to increase 
polymerisation in comparison to wild-type TgACT1 (Skillman et al. 2011).  
Actin sedimentation assays later questioned the existence of a critical 
concentration for actin polymerisation in Toxoplasma (Skillman et al. 2013). This 
was because the concentration of monomeric actin in the supernatant fraction 
continuously increased when more actin was used for polymerisation assay prior 
to centrifugation. In the case of actin polymerisation that depends on critical 
concentration, the concentration of monomeric actin in the supernatant should 
reach a plateau (representing the critical concentration) since all monomeric 
actin molecules above this threshold are assembled into actin filaments (Pollard 
and Borisy 2003). This was the case for yeast actin as shown by Skillman et al. 
(Skillman et al. 2013). Based on the results from the sedimentation assays, 
Skillman and co-worker proposed that an isodesmic model would be best suited 
to explain the observed TgACT1 kinetics (Skillman et al. 2013). According to this 
model, actin assembly and disassembly occur at the same rate. Thus, the 
kinetically unfavourable actin nucleation prior to filament elongation would not 
present a rate limiting step. It was argued by Skillman and colleagues that F-
actin formation could therefore happen independently from nucleation-
promoting factors. In addition, the model was applied to explain the previously 
reported presence of short and unstable actin filaments in Toxoplasma (Sahoo et 
al. 2006). 
Actin sedimentation assays based on ultracentrifugation were later proposed to 
be unreliable for the determination of the critical concentration of 
apicomplexan actin (Kumpula et al. 2017). This is because the short length of 
apicomplexan actin filaments prevents their sedimentation. A method exploiting 
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pyrene-labelled actin was applied to measure the critical concentration for 
PfACT1 (ca. 0.1µM) in vitro (Kumpula et al. 2017). Kumpula and colleagues 
argued that PfACT1 shows similar kinetics to canonical actins with F-actin 
formation depending on nucleation. Crystallography studies recently suggested 
that unique structural features in the PfACT1 molecule promote filament 
destabilisation and, eventually, fragmentation (Kumpula et al. 2019). 
It should be mentioned that a previous study by Olshina et al. suggested that 
PfACT1 might not be correctly folded by heterologous expression systems in 
vitro (Olshina et al. 2016). However, since the authors used in vitro cell free 
expression systems that differ from systems applied in other literature for 
PfACT1 expression (Schmitz et al. 2005; Schüler, Mueller, and Matuschewski 
2005; Ignatev et al. 2012; Vahokoski et al. 2014; Kumpula et al. 2017, 2019), this 
general conclusion might have to be considered with caution.  
As part of the actomyosin motor complex (Frénal, Dubremetz, et al. 2017), 
TgACT1 is highly important for all processes that require parasite motility. For 
instance, TgACT1 was reported to be essential for parasite egress from the host 
cell (Egarter et al. 2014; Whitelaw et al. 2017). TgACT1 was further reported to 
be important, but not essential, for parasite gliding (Egarter et al. 2014; 
Whitelaw et al. 2017). Although most parasites lost their ability to glide after 
TgACT1 depletion, a small number of tachyzoites remained able to glide at 
speeds similar to control parasites  (Whitelaw et al. 2017).  In addition, 
depletion of TgACT1 causes apicoplast loss in parasites (Andenmatten et al. 
2013; Whitelaw et al. 2017). Also, dense granule trafficking appears to rely on 
actin and myosins (Heaslip, Nelson, and Warshaw 2016; Whitelaw et al. 2017). 
Involvement of TgACT1 in host cell invasion (and motility) was first suggested in 
1996 (Dobrowolski and Sibley 1996). Although Cre-Lox-mediated conditional 
depletion of TgACT1 rendered most parasites incapable of host cell invasion, 
some parasites (ca. 10-25%) were still able to invade (Egarter et al. 2014; 
Whitelaw et al. 2017). It was further reported that conditional TgACT1-depleted 
parasites were unable to establish strong attachment to surfaces (Whitelaw et 
al. 2017). Based on these findings, Whitelaw and co-workers suggested a role for 
the actomyosin complex in surface attachment, rather than force generation 
during the invasion process.  
59 
 
The suggestion that actual host cell penetration can occur in the absence of 
TgACT1 sparked controversy. Another study suggested that host cell invasion by 
TgACT1-depleted parasites is facilitated by residual actin after Cre-Lox gene 
excision (Drewry and Sibley 2015). In the context of this debate, potential cross-
reactivity of the exploited antibodies against TgACT1 were discussed (Drewry 
and Sibley 2015; Whitelaw et al. 2017). 
Overall, TgACT1 is essential for parasite survival since no clonal Tgact1 knock-
out line could be generated so far (Andenmatten et al. 2013; Egarter et al. 
2014). Interestingly, the intracellular replication rate in culture appears to be 
largely unaffected by TgACT1 depletion (Egarter et al. 2014; Periz et al. 2017). 
Noteworthy, however, depletion of TgACT1 causes asynchronous replication in 
Toxoplasma  (Periz et al. 2017). In addition, parasites lack the typical rosette 
formation within the PV (Periz et al. 2017).  Actin was also reported to be 
involved in residual body formation (Periz et al. 2017). 
The recent visualisation of Toxoplasma actin via actin-chromobodies allowed for 
a more detailed investigation of actin function in intracellular parasites (Periz et 
al. 2017). Periz and colleagues reported that individual parasites are connected 
by a filamentous actin network. This network appeared to contribute to 
vesicular trafficking between individual parasites within the PV and IMC 
recycling (Periz et al. 2017). Disassembly and reassembly of these intravacuolar 
filaments occur during parasite replication (Periz et al. 2017). A follow-up study 
by Periz et al. proposed that F-actin facilitates recycling of maternal 
micronemes during daughter cell budding (Periz et al. 2019). Further 
exploitation of the chromobody technology suggested a novel function for actin 
in the host cell invasion process (Del Rosario et al. 2019). According to Del 
Rosario and colleagues, the parasite nucleus presents a major obstacle for 
efficient host cell entry.  To allow for efficient nuclear entry, actin is thought to 
stabilise the junction and to push the parasite nucleus into the host cell (Del 
Rosario et al. 2019).  
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1.7.1 Actin binding proteins (ABPs) in Toxoplasma 
Apicomplexan parasites, including Toxoplasma and Plasmodium species, possess 
a limited set of ABPs (Baum et al. 2006) (Table 1-1). For example, Toxoplasma 
encodes a single gene each for ADF and profilin, while three genes encode 
formins. As perspective, humans possess 5 profilin genes, 14 adf/cofilin genes 
and 16 formin genes (Baum et al. 2006). Strikingly, the nucleation factors spire 
(Baum et al. 2006) and Arp2/3 (Gordon and Sibley 2005) are missing in 
Toxoplasma, making formins the only known actin nucleator.  
 
Table 1-1: Depiction of selected actin binding proteins (ABPs) found in 
apicomplexan and eukaryotic genomes 
Please note that this table is not a complete list of ABPs present in the depicted genomes. 
Data presented in this table was reproduced from (Baum et al. 2006). Abbreviations: Pf – 
Plasmodium falciparum, Tg - Toxoplasma gondii, At - Arabidopsis thaliana, Dm - 
Drosophila melanogaster, Hs - Homo sapiens. 
Functional class Protein domain Number of proteins detected in the genome 
  Pf Tg At Dm Hs 
Monomer treadmilling Profilin 1 1 5 4 5 
 CAP 1 1 1 1 2 
 Cofilin 2 1 14 7 14 
Nucleation Formins (FH2) 2 3 20 14 16 
 Spire 0 0 0 4 2 
 ARPC1/p41 1 0 3 3 2 
 ARPC2/p34 0 0 2 1 2 
 ARPC3/21 0 0 1 3 2 
 ARPC4/p20 0 0 1 1 1 
 ARPC5/p16 0 0 1 1 2 
 WAVE/WASp 0 0 0 13 11 
Crosslinking / bundling Coronin 1 1 2 8 8 
 
TgADF was first described in 1997 as a single copy gene (Allen et al. 1997). 
Recombinant TgADF is capable of binding to G-actin and of depolymerising F-
actin (Allen et al. 1997). In vivo, a cytosolic localisation was reported for TgADF 
by antibody staining and endogenous tagging (Allen et al. 1997; Mehta and Sibley 
2011; Haase et al. 2015). Depletion of TgADF compromises host cell invasion, 
egress and overall gliding motility, making TgADF essential for the lytic 
replication cycle (Mehta and Sibley 2011).  
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In vitro sedimentation assays with rabbit actin suggested that TgADF does not 
stably associate with F-actin (Mehta and Sibley 2010). In the same study, TgADF 
also displayed a weaker severing activity than the canonical yeast cofilin and 
appeared to prevent F-actin assembly mainly by sequestering monomeric G-
actin. According to structural analysis, TgADF has enhanced affinity for G-actin 
(Yadav et al. 2011). In vivo, lack of TgADF causes the accumulation of actin 
structures within the parasite (Mehta and Sibley 2011; Periz et al. 2017). 
Initially, conditional depletion of TgFormin1 with the TATi-system was applied to 
report that TgFormin1 is not important for intracellular replication and not 
critical for egress (Daher et al. 2010). Instead, Daher and co-workers suggested 
TgFormin1 to be involved in tachyzoite motility and host cell invasion. A follow-
up publication confirmed TgFormin1 importance for gliding and invasion, but 
also indicated a critical role in parasite egress (Tosetti et al. 2019). Plaque 
assays suggested that TgFormin1 is essential for the completion of the asexual 
lytic cycle in culture (Tosetti et al. 2019). 
By obtaining a clonal TgFormin2-KO line, Tosetti and colleagues showed that 
TgFormin2 is not essential for the completion of the lytic cycle (Tosetti et al. 
2019). However, the Formin2-KO strain was outgrown by wild-type parasites in 
growth competition assays. It should be mentioned that the Formin2-KO line was 
obtained by applying CRISPR/Cas9 to delete a large part of the open reading 
frame (ORF). TgFormin2 is involved in intracellular replication as its deletion 
causes an increase in aberrant daughter cell orientation (Tosetti et al. 2019). 
TgFormin1 and 2 were initially localised to the tachyzoite pellicle (Daher et al. 
2010). Subsequent reports localised TgFormin1 to the apical tip of the parasite 
and TgFormin2 to the vicinity of the apicoplast (Jacot et al. 2016; Tosetti et al. 
2019).  
TgFormin3-KO tachyzoites do not depict any replication defects, making 
TgFormin3 dispensable for the lytic cycle (Daher et al. 2012). Initially, 
TgFormin3 was localised to the apical and the basal pole as well as around the 
mitochondrion (Daher et al. 2012). Later, TgFormin3 localisation was re-defined 
to the basal pole and the residual body based on endogenous tagging (Tosetti et 
al. 2019). Asynchronous replication was observed in parasites lacking TgFormin3 
(Tosetti et al. 2019). In addition, recovery of fluorescence in bleaching 
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experiments was slower for TgFormin3-KO parasites when compared to wild-type 
parasites. Tosetti and colleagues therefore suggested a role for TgFormin3 in 
cell-cell communication.  
Evidence suggests the all three Toxoplasma Formins can nucleate actin in vitro.  
The FH2 domains of TgFormin1 and 2 were reported to initiate nucleation of 
rabbit actin (Daher et al. 2010) and Toxoplasma actin (Skillman et al. 2012) in 
vitro. The TgFormin3 FH2 domain also nucleates rabbit actin (Daher et al. 2012). 
Skillman and colleagues interpreted fluorescence microscopy data as indication 
for the promotion of short filament bundles by TgFormin1 and 2 (Skillman et al. 
2012). Electron microscopy suggested that, in vitro, TgFormin1 causes TgACT1 to 
form an interconnected network, while TgFormin2 mediates the formation of 
straight actin filament bundles (Skillman et al. 2012).  
Intriguingly, TgFormin-mediated actin polymerisation was inhibited by TgProfilin 
in vitro (Skillman et al. 2012). These observations stand in direct contrast to 
observations made in vitro with yeast Profilin, which was reported to enhance 
Formin-mediated F-actin assembly (Sagot et al. 2002). Co-immunoprecipitation 
with TgFormins failed to precipitate TgProfilin (Daher et al. 2010). This lack of 
interaction was further supported by isothermal titration calorimetry and crystal 
structure analysis (Kucera et al. 2010). Taken together, these observations made 
Skillman et al. suggest that the main function of TgProfilin might be to sequester 
TgACT1, rather than enhancing TgFormin2-mediated F-actin assembly (Skillman 
et al. 2012).  
TgProfilin is critical for the completion of the lytic life cycle as depletion of 
TgProfilin rendered parasite defective in gliding motility, invasion and host cell 
egress (Plattner et al. 2008). Intracellular replication was not affected by 
TgProfilin loss. 
The ABPs TgFormin2 (Jacot, Daher, and Soldati-Favre 2013; Tosetti et al. 2019), 
TgADF (Jacot, Daher, and Soldati-Favre 2013; Haase et al. 2015) and TgProfilin 
(Jacot, Daher, and Soldati-Favre 2013) are involved in apicoplast segregation in 
Toxoplasma tachyzoites. 
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Figure 1-10: Schematic of the actin network in Toxoplasma 
In intracellular tachyzoites, actin (green) forms a network that connects parasites within 
the parasitophorous vacuole. Individual parasites display actin accumulation in their apical 
region. The schematic is based on results published by Periz and co-workers (Periz et al. 
2017). 
 
1.8 Aims of this study  
Although actin and its ABPs in Toxoplasma have been the focus of intense 
investigation, the overall conclusions were limited by the lack of a reliable 
method for actin visualisation. Because of this, the action of different ABPs on 
actin dynamics was mainly examined in vitro, making conclusion about their 
exact functions in vivo challenging. 
The visualisation of actin structures in Toxoplasma was recently achieved by 
exploiting actin-chromobodies (Periz et al. 2017). These findings presented a 
major advancement in apicomplexan actin biology since actin visualisation had 
been a major obstacle. Classical antibody staining proved to be unreliable 
(Drewry & Sibley, 2015; Whitelaw et al., 2017) and other fluorogenic actin 
probes could not be expressed in Toxoplasma (Tardieux 2017; Periz et al. 2017). 
Expression of anti-actin-chromobodies in Toxoplasma revealed an extensive  
actin network that connects intracellular parasites within the parasitophorous 
vacuole (PV) (Figure 1-10) (Periz et al. 2017). In addition, Periz and colleagues 
identified a highly dynamic actin accumulation centre anterior to the nucleus in 
individual parasites. 
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Overcoming the challenge of actin visualisation opens the door to in-depth 
analysis of actin dynamics in vivo.  In addition, the actin-chromobody could 
potentially be used for screening approaches aiming at the identification of 
novel ABPs. Since actin is critical for completion of the lytic cycle in Toxoplasma 
(Andenmatten et al. 2013; Egarter et al. 2014), a conditional gene disruption 
system might be advantageous for investigating potentially novel and essential 
actin dynamic factors.   
Recently, a conditional type II CRSIPR/Cas9 system (split-Cas9) was described in 
mammalian cells (Zetsche, Volz, and Zhang 2015). In this system, the Cas9 
enzyme is split into two sub-units (N- and C-terminus) which are fused to a FKBP 
or FRB domain.  Upon rapamycin treatment, the two sub-units are re-united and 
become active.  In theory, this system should have phenotypic screening 
potential. A gRNA library could be transfected into parasites while the 
conditional nature of the split-Cas9 system would allow for controlled phenotype 
induction. In addition, this system should enable rapid targeting of known ABPs. 
The novel ability to visualize F-actin in fixed or live Toxoplasma cells presents 
an exciting opportunity to further investigate actin dynamics in vivo in 
unprecedented detail. Combination of the split-Cas9 system and the actin-
chromobody technology could potentially give, for the first time, insights into 
the exact functions of ABPs within the Toxoplasma actin network in vivo. 
Therefore, the overall aims of this study were defined as follows: 
1) The split-Cas9 system shall be established in Toxoplasma to allow for reliable 
analysis of gene function. 
2) Overall actin dynamics in Toxoplasma shall be investigated by combining the 
split-Cas9 and actin-chromobody technologies. 
3) The specific role of ABPs in maintaining actin dynamics during the lytic cycle 
in Toxoplasma shall be addressed. 
4)  A medium-throughput screen aiming at identifying novel ABPs in Toxoplasma 
shall be initiated.  
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2 Materials and Methods  
2.1 Equipment 
Table 2-1: Equipment 
Applied Precision DeltaVision® Core microscope 
BD Biosciences 
Syringes, Needles (23-25 gauge), FACS tubes with cell 
strainer cap  
 
BioRad 
Agarose gel electrophoreses equipment, UV 
transilluminator, SDS-PAGE system, Blotting apparatus 
(Transblot SD and Mini transblot electrophoretic transfer 
cell), gel documentation system, gene Pulser Xcell, 
Micropulser, S3e™ Cell sorter 
BTX 
Electroporation cuvettes and system (ElectroSquare Pore 
830) 
Eppendorf 
Thermocycler (Mastercycler Epgradient), Thermomixer 
compact 
Fished Scientific Ultrasound water bath FB15047 
Grant Water bath  
Heraeus 
Instruments 
Incubator  
KD scientific Syringe pump 
Kuehner Shaking incubator (ISF-1-W) 
Lonza 
4D-Nucleofactor™X electroporation unit, Single 100 µl 
Nucleovette™   
Milipore MilliQ water deionising facility, 3 µm Millipore filters 
Photometrics CoolSNAP HQ2CCD camera  
Sanyo CO2-incubator for tissue culture 
Satorius Analytical balances  
Sciquip Sigma 6K 15 centrifuge (1150 rotor and 12500 rotor)  
StarLab 
ErgoOne Single & Multi-Channel pipettes, StarPet Pro 
pipette controller  
Stuart Heat block, Roller mixer, Orbital Shaker 
ThermoFisher 
scientific 
CO2-incubator for tissue culture, Nanodrop 
spectrophotometer, Centrifuge (sorvall legend XFR), Table 
top centrifuge Heraeus Pico 21, Tabletop cooling 
centrifuge Heraeus Fresco 21 
Zeiss 
Axioskop 2 (mot plus) fluorescence microscope with 
Axiocam MRm CCD camera, Primo Vert (light microscope), 
Axiovert 40 CFL fluorescence microscope with Axiocam 
ICc1, Axiovert A1 fluorescence microscope with Axiocam 
IMc1, ELYRA PS.1 Super-resolution microscope, sCMOS pco 
SIM camera, Plan Apochromat 63x lens   
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2.2 Computer Software 
Table 2-2: Computer software 
Adobe Systems Inc.  Adobe Acrobat Reader DC  
Inkscape Project InkscapeTM: Open Source Scalable Vector Graphics 
Editor 
AcaClone software  pDraw32  
Applied Precision  SoftWoRx explorer and SoftWoRx suite  
BioRad ProSort™ 
Carl Zeiss Microscopy Zen Black and Zen Blue 
Microsoft Corporation  Windows 7, Microsoft Office 2010  
National Institute for 
Biotechnology Information 
(NCBI) 
Basic Local Alignment search tool (BLAST), Primer-
BLAST 
National Institute of Allergy 
and Infectious Diseases 
(NIAID) 
ToxoDB (Kissinger et al. 2003; Gajria et al. 2008) 
National Institutes of 
Health (NIH) 
ImageJ, Fiji (Schneider, Rasband, and Eliceiri 
2012; Schindelin et al. 2012) 
New England Biolabs (NEB) NEB tools™: Double Digest Finder, Enzyme Finder, 
NEBCutter®, NEBBioCalculator®, Tm Calculator  
Thermo Scientific Thermo Scientific web tools: Tm Calculator 
Mendeley Ltd. Mendeley Desktop  
University of Utah ApE Plasmid Editor v2.0.53c Copyright© by M. 
Wayne Davies 
University of Georgia Eukaryotic Pathogen gRNA Design Tool (EuPaGDT) 
(Peng and Tarleton 2015) 
 
 
2.3 Consumables, biological and chemical reagents 
Table 2-3: Biological and Chemical reagents 
Company Reagents 
Formedium  Tryptone, yeast extract  
Life technologies  Phosphate buffered saline 1X (PBS), Trypsin/EDTA 
(0.05%), DNaseI, Platinum Taq DNA Polymerase High 
Fidelity, NuPage SDS loading buffer and reducing 
agent, Sodium bicarbonate, Ultrapure agarose  
Melford  Agar, ditriothreitol, IPTG, X-Gal 
NEB 1kb DNA ladder, all Restriction enzymes and 
associated buffers, T4 DNA ligase, Taq polymerase, 
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Q5® high-fidelity DNA polymerase, Calf intestinal 
phosphatase (CIP)  
Phenix Research 
Products  
 GelRed nucleic acid stain 
Promega  pGEM®-T Easy vectors system 
Roche  MgSO4 × 7H2O, potassium hydroxide, 
paraformaldehyde  
Sigma Ammonium persulfate, Bromophenol blue sodium salt, 
Casein hydrosylate, Dulbecco’s Modified Eagle Medium 
(DMEM), Ficoll, Ethylene glycol tetraacetic acid, 
Isopropanol, Sodium dodecyl sulfate (SDS), dimethyl 
sulfoxide (DMSO), N,N,N’,N’-
tetramethylethylenediamine, Triton X-100, 
Rapamycin, Giemsa stain, L-glutathione reduced, 
Adenosine 5′-triphosphate disodium salt hydrate, 
Glutamine, 30% acryl-bisacrylamide mix, Sodium 
deoxycholate, K2HPO4, Magnesium chloride, 
Bleomycin (BLEO), Ampicillin sodium salt, Gentamicin, 
Xanthine 
Southern Biotech DAPI-Fluoromount G 
Thermo Scientific  Bovine serum albumin (BSA), Ethylene diamine 
tetraacetic acid, Glycerol, Glycine, Methanol, Tris, 
Sodium chloride, 40nM FluoSpheres® Carboxylate-
Modified Microspheres, Platinum Taq DNA Polymerase 
High Fidelity, 1kb plus DNA ladder 
VWR CaCl2 × 2 H2O, Glacial acetic acid, Ethanol, HEPES, 
Potassium chloride, Na2HPO4, KH2PO4 
Zeiss  Immersion oil 
 
2.4  Kits 
Table 2-4: Kits 
Company Kits 
Qiagen Spin Mini-prep, Plasmid Midi-prep, PCR Purification 
MinElute, QIAquick gel extraction Kit, DNeasy blood and 
tissue Kit 
Roche High Pure PCR product purification Kit 
New England 
Biolabs 
Q5® Site-Directed Mutagenesis Kit 
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2.5 Buffers, solutions and media 
Table 2-5: Buffers for DNA analysis 
Buffer Components 
50X TAE buffer 2M Tris, 05M Na2EDTA, 5.71% glacial acetic acid (v/v) 
5X loading dye 15% Ficoll (v/v), 20 mM EDTA, 0.25% Bromophenol Blue 
in H2O 
1kb plus DNA 
ladder 
150 μl 1kb ladder (1 μg/μl), 300 μl 5X DNA loading 
buffer, 1050 μl H2O 
 
Table 2-6: Buffers and media for bacterial culture 
Buffer Components 
LB medium  10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl  
LB agar  1.5% (w/v) agar in LB medium  
SOB medium  2% tryptone (w/v), 0.5% yeast extract (w/v), 0.05% NaCl 
(w/v), 2.5 mM KCl, 10mM MgCl2  
SOC medium  20 mM glucose in SOB medium  
NYZ broth  5 g/l NaCl, 2 g/l MgSO4*7H20, 5 g/l yeast extract, 10 g/l 
casein hydrolysate, pH adjusted to 7.5 with NaOH  
Ampicillin (1000X)  100 mg/ml in H2O  
IPTG (100 μl/petri 
dish)  
100 mM IPTG in H2O  
X-Gal (10 μl/Petri 
dish)  
50 mg/ml in N,N-dimethylformamide  
 
Table 2-7: Buffers and media for Toxoplasma and mammalian cell culture 
Buffer Components 
DMEMCOMPLETE  
 
500 ml DMEM, 10 % FCS (v/v), 2 mM glutamine, 20 
μg/ml gentamicin  
DMEM FluorobriteCOMPLETE 500 ml DMEM, 10 % FCS (v/v), 2 mM glutamine, 20 
μg/ml gentamicin 
2 x Freezing solution  25 % FCS (v/v), 10 % DMSO (v/v) in DMEMCOMPLETE  
Electroporation buffer 
(Cytomix) 
10 mM K2HPO4/KH2PO4, 25 mM HEPES, 2 mM 
EGTA pH 7.6, 120 mM KCl, 0.15 mM CaCl2, 5 mM 
MgCl2 with 5 mM KOH adjusted to pH 7.6, 3 mM 
ATP, 3 mM GSH  
MPA (500X)  12.5 mg/ml in methanol  
XAN (500X) 20 mg/ml, 1M KOH 
Pyrimethamine (1000X) 1 mM in EtOH 
Rapamycin (1000X)  50 μM in DMSO 
FACS buffer  1 % FCS, 1 mM EDTA in PBS  
PFA fixing solution  4 % PFA (w/v) in PBS  
Permeabilisation solutions  0.2 % triton X-100 (v/v) in PBS   
Blocking solution % BSA (w/v) in permeabilisation solution  
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2.6 Antibodies 
Table 2-8: Antibodies 
Abbreviations: 1st - primary antibody, 2nd - secondary antibody. 
Antibody Species of 
origin 
Dilution 
IFA 
Source 
anti-gap40 (1st) rabbit 1:250 Dr Dominique Soldati-
Favre 
anti-IMC1 (1st) mouse 1:1000 Dr Gary Ward 
anti-SAG1 (1st) mouse 1:500 Dr Sebastian Lourido 
anti-MIC8 (1st) rabbit 1:500 Dr Markus Meissner 
anti-K40acteylation (1st) mouse 1:500 Sigma, cat# T6793 
anti-gap45 (1st) rabbit 1:2000 Dr Dominique Soldati-
Favre 
anti-HSP60 (apicoplast) 
(1st) 
rabbit 1:2000 Dr Lilach Sheiner 
anti-HA (1st) rat 1:500 Roche, cat# 1187431001 
anti-GFP/YFP (1st) rabbit 1:500 Abcam, cat #ab6556 
anti-Atrx1  (apicoplast) 
(1st) 
mouse 1:500 Dr Lilach Sheiner 
anti-G2Trx (apicoplast) 
(1st) 
rabbit 1:500 Dr Lilach Sheiner 
anti-TOM40 (1st) rabbit 1:1000 Dr Lilach Sheiner 
anti-Rop 2,4 T34A7 (1st) mouse 1:500 Dr Jean-François 
Dubremetz  
AlexaFluor594 anti-rabbit 
(2nd) 
goat 1:3000 Life Technologies 
AlexaFluor488 anti-rabbit 
(2nd) 
goat 1:3000 Life Technologies 
AlexaFluor594 anti-
mouse (2nd) 
goat 1:3000 Life Technologies 
AlexaFluor488 anti-
mouse (2nd) 
goat 1:3000 Life Technologies 
AlexaFluor594 anti-rat 
(2nd) 
goat 1:3000 Life Technologies 
AlexaFluor488 anti-rat 
(2nd) 
goat 1:3000 Life Technologies 
 
 
 
 
70 
 
2.7 Oligonucleotides 
Table 2-9: Oligonucletides 
1- PCR amplification, 2 - Integration PCR, 3-sequencing 
Oligonucleotide  Sequence (5`- 3`) Purpose 
sCas9-C-term-split4-
fw 
GAATTCGaCAAAATGGCCCCAAAGAAGAAGCG 1 
sCas9-C-term-split4-
rev 
cTTAATTAACTTACTTTTTCTTTTTTGCCTGGCCGG 1 
sCas9-N-term-split4-
fw 
GAATTCGaCAAAATGCTAGATTTAGCTAGC 1 
sCas9-N-term-split4-
rev 
 CTTAATTAACTTACTGCTTGCTGATTCTTC 1 
Q5-universal-rev AACTTGACATCCCCATTTAC 1 
sag1-sgRNA3-fw GAATGTCGCAAGGTGCTCCTAGTTTTAGAGCTAGAAATAGC 1 
mec17-sgRNA2-fw GTGTTCTGCGACTTTCGTCTGTTTTAGAGCTAGAAATAGC 1 
mec17-sgRNA3-fw GCTCAAGGGCCTCACCCGACGTTTTAGAGCTAGAAATAGC 1 
actin1-sgRNA-fw GTCCATTCCGACCATGATACCGTTTTAGAGCTAGAAATAGC 1 
adf-sgRNA-fw GAGATCCGCAAGACGGTGAAGGTTTTAGAGCTAGAAATAGC 1 
formin2-sgRNA-fw GTGGTTACTCGGAGTCAGCGAGTTTTAGAGCTAGAAATAGC 1 
profilin-sgRNA-fw GCCAATCCAAACACCGTTAGGTTTTAGAGCTAGAAATAGC 1 
drpA-sgRNA-fw GTCGGCTTCTGCAGAAAACAGGTTTTAGAGCTAGAAATAGC 1 
actin1-gRNA-cutside-
fw 
GCGGATGAAGAAGTGCAAGC 1 
actin1-gRNA-cutside-
rev 
GGAGGTGGTGAAGCCGTATC 1 
adf-gRNA-cutside-fw GCTACGTCGGAGGTGTGAAA 1 
adf-gRNA-cutside-
rev 
TTCGACTGAACACCGCAACA 1 
formin2-gRNA-
cutside-fw 
CCTTCGTTCGAGTCTGTCTTC  1 
formin2-gRNA-
cutside-rev 
AGAGCTGCTTGTGTGCTAAA  1 
mec17-gRNA-
cutisde-fw 
cctataATGCATGAAGTTCCGTTTGAATTTCTGCAC 1 
mec17-gRNA-
cutside-rev 
GTCTTGAGTGTGAGCCACCA 1 
DiCre-formin2-3`-fw GGTGAAAGTTGTTCCCTCG 2 
DiCre-formin2-3`-
rev 
ATCCCTTTCCCTGCAGGAG 2 
DiCre-formin2-5`-
loxP-fw 
CACTTTTCATAGTATAGGATAACTTCG 2 
DiCre-formin2-5`-
rev 
CCATTTTGCCTGTTCAAGTG 2 
DiCre-formin2-
excision-fw 
TTCTCATTTTAGCTTCACCACG 2 
pGEM-sequencing -
fw 
TGTAATACGACTCACTATAGGGC 3 
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pGEM-sequencing -
rev 
ATTTAGGTGACACTATAGAATACTC 3 
C-term-Cas9_seq-
fw1 
TGGAGCTGCTGAAGCTGGAG 3 
C-term-Cas9_seq-
fw2 
GACAGCCTGACCTTTAAAGAGG 3 
C-term-Cas9-seq-
fw3 
GATGAAGAACTACTGGCGGC 3 
C-term-Cas9-seq-
fw4 
CTCTGATCGAGACAAACGGC 2, 3 
N-term-Cas9-seq-
fw1 
AGAAGTACCCCACCATCTACC 3 
N-term-Cas9-seq-
fw2 
ATAGTACGCCGACCTGTTTCTG 2, 3 
TUB8-sequencing-
fw1 
GTTCTTGCGGAAAACTACTCG 3 
TUB8-sequencing-
fw2 
CGCCCTTTCCTTCTCTTTGCG 3 
sequencing-rev CCACAGCGGAACAACTCAGTTTC 2, 3 
Int-gRNA-fw CAGTCACGACGTTGTAAAAC 2 
Int-RNA-rev CAAGTTGATAACGGACTAGCC 2 
gRNA-sequencing-
rev GACAGCAGACAACTTTCC 
3 
pU6-gRNA-
sequencing-fw CTTGCGCAGCATACACTCGAAGC 
3 
 
2.8 Plasmids 
Table 2-10: Plasmids 
*Please note that the lacZ-sgRNA plasmid was generated by Marleen Büchler under the 
supervision of Dr Elena Jimenez-Ruiz. The formin2- and the profilin-sgRNA plasmids were 
created by Dana Aghabi under my supervision.  
Plasmid  reference 
sgRNA-
plasmids 
pU6_sgRNA_dhfr_Amp This study* 
sCas9-N-term-
split4 
pTUB8_NES_N-terminus-Cas9-
split4_FRB_HX_Amp 
This study 
sCas9-C-term-
split4 
pTUB8_NLS_FKBP_C-terminus-Cas9-
split4_NLS_Amp 
This study 
Actin-
chromobody-
emerald 
pDHFR_Actin-Chromobody_Emerald_Amp (Periz et al. 
2017) 
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2.9 Cell strains 
2.9.1 Bacteria strains and mammalian cell lines 
Table 2-11: Bacteria strains 
Strain Competence Source 
DH5α Chemically competent New England BioLabs 
One Shot Top10 Chemically competent Thermo Fisher Scientific 
XL-10 Gold Chemically competent Stratagene 
 
Table 2-12: Mammalian cells 
Cells Organism Source 
Human foreskin fibroblasts  (HFF), 
primary cell line 
Homo sapiens ATCC® SCRC-
1041™ 
 
2.9.2 Toxoplasma strains 
Table 2-13: Toxoplasma strains 
Strain  Genotype Reference 
RH RHΔhx (Donald et al. 
1996) 
RHΔku80 RHΔku80Δhx (Fox et al. 2009; 
Huynh and 
Carruthers 2009) 
RHΔku80-
DiCre 
RH_DiCre_T2A_∆ku80∆hx_CAT (Hunt et al. 2019) 
RH-gap40 RH_gap40sgRNA_dhfr_Δhx this study 
RHsCas9-
gap40 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_gap40sgRNA_dhfr_hx 
this study 
RHsCas9 RH_ Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_hx 
this study 
RHsCas9-Δhx RH_ Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_Δhx 
Matthew Gow, 
unpublished 
RHsCas9-sag1-
1 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_sag1sgRNA1_dhfr_hx 
this study 
RHsCas9-sag1-
1-KO 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-
split4_sag1sgRNA1_dhfr_hx_sag1disrupted 
this study 
RHsCas9-Δhx-
sag1-1-KO 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-
split4_sag1sgRNA1_dhfr_Δhx_sag1disrupted 
Matthew Gow, 
unpublished 
RHsCas9-sag1- RH_Cas9-N-Termius-split4_split-Cas9-C- this study 
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3 Terminus-split4_sag1sgRNA3_dhfr_Δhx 
RHsCas9-
sag1KO-sag1* 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-
split4_sag1sgRNA1_dhfr_hx_sag1disrupted_s
ag1* (sag1* represents a mutated sag1 gene 
variant) 
Matthew Gow, 
unpublished 
RHsCas9-lacZ RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_lacZsgRNA_dhfr_hx 
Marleen Büchler 
and Dr Elena 
Jimenez-Ruiz, 
unpublished 
RHsCas9-
mec17-2 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_mec17sgRNA2_dhfr_Δhx 
this study 
RHsCas9-
mec17-3 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_mec17sgRNA3_dhfr_Δhx 
this study 
RHΔku80-
DiCre-
Pfmec17loxP 
RHΔku80_DiCre_loxP-Pfmec17-loxP_dhfr_hx Stortz 2014, 
Master Thesis, 
Ruprecht-Karls-
University of 
Heidelberg 
RHsCas9-
CbEmerald 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_actin-chromobody-
Emerald_dhfr_Δhx 
this study, in 
collaboration with 
Dr Simon Gras 
RHsCas9-
CbEm-actin1 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_actin-chromobody-
Emerald_actin1sgRNA_dhfr_Δhx 
this study  
RHsCas9-
CbEm-adf 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_actin-chromobody-
Emerald_adfsgRNA_dhfr_Δhx 
this study 
RHsCas9-
CbEm-sag1-3 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_actin-chromobody-
Emerald_sag1sgRNA3_dhfr_Δhx 
this study 
RHΔku80-
TgFormin2-HA 
RHΔku80_formin2_HA_Δhx Dr Mirko Singer, 
(Stortz et al. 
2019) 
RHΔku80-
DiCre-loxP-
frm2YFP-loxP 
RHΔku80_DiCre_loxP_formin2_YFP_loxP_Δhx Dr Mirko Singer, 
(Stortz et al. 
2019) 
RHsCas9-
CbEm-formin2 
RH_Cas9-N-Termius-split4_split-Cas9-C-
Terminus-split4_ actin-chromobody-
Emerald_formin2sgRNA_dhfr_Δhx 
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2.10  Microbiology Methods 
2.10.1 Liquid cultures and cryopreservation stocks of E. coli  
After a growth period of 14-17h on an agar plate, a single bacterial colony was 
picked and added to LB-medium containing ampicillin (100μg/ml). Liquid 
cultures were incubated at 37°C while shaking. Cryopreservation was achieved 
by mixing freshly grown E. coli liquid cultures with freezing media (LB-Medium 
containing 40% glycerol and 2% peptone) in a ratio 1:2. Cryostocks were stored at 
-80°C.   
 
2.10.2 Transformation of chemically competent E. coli 
For transformation purposes, chemically competent E. coli cells were defrosted 
on ice.  After this, DNA was added to 25µl of bacterial suspension, followed by 
an incubation time of 45min on ice. The heat-shock was performed at 42°C for 
30s. Subsequently, bacteria were again incubated in ice for 2min. The bacterial 
suspension was then spread on ampicillin-containing (100µg/ml) LB-agar plates 
(1.5 % (w/v) agar in LB medium) and incubated at 37°C for 14-17h.   
When the pGEM®-T Easy vectors system (Promega) was used for transformation, 
the LB-agar plates were treated with IPTG and X-Gal prior to bacteria spreading. 
This allowed for blue/white colony screening. 
 
2.11 Molecular Biology Methods 
2.11.1 Polymerase Chain Reaction (PCR)   
PCR was performed to amplify DNA fragments from various template DNAs. The 
PCR mix (25µl) contained the following reagents: template DNA, 2.5µl 10 x PCR 
reaction buffer, 0.5µl dNTPs (stock: 10mM, final: 0.2mM), 1µl forward primer 
(stock: 10pmol/µl, final: 0.4pmol/µl), 1µl reverse primer (stock:10pmol/µl, 
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final: 0.4pmol/µl) (for primers refer to Table 2-9), 0.1µl Platinum Taq DNA 
polymerase High-Fidelity (Invitrogen), 1 µl of the Q5® high-fidelity DNA 
polymerase or 0.125 Taq DNA polymerase (New England Biolabs) and water 
(Fisher Scientific, DNA grade). Platinum Taq DNA polymerase High Fidelity 
(Invitrogen) required addition of 1µl MgSO4 (stock: 50mM, final: 2mM). If 
necessary, betaine solution (Sigma-Aldrich) was added (stock: 5M, final: 0.2M). 
The Q5 high CG enhancer was added to the reaction mix when the Q5® high-
fidelity DNA polymerase was used. All Polymerases were used with their 
respective buffers as supplied by the manufacturer. High-fidelity Polymerases 
were exploited to avoid mutations during DNA fragment amplification. The Taq 
DNA Polymerase was used for analytical purposes.  
PCR cycles were set to an initial denaturation at 95°C for 3-10min, followed by 
30 repeats of denaturation (95°C, 30 sec), annealing (30 sec) and elongation. A 
final elongation step was performed for 5-10min. The annealing temperature 
depended on the melting temperature of the primers used. Elongation duration 
was calculated according to the size of the amplified DNA fragment. The 
temperature for the elongation steps was chosen based on the specific Tag 
polymerase requirements as described by the manufacturer.  
 
2.11.2 Agarose Gel Electrophoresis (AGE) 
To separate DNA fragments, agarose gel electrophoresis (AGE) was performed.  
Depending on the size range of DNA fragments gels containing 0.8-1.2% agarose 
in 1x TAE buffer were exploited. The DNA was visualized by UV light. For this 
purpose, gels were supplemented with 1/100 GelRed Nucleic Acid Stain (Phenix 
research products). A 6x laoding dye was used for DNA loading onto the gel. DNA 
ladders were used to calculate the size of the DNA fragments. 
 
2.11.3 DNA restriction  
Restriction enzymes (New England BioLabs) and their respective buffers were 
used according to the manufacturer’s instructions. Duration of the restriction 
reaction was calculated depending on the DNA amount and the number of units 
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per ml (U/ml) of the enzyme stock. Usually, analytic restriction digests were 
performed in a total volume of 30µl for 1-4h, while preparative restriction 
digests were usually incubated overnight.When plasmid backbones were 
prepared for future sub-cloning by restriction digest, the reaction was treated 
with CIP (10U, New England BioLabs) at 37°C for 1h.  
When larger amounts of DNA were digested, e.g. for Toxoplasma transfections, 
reactions were incubated for 14-17h in total volume of 100-120µl. To maximise 
restriction efficiency, the reactions were toped up with their respective 
enzymes after the initial 14-17h and incubated again for 1h. 
 
2.11.4 DNA purification 
DNA fragments were purified from PCR using either the MinElute PCR 
Purification Kit (Qiagen) or High Pure PCR Product Purification Kit (Roche). To 
extract DNA from an agarose gel, the MinElute Gel Extraction Kit (Quiagen) was 
exploited. The procedures were performed according to the manufacturer´s 
instructions. DNA was eluted in water (Fisher Scientific, DNA grade). 
 
2.11.5 DNA ligation 
For sub-cloning purposes, the T4-DNA-Ligase (New England BioLabs) was applied 
to ligate restricted DNA fragments. The ligation mix had a total volume of 10µl. 
The mix contained 1µl of T4-DNA-Ligase and 1µl of 10x T4-DNA ligase buffer 
(New England BioLabs). When DNA fragments were ligated into the pGEM®-T 
Easy vector (Promega), the ligation mix was set up according to the 
manufacturer’s instructions. Ligation reactions were incubated at 4°C for at 
least 12h.   
 
2.11.6 Isolation of plasmid DNA from E.coli 
Isolation of plasmid DNA from bacterial liquid cultures was performed according 
to the QIAprep Spin Miniprep Kit (Qiagen) or the QIAGEN Plasmid Plus Midi Kit 
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(Qiagen). To achieve maximum elusion efficiency, DNA was incubated with water 
(Fisher Scientific, DNA grade) at room temperature for 10min, followed by a 
centrifugation step of 3min at 13,000rpm. 
Alternatively, the QIAprep Spin Miniprep Kit (Qiagen) was followed until the 
centrifugation step (10min, 13,000 rpm). Then, the supernatant was taken off 
and mixed with 100% Isoporopanol (ice-cold) in a ratio 1:1. The samples were 
stored at -80°C for at least 1h. To pellet the plasmid DNA, the mixture was 
centrifuged at 14,000rpm at 4°C. The DNA pellet was washed twice with 70% 
Ethanol. After this, the pellet was air dried and finally resuspended in 100µl 
water (Fisher Scientific, DNA grade). 
 
2.11.7 Alcohol precipitation of plasmid DNA for Toxoplasma 
transfections  
Toxoplasma transfection required DNA to be purified and concentrated via 
ethanol precipitation. To achieve this, DNA was mixed with 2.5 volume of ice-
cold 100% ethanol and 1/10 NaAc (3M, pH5). This mix was incubated at -20°C for 
at least 14h. The DNA was subsequently pelleted for 60min at 4°C and maximum 
speed. After two washing steps with ice-cold 70% ethanol (centrifugation: 10min, 
4°C, maximum speed), the supernatant was removed under sterile conditions. 
The DNA pellet was air dried for approximately 15-45min. Depending on the 
transfection system, the DNA was resuspended in cytomix (BioRad© system) or P3 
buffer (Amaxa© system). DNA was stored until transfection at 4°C for up to 2 
days or at -20°C until use. 
 
2.11.8 Isolation of genomic DNA (gDNA) from Toxoplasma 
To isolate genomic DNA from tachyzoites, the DNeasy Blood & Tissue Kit 
(Qiagen) was applied according to the manufacturer´s instructions. Prior to Kit 
application, freshly lysed tachyzoites (0.4-1ml) were pelleted by centrifuging at 
6,000rpm for 10min. Genomic DNA was eluted in 100µl of water (Fisher 
Scientific, DNA grade) after an incubation time of 5-10min. 
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2.11.9 Sub-cloning of the split-Cas9 plasmids 
The N and C-terminus of the Cas9 enzyme (split4 variant) (Figures 2-1 and 2-2) 
were amplified from the original plasmids provided by Zetsche and colleagues 
(Zetsche, Volz, and Zhang 2015) via PCR. The PCR amplicons were ligated into 
the pGEM®-T Easy vector and sequenced. Subsequently, the Cas9 N and C-
terminus were cloned into a Toxoplasma expression vector via the restriction 
enzymes EcoRI and PacI. For the C-term-Cas9 vector, the hx selection marker 
was removed by restriction with SacII. Correct positioning of the Cas9 N and C-
terminus in the expression vector was confirmed by sequencing.  
 
Figure 2-1: Plasmid encoding the split-Cas9 N-terminus (split4 variant) 
The Cas9-N-terminus was expressed under the TUB8 promoter. The restriction site KpnI 
was used to linearize the plasmid for transfection. The plasmid codes for the hx selection 
marker 
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Figure 2-2: Plasmid encoding the split-Cas9 C-terminus (split4 variant) 
The Cas9-C-terminus was expressed under the TUB8 promoter. The restriction site KpnI 
was used to linearize the plasmid for transfection. Please note that this plasmid does not 
code for a selection marker. 
 
2.11.10 Sub-cloning of gRNA plasmids 
The Q5® Site-Directed Mutagenesis Kit (New England Biolabs) was used to insert 
gene-specific sgRNAs into the universal sgRNA plasmid (Figure 2-3) according to 
the manufacturer’s instructions.  Importantly, a universal reverse primer was 
used together with a forward primer to which the whole sgRNA sequenced was 
attached (Table 2-9). All sgRNA-plasmids were sequenced to confirm proper 
sgRNA insertion and sequence.  
 
2.11.11 DNA sequencing 
Plasmid DNA was sequenced by Eurofins (GATC services, LightRun Tubes). DNA 
was prepared for sequencing in accordance with the company’s protocol. 
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Figure 2-3: Plasmid encoding sgRNAs 
The sgRNA (gene-specific gRNA and tracrRNA) were expressed under a pU6 promoter. 
The selection marker is dhfr. The restriction site NotI was used to linearize the plasmid for 
transfection. This figure shows the gap40sgRNA plasmid as an example. All other gRNA 
plasmids possess the same sequence with the gene-specific gRNA being the only 
difference.  
 
2.12 Biochemistry Methods 
2.12.1 Indirect Immunofluorescence Analysis (IFA) 
For IFA analysis, tachyzoites were grown in HFFs cells on glass coverslips until 
fixation with 4%PFA for 20min at RT. Samples were then washed with 1xPBS and, 
subsequently, permeabilised with 0.2% Triton X-100/1xPBS for 20min at RT. A 
3%BSA (in 0.2% Triton X-100/1xPBS) solution was used for blocking purposes. 
Samples were incubated with the blocking solution for at least 20min at RT. 
Subsequently, primary antibodies (diluted in 3%BSA/0.2%TritonX-100/1xPBS) 
were applied to the sample for 60min at RT. After washing the samples with 
1xPBS, the secondary antibodies were applied for 45-60min at RT. Another 
washing step with 1xPBS was performed prior to coverslip mounting with Dapi 
fluoromount G (Southern Biotech). To protect fluorescent proteins from 
bleaching, all steps were carried out in the dark. Please refer to Table 2-8 for a 
full list of primary and secondary antibodies. 
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2.13 Cell Culture 
2.13.1 Culturing host cells (HFFs) and Toxoplasma 
Human foreskin fibroblasts (HFFs) were cultured in DMEMcomplete at 37°C and 
5%CO2. HFFs are a primary cell line and were used until passage 25. Toxoplasma 
tachyzoites were grown on a HHF monolayer at 37°C and 5%CO2 in 
DMEMcomplete. After complete lysis of the host cell monolayer, parasites were 
inoculated onto a fresh monolayer. Please refer to Table 2-13 for the complete 
list of Toxoplasma lines used in this study. 
 
2.13.2 Cryopreservation of Toxoplasma  
Cryopreservation was performed to enable long term storage of Toxoplasma 
lines. For this purpose, host cells containing large vacuoles of intracellular 
parasites were taken up in DMEM only and added to 2x freezing mix (pure DMEM, 
25% FCS, 10% DMSO) in a ratio of 1:1. These stabilates were frozen at -80°C and, 
subsequently, stored in liquid nitrogen.  
Cryopreserved parasites were thawed at 37°C and immediately inoculated onto a 
fresh HFF cells. The medium was changed every 48h until healthy parasites were 
detectable.   
 
2.13.3 Stable and transient transfections of Toxoplasma  
Stable transfections 
In this study, freshly lysed Toxoplasma tachyzoites were transfected with the 
Bio-Rad© or the Amaxa© system. For the Bio-Rad© electroporator, parasites were 
resuspended in 640µl cytomix together with 30µl ATP (100mM), 30µl GSH 
(100mM) and 100µl of linearized plasmid DNA (30-60µg). This mix was 
transferred into an electroporation cuvette. After electroporation (1700V, 2 
pulses for 0.2s), parasites were inoculated on HFF cells. About 1ml of freshly 
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lysed parasites from a 6cm dish (total volume 4ml) were used for the Bio-Rad© 
electroporator. 
The Amaxa© system required the resuspension of parasites in 10µl (transfection 
in strips) or 50µl (transfection in cuvettes) P3 buffer. For strips, parasites were 
mixed with 10µl of linearized DNA in P3 buffer. For cuvettes, 50µl of linearized 
DNA in P3 buffer was added to the parasites. Between 20-35µg of DNA was used 
for Amaxa© transfections. 100µl (strips) or 200µl (cuvettes) of freshly lysed 
parasites from a 6cm dish (total volume 4ml) were used for Amaxa© 
transfections. 
Selection for stable plasmid integration into the Toxoplasma genome was 
achieved by culturing transfected population with selection markers. In this 
study, parasites were selected with 25mg/ml MPA in combination with 40mg/ml 
XAN when parasites were selected for the hx gene (Donald et al. 1996). When 
selected for the dhfr resistance marker, parasites were treated with 1μM 
pyrimethamine (Donald and Roos 1993). 
 
Transient transfections 
For transient transfections, circular plasmid DNA was used. Apart from this, the 
same protocols as described for stable transfections were applied. Transiently 
transfected parasites were used for IFA analysis (refer to section 2.12.1) 24-72h 
after transfection.  
 
2.13.4 Generation of the parental split-Cas9 (sCas9) strain  
The Cas9 N and C-terminus plasmids (Figures 2-1 and 2-2) were co-transfected 
into RHΔhx parasites. Parasites were selected with 25mg/ml MPA in combination 
with 40mg/ml XAN for the hx gene (Donald et al. 1996). Prior to transfection, 
the plasmids had been linearized with the restriction enzyme KpnI (New England 
BioLabs). This restriction enzyme was added to the transfection mix prior to 
electroporation to allow for Restriction Enzyme Mediated Insertion (REMI) (Black 
et al. 1995). Clonal lines were obtained from this transfection by serial dilution. 
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Analytic PCR confirmed the presence of the Cas9 N and C-terminus in the 
parasite genome. Split-Cas9 activity was confirmed by transient transfection of 
RHsCas9 parasites with the gap40-sgRNA and subsequent induction with 
rapamycin.  
 
2.13.5 Generation of sCas9-sgRNA strains 
RHsCas9 or RHsCas9-CbEmerald parasites were transfected with linearized 
sgRNA-plasmids. sgRNA plasmids were linearized via the NotI restriction enzyme. 
NotI was also added to the transfection mix to enable Restriction Enzyme 
Mediated Insertion (REMI) (Black et al. 1995). Transfected parasites were 
cultured with 1μM pyrimethamine which selects for the dhfr resistance marker 
(Donald and Roos 1993). Presence of the sgRNA-plasmid in the parasite genome 
was verified via integration PCR.  
 
2.13.6 Generation of RHsCas9-CbEmerald strain 
The RHsCas9-CbEmerald strain was generated in collaboration with Dr Simon 
Gras. Initial transfection of the actin-chromobody-emerald plasmid (Figure 2-4) 
and enrichment of positive parasites via FACS sorting was performed by Dr Simon 
Gras. Subsequently, I isolated clonal RHsCas9-CbEmerald lines and tested them 
for split-Cas9 activity. For this purpose, I transfected parasites with the gap40-
sgRNA in transient, induced with rapamycin and analysed split-Cas9 activity by 
quantifying vacuoles depicting a gap40 phenotype. 
 
2.13.7 Serial dilution of transfected Toxoplasma parasites 
Serial dilution was performed to isolate clonal parasite lines from the 
transfection pool after drug selection. For this purpose, parasites were serial 
diluted on 96 well plates and cultivated for 5-7 days in the presence of the 
respective selection marker under normal culturing conditions. Eventually, each 
well of the 96 well plates was examined for plaque formation. A single plaque 
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indicated a clonal parasite line. Clonal populations were subsequently cultured 
under normal conditions for further examination and experiments.  
 
Figure 2-4: Plasmid encoding the actin-chromobody-Emerald 
The actin-chromobody-emerald was expressed under the DHFR promoter. Please note 
that this plasmid does not code for a selection marker. 
 
2.13.8 Induction of the split-Cas9 or DiCre system in 
Toxoplasma 
Conditional split-Cas9 or DiCre mutants were obtained by adding 50nM 
rapamycin to the parental lines. Parasites were incubated for 1h (split-Cas9) or 
4h (DiCre) at 37°C and 5% CO2 and then cultured as described above (refer to 
section 2.13.1). Alternatively, parasites were treated with 50nM rapamycin until 
fixation. To enrich RHsCas9-CbEm-actin1-KO mutants for time-lapse microscopy, 
these parasites were cultured in DMEMcomplete supplemented with 2.5% dextran 
sulphate at 24h after induction. This was done to inhibit re-invasion of wild-type 
parasites.  
Successful gene targeting by the respective gRNAs was confirmed by sequencing 
the predicted DNA cleavage site after rapamycin induction. For this purpose, 
RHsCas9 parasites were induced for 1h with 50nM rapamycin. After 48h, gDNA 
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was isolated from induced parasites and the predicted DNA cleavage sites were 
amplified by PCR. After sub-cloning into the pGEM®-T Easy vector (Promega), 
the cleavage sites were sequenced. The disruption of Tgmec17 and Tgsag1 genes 
was confirmed in clonal knock-out populations. The obtained sequences were 
compared to the predicted wild type sequence (Tgadf, Tgactin1, Tgmec17 and 
Tgsag1) or to the non-induced strain (Tgformin2).  
 
2.13.9 Egress Assay 
Induced (50nM Rapamycin, 1h) and non-induced RHsCas9-CbEm parasites were 
grown for 48h. Egress was then induced by incubating parasites with 2µM A23187 
for 5-8min under normal culturing conditions (refer to section 2.13.1). 
Subsequently, parasites were fixed with 4%PFA and IFA was performed as 
described above (refer to section 2.12.1).  
 
2.14 Microscopy 
2.14.1 Light microscopy 
Fluorescent microscopy was performed on a DV Core microscope 
(AppliedPrecision, GE) attached to a CoolSNAP HQ2 CCD camera. Images were 
de-convolved with SoftWoRx Suite 2.0 (Applied Precision, GE). Images were 
processed with ImageJ (Schneider, Rasband, and Eliceiri 2012; Schindelin et al. 
2012). 
Super-resolution microscopy was conducted on an ELYRA PS.1 microscope 
(Zeiss). A Plan Apochromat 63×, 1.4 NA oil immersion lens was used together 
with a CoolSNAP HQ camera (Photometrics). Structure Illumination was achieved 
exploited ZEN Black software (Zeiss). Images were processed with ImageJ and 
Fiji (Schneider, Rasband, and Eliceiri 2012; Schindelin et al. 2012). 
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2.14.2 Time-lapse video microscopy for Toxoplasma 
Conditional split-Cas9 strains were grown on fresh HFF cells for 72h as described 
above. Subsequently, parasites were mechanically lysed and inoculated on glass 
bottom dishes (MaTek) for another 24h. RH-GFP parasites were inoculated on 
glass bottom dishes (MaTek) for 24h. Prior to live microscopy, the 
DMEMcomplete culturing media was replaced with FluoroBrite DMEM media 
supplemented with 10% FBS, 2 mM L-glutamine and 25 mg/mL gentamycin. The 
dish was then transferred to the DV Core microscope (AppliedPrecision, GE) and 
maintained under standard culturing conditions (37°C, 5% CO2). Images were 
taken at a speed of 10 frames per second using a 100x oil objective lens. Please 
note that the actual movie frame rate differs. Deconvolution was performed 
using SoftWoRx Suite 2.0 (Applied Precision, GE). Videos were processed with 
ImageJ and Fiji (Schneider, Rasband, and Eliceiri 2012; Schindelin et al. 2012).  
 
2.15 Bioinformatics 
2.15.1 Design of gRNAs for Toxoplasma 
In this study, sgRNAs design was based on the available literature at the time. It 
was reported that a so-called seed sequence within the CRISPR/Cas9 target 
sequence is important for DNA cleavage. This seed sequence is located at the 3` 
region of the protospacer, adjacent to the crucial PAM motif (Gorski, Vogel, and 
Doudna 2017).  
Jinek and co-workers provided data indicating that mutations within the seed 
sequence close to the PAM can interfere with CRISPR/Cas9 mediated cutting 
(Jinek et al. 2012). Further studies revealed that single-nucleotide mismatches 
up to 11bp upstream of the PAM sequence prevent CRSIPR/Cas9-activity in 
mammalian cells (Cong et al. 2013). Yet another study supported the concept of 
a seed sequence by showing that mutations within the 12 nucleotides upstream 
of the PAM stopped DNA cutting by CRISPR/Cas9 (Jiang et al. 2013). The same 
study, however, also pointed out that only certain nucleotide exchanges prevent 
cleavage, depending on their position in the seed sequence. Mutations are more 
likely to terminate Cas9-mediated DNA cutting when they take place closer to 
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the PAM (Jiang et al. 2013). Outside the seed sequence, a number of 8 
consecutive mismatches at the position 13-20 upstream of the PAM sequence was 
required to render the Cas9 nuclease ineffective (Jinek et al. 2012). 
It was proposed that, after PAM recognition and binding, the Cas9-gRNA complex 
scans the protospacer seed sequence for its gRNA complementarity (Sternberg et 
al. 2014; Jiang et al. 2015). Sternberg and colleagues suggested that mismatches 
within the seed sequence would cause Cas9 to abort further target sequence 
interrogation (Sternberg et al. 2014). Importantly, the PAM was shown to be 
critical for target DNA cleavage by the Streptococcus pyogenes type II Cas9 
system (Jinek et al. 2012). Jinek and co-workers suggested that this is because 
the PAM is required for CRISPR/Cas9 binding to the target DNA. The PAM 
sequence is NGG (Jinek et al. 2012). 
Based on these findings, it was proposed that the lack of a PAM sequence 
adjacent to a potential genomic off-target sequence should prevent Cas9-
mediated DNA cleavage (Jiang et al. 2013; Sternberg et al. 2014). In the 
presence of a PAM sequence, Jiang and co-workers suggested that multiple 
mutations in the seed sequence could protect from nuclease activity (Jiang et 
al. 2013). In Toxoplasma, two mismatches within the seed sequence 
dramatically decreased the gRNA efficiency (Shen et al. 2014).  
As described previously for the CRISPR/Cas9 system in Toxoplasma, sgRNAs were 
designed to have a length of 20 nucleotides (Shen et al. 2014; Sidik et al. 2014, 
2016; Sidik, Huet, and Lourido 2018). In addition, a leading “G” was added to 
the 5´ end when the complementary sgRNA sequence did not naturally start with 
a “G” (Sidik et al. 2016; Sidik, Huet, and Lourido 2018). 
The observed findings described above were taken into account to avoid off-
target gene disruption by the sgRNA-Cas9 complex. A newly designed sgRNA was 
only considered suitable for specific gene targeting if potential off-target 
sequences (1) lacked a complete PAM and/or (2) had at least one mismatch 
within the seed sequence defined as the 11bp adjacent to the PAM and/or (3) 
showed at least 8 mismatches outside the seed sequence.  
To ensure the application of these guidelines, a two-step process was applied for 
the purpose of sgRNA design. First, sgRNAs were designed exploiting the 
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Eukaryotic Pathogen gRNA Design Tool (EuPaGDT) (Peng and Tarleton 2015). 
Settings were chosen to reflect the guidelines described above. Only sgRNAs 
predicted to have no off targets were accepted. Secondly, the accepted sgRNAs 
were blasted against the Toxoplasma genome and the Cb-Emerald sequence (if 
present in the genome) using NCBI BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to manually check for potential off-
targets.  
 
2.15.2 Kymograph analysis 
Colour-coded kymographs were generated by applying the ImageJ plugin 
“KymographClear” as described previously (Mangeol, Prevo, and Peterman 
2016). In short, a track was defined on a maximum intensity image that was 
calculated from an image sequence (movie). A kymograph was then generated, 
depicting particle movement alongside the chosen track. Fourier filtering of the 
kymograph enables the distinction between forward-moving (red), backward-
moving (green) and static (blue) particles.  
Kymograph data was exported to the stand-alone software “KymographDirect” 
to generate time-averaged local intensity profiles (Mangeol, Prevo, and 
Peterman 2016). Intensity profiles depict Cb-Emerald or GFP intensity along the 
measured axis over the entire duration of the movie. Background corrections 
were performed for all imported kymographs.  
 
2.15.3 Skeletonization analysis 
Image sequences (movie) were skeletonized with the ImageJ plugin “Skeleton” 
(Schindelin et al. 2012). Prior to skeletonization, thresholding was performed on 
the movie stacks to create binary images. These binary images were then used 
for skeletonization. Skeletonized images in this study represent collapsed t-
stacks. 
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3 Establishment of a novel conditional CRISPR/Cas9 
system for reliable gene disruption in 
Toxoplasma 
The overall aim of this thesis is to gain insights into actin factors and dynamics 
in the apicomplexan parasite Toxoplasma gondii by exploiting the recently 
introduced Chromobody technology for actin visualization (Periz et al. 2017). 
This endeavour will require the generation of several strains and, eventually, 
shall initiate a medium throughput screen to identify potentially novel actin 
binding proteins. Therefore, initial experiments of this study will focus on 
establishing a reliable and rapid CRSIPR/Cas9-based methodology that allows 
investigation of genes on a screening scale.  
Prior to this study, CRISPR/Cas9 systems had been established successfully for 
genome modification in Toxoplasma. Single target gene disruption and site-
specific insertions were achieved (Shen et al. 2014; Sidik et al. 2014). 
CRISPR/Cas9 also enabled genome-wide screening leading to the discovery of 
novel fitness-conferring apicomplexan genes (Sidik et al. 2016; Sidik, Huet, and 
Lourido 2018). In addition, a conditional nuclear Cas9 fused to ddFKBP was 
introduced and applied to identify factors involved in the nuclear export of RNA 
(Serpeloni et al. 2016).  
Despite significantly advancing the understanding of Toxoplasma biology, 
CRISPR/Cas9 systems are also associated with certain challenges. For instance, 
data suggest that constitutive or prolonged Cas9 expression negatively impacts 
parasite fitness (Sidik et al. 2016; Serpeloni et al. 2016; Markus et al. 2019). 
Transient Cas9 expression was suggested to cause aberrant mitochondria 
morphology (Lacombe et al. 2019). Furthermore, disruption of non-essential 
genes was reported to sometimes result in parasites displaying aberrant 
morphology (Serpeloni et al. 2016). Finally, the conditional Cas9-ddFKBP system 
appears to suffer from background activity leading to undesired disruption of the 
target gene in the parental strain (Dr Elena Jimenez-Ruiz, unpublished data).  
Since actin is highly crucial for the lytic cycle of Toxoplasma (Andenmatten et 
al. 2013; Egarter et al. 2014), a conditional gene disruption system is 
advantageous for investigating potentially essential actin dynamic factors. 
Therefore, I aimed at further exploring the potential of conditional CRSIPR/Cas9 
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systems in Toxoplasma research. To circumvent reported issues with previous 
systems, I chose to establish the conditional split-Cas9 system that had recently 
been described in mammalian cells (Zetsche, Volz, and Zhang 2015) (Figure 3-
1). In this rapamycin-inducible system, the Cas9 enzyme is split into two sub-
units (N- and C-terminus) which are fused to a FKBP or FRB domain. Split-Cas9 
activity was reported to be tightly regulated due to spatial separation of the 
Cas9 N- and C-terminus which are linked to a nuclear localisation sequence (NLS) 
or nuclear export signal (NES). In addition, the re-assembled split-Cas9 enzyme 
possesses decreased nuclease activity compared to the wild-type Cas9 enzyme. 
This aspect might be beneficial for parasite tolerance towards prolonged Cas9 
presence within the cell. 
In this chapter, I will present results that illustrate split-Cas9 functionality and 
shed further light on the advantages and disadvantages of CRISPR/Cas9-based 
gene analysis in Toxoplasma.  
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Figure 3-1: Schematic depicting the split-Cas9 system in Toxoplasma 
Please see page 90 for the schematic. Parasites are expressing the two split-Cas9 sub-
units together with a single-guide RNA (sgRNA). The system remains inactive in the 
absence of rapamycin. Activation of split-Cas9 by reassembly of the sub-units results in 
gene disruption due to insertion or deletion of nucleotides (INDELs). 
 
3.1 Proof of Principle I: Targeting Tggap40 with split-Cas9 
To verify functionality of split-Cas9 in Toxoplasma, I chose to target the 
essential Tggap40 gene (Harding et al. 2016). This decision was based on the 
severe and very distinguishable phenotype that is caused by loss of Tggap40 gene 
function (Harding et al. 2016). In addition, Tggap40 had previously been 
exploited as a successful proof of principle target for CRISPR/Cas9 systems 
(Serpeloni et al. 2016). 
For this purpose, I decided to adapt the split 4 variant of the split-Cas9 system 
(Zetsche, Volz, and Zhang 2015). A parasite line coding for the two split-Cas9 
sub-units (RHsCas9), a parasite expressing a gap40sgRNA (RH-gap40) and a line 
that encoded the two split-Cas9 units together with the gap40sgRNA (RHsCas9-
gap40) were created (Figure 3-1 and 3-2). The gap40sgRNA plasmid and the 
split-Cas9 sub-units were randomly integrated into the parasite genome. 
Integration was confirmed by analytical PCR amplifying specific plasmid DNA 
sequences present in successfully transfected parasites, but not the parental 
strains (Figure 3-2). 
Upon rapamycin treatment, a gap40 phenotype as described in the literature 
(Harding et al. 2016) was observed in up to 95% of RHsCas9-gap40 parasites, but 
not in RH-gap40 or RHsCas9 parasites (Figure 3-3). Induced RHsCas9-gap40 
parasites showed a lack of TgGAP40 protein in IFA, indicating that the Tggap40 
gene was successfully disrupted by the split-Cas9 system (Figure 3-3 A). No 
difference in Tggap40 gene disruption efficiency was detected when RHsCas9-
gap40 parasites where treated with rapamycin for 1h or 48h (Figure 3-3 B). 
About 10% of non-induced RHsCas9-gap40 parasites displayed a partial gap40 
phenotype, potentially hinting towards a certain degree of split-Cas9 background 
activity (Figure 3-3 A and B). 
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Figure 3-2: Generation of RH-gap40sgRNA (RH-gap40), RHsplit-Cas9-
gap40sgRNA (RHsCas9-gap40) and RHsplit-Cas9 (RHsCas9) parasites 
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Figure 3-2 continued: (A) Plasmid coding for the gap40 single-guide gRNA (sgRNA). 
This plasmid was universally used for sgRNA expression in this thesis. Arrows indicate 
PCR amplicon for verification of plasmid integration (see (B)). (B) Analytical PCR 
confirming integration of sgRNA-plasmid into the parasite genome. (C) Plasmids coding 
for the N- and C-terminus of the Cas9 enzyme (split 4 variant). Arrows indicate PCR 
amplicon for verifying plasmid integration (see (D)). (D) Analytical PCR confirming 
integration of split-Cas9 plasmids into the genome of RH-gap40 parasites. (E) Analytical 
PCR confirming of integration of split-Cas9 plasmids into the RH parasites. If more than 
one clonal line was obtained, the one used for further experiments in this study is 
highlighted. 
Interestingly, Cas9-mediated Tggap40 disruption impacts nuclear replication as 
nuclei appear to be heavily deformed and, potentially, not properly divided 
(Figure 3-3 A). Depletion of Tggap40 was reported to have no effect on nuclear 
replication (Harding et al. 2016). Although data presented by Harding and 
colleagues would suggest some impact of Tggap40 loss on the morphology of 
single nuclei, nuclear division in general seems unaffected. Due to the 
detrimental effect of Tggap40 loss on the overall parasite fitness and 
morphology, it is difficult to finally conclude whether these observations 
represent a secondary effect of Tggap40 loss or a potential artefact caused by 
split-Cas9 expression or activity.  
Since reports have been made about negative effects of Cas9 on Toxoplasma 
(Sidik et al. 2016; Serpeloni et al. 2016; Lacombe et al. 2019), I decided to 
further analyse the effect of (split-)Cas9 expression and activity on parasite 
fitness. I chose to target the genes Tgsag1 (refer to sections 3.2 - 3.4) and 
Tgmec17 (refer to section 3.5) with the spit-Cas9 system. The major tachyzoite 
surface protein TgSAG1 is considered to be dispensable for parasite survival (Kim 
and Boothroyd 1995; Lekutis et al. 2001). TgMec17 acts as an α-tubulin 
acetyltransferase in Toxoplasma and was suggested to be important for nuclear 
division (Varberg et al. 2016). I hypothesized that these two genes could be 
exploited to further investigate the impact of Cas9-based systems on nuclear 
morphology and replication.  
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Figure 3-3: IFA analysis and quantification of the gap40 phenotype observed 
in the strains RHsCas9-gap40, RH-gap40 and RHsCas9 upon Rapamycin 
treatment 
(A) IFA depicting the three phenotypes observed in this experiment: the gap40 phenotype 
with collapsed IMC and loss of GAP40 expression (top panel, asterisk); a partial gap40 
phenotype where only parts of the vacuole show a collapsed IMC and loss of GAP40 
signal (bottom panel); and wild type parasites with normal IMC and GAP40 localisation 
(top panel, arrow). Images show RHsCas9-gap40 parasites that were treated with 50nM 
rapamycin for 48h. Parasites were grown for a total of 48h and fixed with 4%PFA. IFA 
analysis was performed using α-GAP40 and α-IMC antibodies. Nuclei were stained with 
DAPI. Scale bars are 5µm. (B) Quantification of gap40 phenotypes in different strains 48h 
post inoculation (p.i.). Only parasites expressing both, the gap40sgRNA and the split-
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Cas9 system, presented a gap40 phenotype after rapamycin treatment. Parasites were 
treated with rapamycin for 1h or the whole growth period of 48h as indicated. Data 
represents three independent experiments. For each condition 100 vacuoles were 
counted (total n=300). 
 
 
Figure 3-4: Generation of strains RHsCas9-sag1sgRNA1 (RHsCas9-sag1-1), 
RHsCas9sag1sgRNA3 (RHsCas9-sag1-3), RHsCas9-mec17sgRNA2 
(RHsCas9-mec17-2), RHsCas9-mec17sgRNA3 (RHsCas9-mec17-3) and 
RHsCas9-Δhx-sag1sgRNA1 (RHsCas9-Δhx-sag1-1) 
(A) Analytical PCR confirming integration of indicated sgRNA-plasmids into the parasite 
genome. (B) Analytical PCR confirming integration of the sag1sgRNA1 plasmid into the 
genome of RHsCas9-Δhx parasites. For (A) and (B), integrated plasmids were amplified 
from the genome as described in Figure 3-2 A. (C) Genome sequencing performed for the 
clonal RHsCas9-Δhx-sag1-1-KO mutant. Green letters indicates sgRNA sequence. Red 
letters represent nucleotide insertion in the mutant strain, causing a frame shift and, thus, 
the functional knock-out of the Tgsag1 gene. The black arrow indicates the predicted cut 
side. Please note that data presented in parts (B) and (C) of this figure were generated by 
Mr Matthew Gow. 
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3.2 Proof of Principle II: Targeting Tgsag1 with split-Cas9 
Since loss of Tgsag1 gene function is not linked to any detrimental effects in 
Toxoplasma (Kim and Boothroyd 1995; Lekutis et al. 2001), I argued that 
disruption of Tgsag1 with split-Cas9 should have no measureable effects on the 
morphology and behaviour of the parasite. To investigate this, split-Cas9 
parasites were stably transfected with the sag1sgRNA1 to generate RHsCas9-
sag1sgRNA1 (RHsCas9-sag1-1) parasites (Figure 3-4 A). When treated with 
rapamycin for 1h or 48h, RHsCas9-sag1-1 parasites lost their SAG1 signal in IFA, 
strongly suggesting Tgsag1 gene disruption (Figure 3-5 A). Strikingly, 54% (±6.1) 
and 52.3% (±2.1) of parasites showed aberrant nuclei and morphology in addition 
to TgSAG1 loss after 1h and 48h rapamycin induction time, respectively (Figure 
3-5 A and B). This phenotype was only present in rapamycin-treated parasites 
expressing split-Cas9 together with the sag1sgRNA1. No impact on parasites 
morphology was observed in non-induced RHsCas9-sag1-1 parasites or RHsCas9 
parasites (cultured with or without rapamycin present).   
To further understand the occurrence of aberrant parasites, I induced RHsCas9-
sag1-1 parasites for 1h with rapamycin and mechanically lysed the parasites 
after 48h of growth.  These parasites were then inoculated again (without 
rapamycin) and fixed for IFA after 48h, thus representing the 2nd lytic cycle (2nd 
generation) of parasites after rapamycin induction. The number of parasites with 
aberrant nucleus and cellular morphology was comparable to the background 
seen in non-induced RHsCas-sag1-1 parasites (Figure 3-5 B). About 79% (±4.8) of 
2nd generation parasites were TgSAG1 negative in IFA and displayed a normal 
nucleus and cell morphology.  
A TgSAG1 negative clonal line (RHsCas9-sag1-1-KO) was created by inducing 
RHsCas9-sag1-1 parasites and, subsequently, cloning them out by serial dilution. 
These parasites displayed normal nuclear and cellular morphology while TgSAG1 
could not be detected by IFA. In addition, another sgRNA targeting the Tgsag1 
gene (sag1sgRNA3) was stably transfected into RHsCas9 parasites (Figure 3-4 A). 
This was done to exclude sgRNA off-targets as a reason for the detrimental 
effect on parasites appearance. The obtained clonal lines of RHsCas9-sag1-3 
parasites displayed highly similar behaviour upon rapamycin treatment (Table 3-
1). 
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Figure 3-5: IFA analysis and quantification of Tgsag1 disruption with split-
Cas9 
(A) IFA depicting the three phenotypes observed in this experiment: healthy vacuoles with 
SAG1 expression on the parasite surface (top and middle panel); healthy vacuoles lacking 
SAG1 expression (bottom panel, arrow); and parasites lacking SAG1 while displaying 
aberrant nuclei and cellular morphology (bottom panel, asterisk). Images show the strains 
RHsCas9 and RHsCas9-sag1-1. RHsCas9-sag1-1 parasites were treated with 50nM 
Rapamycin for 48h. Parasites were grown for a total of 48h and fixed with 4%PFA. IFA 
analysis was performed using α-SAG1 and α-MIC8 antibodies. Nuclei were stained with 
98 
 
DAPI. Scale bars are 5µm. (B) Quantification of the phenotypes 48h post inoculation (p.i.) 
as described in (A). Aberrant nuclei and cellular morphology was observed only when 
sag1 was disrupted (KO) by split-Cas9 activation.  Abundance of non-healthy parasites 
was reduced to background levels when induced RHsCas9-sag1-1 parasites were 
mechanically lysed, transferred onto fresh host cells and grown again for 48h in this 
second lytic cycle (total incubation of 96h). Parasites were treated with rapamycin for 1h 
or the whole growth period of 48h as indicated. Data represent three independent 
experiments. For each condition 100 vacuoles were counted (total n=300). 
 
Table 3-1: Phenotypic characterisation of the lines RHsCas9-sag1-3 clone1 
and 2  
Numbers were obtained by analysing IFA results. IFAs were conducted as described in 
Figure 3-5. The asterisk (*) indicates vacuoles that lack TgSAG1 signal and display 
aberrant nuclei and cellular morphology. 
 Rapamycin SAG1  lack of 
SAG1 
lack of 
SAG1* 
# vacuoles 
RHsCas9-sag1-3 
clone 1 
50nM (1h) 7 31 62 100 
 50nM (48h) 4 35 61 100 
 none 99 1 0 100 
      
RHsCas9-sag1-3 
clone 2 
50nM (1h) 7 36 57 100 
 50nM (48h) 4 45 51 100 
 none 100 0 0 100 
 
Data obtained so far suggest that the observed abnormalities occur within the 1st 
lytic cycle after split-Cas9 activation. To the author’s knowledge no conditional 
Tgsag1 knock-out mutant has been described to this point. Therefore, three 
hypotheses might explain the phenomenon in question. For one, the affected 
nuclear and cellular morphology might represent a sag1-specific phenotype that 
only half of the parasites lacking TgSAG1 are able to overcome. Another 
explanation could be that the double stranded break caused by split-Cas9 is 
causing the described effects. Finally, the sgRNA/split-Cas9 complex might cause 
the aberrant appearance independently of DNA cutting.  
 
3.3 Investigating the effect of split-Cas9 activation on 
Toxoplasma I: TgSAG1 complementation studies  
To finally clarify what causes the aberrant appearance of the nucleus and overall 
cellular morphology in the 1st lytic cycle after split-Cas9 induction, a TgSAG1 
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negative strain (RHsCas9-sag1-1-KO) was complemented with an additional 
Tgsag1* gene that was modified to prevent the sag1sgRNA1 from cutting (Figure 
3-6 A). In addition, the mutated Tgsag1* gene was also introduced into TgSAG1 
positive parasites (RHsCas9-sag1-1-wt) (Figure 3-6 A). Since both lines were 
generated in the RHsCas9-sag1-1 background, they expressed the split-Cas9 
components and sag1sgRNA1.  
The strain RHsCas9-sag1-1-sag1KO-sag1* should have no valid target for the 
sag1sgRNA as the endogenous gene had already been mutated due to previous 
split-Cas9 activation and the modified sag1 version was altered to prevent sgRNA 
recognition. RHsCas9-sag1-1-sag1wt-sag1* parasites still coded for the original 
version of the endogenous gene and, thus, presented one valid sag1sgRNA 
target.  
To generate both strains, the hx gene in RHsCas9 parasites was disrupted to 
generate RHsCas9-Δhx parasites. These parasites were transfected with 
sag1sgRNA1 (Figure 3-4 B). Subsequently, the stable RHsCas9-Δhx-sag1-1 line 
was induced and cloned out to obtain a TgSAG1 negative clonal line (RHsCas9-
Δhx-sag1-1-sag1KO). Disruption of the endogenous Tgsag1 gene was confirmed by 
sequencing (Figure 3-4 C) Re-generation of an hx deficient TgSAG1 negative line 
was necessary to allow insertion of the modified Tgsag1 gene resulting in the 
strain RHsCas9-Δhx-sag1-1-sag1KO-sag1*. As described above, this strain should 
not have any valid sag1sgRNA target. In both gene copies (Tgsag1 and Tgsag1*), 
the target site is mutated either due to previous Cas9-mediated cutting 
(endogenous Tgsag1) or due to design (Tgsag1*). The mutated Tgsag1* gene was 
also introduced into the non-induced RHsCas9-Δhx-sag1-1 strain, thus generating 
RHsCas9-Δhx-sag1-1-sag1wt-sag1* parasites. This strain encodes two Tgsag1 
versions (sag1wt and sag1*) from which only the endogenous Tgsag1 should be 
cut by the sag1sgRNA1. 
100 
 
 
Figure 3-6: Effect of split-Cas9 activation in parasites encoding an additional 
copy of the sag1 gene 
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(A) Schematic depiction of the strains sag1KO-sag1* and sag1wt-sag1*. Both strains 
were generated in the RHsCas9-sag1-1 background and, thus, express split-Cas9 and the 
sag1sgRNA1. The endogenous Tgsag1 gene in the sag1KO-sag1* line had been 
disrupted by prior split-Cas9 activation (refer to Figure 3-4 C). The endogenous Tgsag1 
gene of sag1wt-sag1* is still intact. Both lines express an additional sag1 copy that has 
been modified as indicated to be resistant to sag1sgRNA1 recognition. (B) IFA depicting 
the impact of split-Cas9 activation on sag1KO-sag1* and sag1wt-sag1* parasites. 
Parasites were induced with 50nM rapamycin for 1h or in the absence of rapamycin. 
Parasites were grown for a total of 48h and fixed with 4%PFA. IFA analysis was 
performed using α-SAG1 and α-GAP45 antibodies. Nuclei were stained with DAPI. Scale 
bars are 5µm. (C) Quantification of vacuoles displaying aberrant nuclei and cellular 
morphology after split-Cas9 activation at 48h post inoculation. High abundance of 
vacuoles displaying aberrant nuclei and cellular morphology were observed upon 
rapamycin treatment only in the sag1wt-sag1* strain.  Levels of aberrant parasites did not 
increase in sag1KO-sag1wt parasites compared to the non-induced population. Data 
represent three independent experiments. For each condition at least 100 vacuoles were 
counted (total n≥300).Please note that data shown in this figure were generated by Mr 
Matthew Gow. 
 
When RHsCas9-Δhx-sag1-1-sag1KO-sag1* parasites were induced with rapamycin, 
parasites did not display any abnormalities and did not lose TgSAG1 on the 
surface (Figure 3-6 B and C). This confirms that the mutated copy of Tgsag1 
(sag1*) cannot be cut by Cas9 and that TgSAG1 remains on the parasites surface. 
It also suggests that the sheer assembly of the sgRNA/split-Cas9 complex without 
having a valid target has no impact on parasites fitness. Split-Cas9 activation in 
parasites coding for the non-disrupted endogenous Tgsag1 gene and the mutated 
Tgsag1* gene (RHsCas9-Δhx-sag1-1-sag1wt-sag1*) caused the parasites to display 
the nuclear phenotype while still showing SAG1 on their surface (Figure 3-6 B 
and C).  
In sum, this data indicate that aberrant nuclei and morphology in parasites do 
not represent a sag1-specific phenotype. This is because parasites still express 
TgSAG1 on their surface. Split-Cas9 is able to cut the endogenous copy of 
Tgsag1, but not the mutated version. If the aberrant phenotype was due to 
TgSAG1 loss on the surface, no phenotype should have been observed in 
RHsCas9-Δhx-sag1-1-sag1wt-sag1* parasites. Instead these results strongly 
indicate that the nuclear phenotype is most likely linked to Cas9-mediated DNA 
cutting since it only occurs in parasites after a double stranded break has been 
introduced into their genome by Cas9. 
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I confirmed this observation with RHsCas9-lacZsgRNA (RHsCas9-lacZ) parasites 
(Figure 3-7 A). The lacZsgRNA targets an exogenous sequence and, therefore, 
has no predicted target in the Toxoplasma genome. Upon split-Cas9 activation, 
no aberrant parasites were observed (Figure 3-7 B). The same results had been 
obtained previously for the ddFKBP-Cas9 system (Serpeloni et al. 2016). This 
suggests that the aberrant phenotype is caused by Cas9-mediated double-strand 
breaks (DSBs) in genomic DNA.   
 
Figure 3-7: Effect of split-Cas9 activation in parasites encoding a lacZsgRNA 
(A) Analytical PCR confirming integration of lacZsgRNA into the parasite genome. 
Integrated plasmids were amplified from the genome as described in Figure 3-2 A. (B) 
Quantification of vacuoles displaying aberrant nuclei and cellular morphology upon 
treatment with 50nM rapamycin for 48h. Parasites were fixed at 48h post inoculation. 
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Split-Cas9 activation did not cause aberrant nuclei or morphology in RHsCas9-lacZsgRNA 
(RHsCas9-lacZ) parasites. Data represents three independent experiments. For each 
condition at least 100 vacuoles were counted (total n=300). Please note that the 
RHsCas9-lacZsgRNA strains were generated by Marleen Büchler under the supervision 
from Dr Elena Jimenez-Ruiz. Experiments shown in this figure represents my own work. 
 
3.4 Investigating the effect of split-Cas9 activation on 
Toxoplasma II: Disruption of Tgsag1 in RH vs RHΔku80 
parasites  
Since introduction of DNA DSBs appear to be required for the aberrant nuclei and 
morphology to emerge, I argued that the observed phenotype might be the 
consequence of unrepaired DNA damage. To test this hypothesis, RHΔku80 
parasites were transiently transfected with a plasmid coding for Cas9-YFP and 
the sag1sgRNA2. The RHΔku80 strain lacks the ku80 gene which has been 
reported to be important in non-homologous end joining (NHEJ), a process that 
allows eukaryotes to repair DSBs their genomes (Critchlow and Jackson 1998). I 
hypothesized that RHΔku80 parasites should not be able to repair the Cas9-
mediated double strand break and display the aberrant phenotype as response to 
Cas9 activity. Indeed, 99.15% (±1.5) of transfected RHΔku80 parasites displayed 
the aberrant nuclei and morphology (Figure 3-8).  
In comparison, 53.8% (±14%) of RH parasites appeared aberrant when transiently 
transfected with the Cas9-YFP-sag1sgRNA2 plasmid. 40.5% (±11.1) of RH 
parasites were TgSAG1 negative and did not show any morphological defect 
(Figure 3-8). Thus, the RH strain showed very similar behaviour to the RHsCas9-
sag1-1 strain upon split-Cas9 activation. This strongly indicates that the 
described aberrant effects are not split-Cas9 specific, but a general CRISPR/Cas9 
phenomenon.  
The fact that the lack of the ku80 gene makes Toxoplasma more susceptible to 
displaying the aberrant phenotype indicates that proper DNA repair is vital for 
recovery from the effects of Cas9 activity. Hence, aberrant nuclei and 
morphology are most likely the result of parasites failing to repair the Cas9-
mediated DNA damage.  
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Figure 3-8: Disruption of Tgsag1 in RH and RHΔku80 parasites 
RH and RHΔku80 parasites were transiently transfected with a Cas9-YFP-sag1sgRNA2 
plasmid. Parasites were fixed 48h after transfection with 4%PFA and IFA analysis was 
performed to allow for subsequent quantification. Only parasites that had been transfected 
successfully were counted. Transfected parasites were identified by YFP signal (Cas9-
YFP) in the nucleus or loss of SAG1. Data represents three independent experiments. 
Transfection efficiencies were 21.5% (±4.8) for RHΔku80 and 13.2% (±3.6) for RH 
parasites. Total n=129 (RHΔku80), total n=79 (RH). Please note that data shown in this 
figure were generated by Dr Elena Jimenez-Ruiz. 
 
3.5 A case study: Disruption of TgMec17-mediated tubulin 
acetylation via the split-Cas9 and DiCre systems 
In 2010, two research groups independently reported α-tubulin acetyltransferase 
1 (Mec17, also named αTAT1) to specifically mediate α-tubulin acetylation at 
lysine (K) 40 in a variety of eukaryotic organisms (Akella et al. 2010; Shida et al. 
2010). Recently, this enzyme was also described to be responsible for 
acetylation of lysine 40 of α-tubulin in Toxoplasma (Varberg et al., 2016). 
Varberg and co-workers further reported that acetylation of α-tubulin at the 
lysine 40 residue is essential for asexual replication in culture. Cas9-mediated 
disruption of Tgmec17 led to the lack of acetylation and to deformed and 
fragmented nuclei within the first generation of parasites after transient Cas9-
mediated DNA cutting.  
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The phenotype described by Varberg and colleagues highly resembled the 
aberrant nuclei caused by Cas9-activity as described above. To clarify whether 
the nuclear replication phenotype was specific to Tgmec17 loss of function or 
caused by Cas9 activity, I decided to target the Tgmec17 gene with two 
independent conditional systems, namely the split-Cas9 system and the DiCre 
system (Andenmatten et al. 2013). For this purpose, the RHsCas9-mec17sgRNA2 
(RHsCas9-mec17-2) line was generated (Figure 3-4 A). In addition, an RHΔku80-
DiCre-Pfmec17loxP strain, that I had created prior to my thesis studies (Stortz 
2014, Master thesis, Ruprecht-Karls-University of Heidelberg), was used for 
experiments. In this strain the endogenous Tgmec17 gene was replaced by the P. 
falciparum (Pf) mec17 orthologue flanked with loxP sites as described previously 
by Andenmatten et al. (Andenmatten et al. 2013). This was done because 
amplification of the full Tgmec17 cDNA was not possible. 
After split-Cas9 activation with 50nM rapamycin for 48h, 40.3% (±12.7) of 
vacuoles showed a lack of acetylated α-tubulin at the lysine 40 residue without 
displaying any abnormalities (Figure 3-9). In some parasites (16% [±5.2]), the 
absence of α-tubulin acetylation was accompanied with aberrant nuclei and cell 
morphology. Highly similar results were obtained when parasites were induced 
for only 1h or when Tgmec17 was targeted with a different sgRNA (RHsCas9-
mec17-3) (Table 3-2; Figure 3-4 A).  
In addition, I induced RHsCas9-mec17-2 parasites and cloned them out by serial 
dilution to obtain five independent clonal lines. All lines lacked α-tubulin 
acetylation. In only two lines 1% of vacuoles showed morphological defects, 
while no abnormalities could be observed in the other lines (Figure 3-10 C). 
Exemplarily, the sgRNA region was sequenced for one of the clonal lines 
revealing a frame shift in the Tgmec17 gene (Figure 3-10 B). 
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Figure 3-9: Effect of Tgmec17 gene function loss in DiCre and split-Cas9 
parasites 
(A) IFA depicts α-tubulin acetylation at lysine (K) 40 (K40tubac) in RHsCas9-mec17-2 (wt) 
and RHsCas9-mec17-2-KO (KO) parasites. Acetylation of α-tubulin K40 was lost upon 
mec17 gene disruption. In some vacuoles, loss of acetylation was associated with 
aberrant nuclei and morphology (bottom panel). Other vacuoles appeared healthy (middle 
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panel). Parasites were incubated in the presence or absence of 50nM rapamycin for 48h. 
Parasites were then fixed with 4%PFA and stained with α-K40tubac and α-GAP45 by IFA. 
Nuclei were stained with DAPI. Scale bars are 5µm. (B) Quantification of parasites 
presenting aberrant nuclei and morphology after mec17 gene disruption in the RHsCas9-
mec17-2 (RHsCas9-mec17) line and mec17 gene excision in RHΔku80-DiCre-
Pfmec17loxP (mec17loxP) parasites. While parasites lost α-tubulin acetylation after loss 
of mec17 gene function in both conditional systems, only split-Cas9 parasites showed 
aberrant nuclei and morphology. Parasites were grown with or without 50nM rapamycin as 
indicated. Cells were fixed 48h post inoculation (p.i.). Data represent three independent 
experiments. For each condition 100 vacuoles were counted (total n=300). 
Table 3-2: Phenotypic characterisation of the lines RHsCas9-mec17-2 and 
RHsCas9-mec17-3  
Numbers were obtained by analysing IFA results. IFAs were conducted as described in 
Figure 3-9. The asterisk (*) indicates vacuoles that lack α-tubulin acetylation at lysine 40 
(K40ac) and display aberrant nuclei and cellular morphology. 
 Rapamycin K40ac lack of 
K40ac 
lack of 
K40ac* 
# vacuoles 
RHsCas9-
mec17-2  
50nM (1h) 38 45 17 100 
      
RHsCas9-
mec17-3  
50nM (1h) 43 27 30 100 
 50nM (48h) 42 29 29 100 
 none 98 2 0 100 
 
With the DiCre system, excision of Pfmec17 led to the loss of K40 acetylated α-
tubulin in 98.2% (±0.29) of parasite vacuoles after 48h (Figure 3-9 B and Figure 
3-10 A). Aberrant nuclei together with loss of acetylation were observed in 
0.33% (±0.29). In the non-induced population, 3.33% of vacuoles (±1.6) lacked α-
tubulin acetylation. Loss of acetylation and aberrant nuclei were observed in 
0.33% (±0.58%). This shows that the level of aberrant nuclei was not elevated 
when α-tubulin acetylation was increasingly lacking in the parasite population 
(induced vs non-induced population). I therefore propose that aberrant nuclei do 
not represent a result of Pfmec17 excision and the subsequent loss of 
acetylation. 
All in all, Tgmec17 and Pfmec17 appear to be responsible for microtubule 
acetylation at the lysine 40 residue of α-tubulin, as previously reported (Varberg 
et al. 2016). A nuclear replication phenotype, however, was only observed in 
some parasites when α-tubulin acetylation was disrupted with the split-Cas9 
system. The discrepancy between the split-Cas9 and DiCre system regarding 
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nuclear integrity is most likely rooted in their different mode of actions. 
CRSIPR/Cas9 induces a DSB in the genome and leaves the organisms DNA repair 
machinery to repair the damage (Doudna and Charpentier 2014). The Cre system 
recombines the organisms genomic DNA in the process of excising the target 
sequence, thus preserving genome integrity (Nagy 2000). Based on data 
presented in this chapter, I am proposing that the described replication defect is 
not caused by loss of microtubule acetylation, but rather represents the effect 
of Cas9-mediated DNA damage in the 1st lytic cycle of Toxoplasma parasites.  
 
Figure 3-10: Mec17 gene excision with the DiCre system and analysis of 
clonal RHsCas9-mec17-KO lines 
(A) IFA depicting α-tubulin acetylation at lysine 40 (K40tubac) in RH-DiCre-Pfmec17loxP (wt) 
and RH-DiCre-mec17-KO (KO) parasites. To achieve mec17 gene excision, parasites were 
incubated with 50nM rapamycin for 4h. Successful gene excision resulted in GFP expression 
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(lower panel). Loss of mec17 gene function resulted in parasites lacking α-tubulin acetylation.  
Parasites were grown for 48h and fixed with 4%PFA. Parasites were stained with α-K40tubac 
by IFA. Nuclei were stained with DAPI. Scale bars are 5µm. (B) Genome sequencing 
performed for the RHsCas9-mec17-2-KO line (clone 1). Green letters indicates sgRNA 
sequence. Red letters represent nucleotide insertion in the mutant strain, causing a frame shift 
and, thus, the functional knock-out of the mec17 gene. The black arrow indicates the predicted 
cut side. (C) Quantification of parasite vacuoles presenting aberrant nuclei and morphology in 
clonal RHsCas9-mec17-2-KO populations. Parasites were grown for 48h and fixed with 
4%PFA. IFA analysis was performed to allow for quantification. For each clone, one 
experiment was conducted (n=100). 
 
3.6 Summary and conclusions 
In this chapter, the split-Cas9 system (Zetsche, Volz, and Zhang 2015) was 
introduced to the apicomplexan parasite Toxoplasma. The genes Tggap40 
(Harding et al. 2016), Tgsag1 (Kim and Boothroyd 1995; Lekutis et al. 2001) and 
Tgmec17 (Varberg et al. 2016) were targeted and previously described 
phenotypes were successfully reproduced. Interestingly, my data most strongly 
suggest that Cas9-mediated DSBs in the genome cause Toxoplasma to display a 
DNA damage phenotype. This phenotype features aberrant and fragmented 
nuclei as well as abnormal cell shape. Most likely, this phenotype occurs in 
parasites that fail to repair the DSB introduced by Cas9 activity. It became 
apparent that DNA damage only occurs when split-Cas9 was activated in the 
presence of a sgRNA targeting the parasite genome (Table 3-3).  
Table 3-3: Prerequisites for DNA damage to occur in Toxoplasma upon split-
Cas9 activation 
Toxoplasma displays DNA damage at 48h post inoculation only when split-Cas9 is 
activated by Rapamycin in the presence of a sgRNA with an actual target sequence and 
the parasite genome. 
split-Cas9 sgRNA 
(valid target) 
sgRNA 
(no target) 
rapamycin DNA damage 
+ - - - - 
- + - - - 
- - - + - 
+ + - - - 
+ - - + - 
- + - + - 
+ - + + - 
+ + - + + 
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A detrimental effect of Cas9 activity on Toxoplasma fitness had been suggested 
previously. Transient transfection of a Cas9-sag1sgRNA plasmid impacted 
parasite fitness as measured by plaque assay immediately after transfection 
(Sidik et al. 2014).  The effect was observed in RH parasites and, to a greater 
extent, in RHΔku80 parasites. Sidik and co-workers hypothesised that DNA 
damage caused by Cas9 could be responsible for this decrease in fitness, 
especially in the RHΔku80 strain. Data presented in this chapter stands in strong 
agreement with this hypothesis. Unsurprisingly, the repair of DSB in the parasite 
genome appears to present the bottleneck for parasite recovery after CRISPR-
Cas9 activity. 
It was also shown that stabilisation of conditional ddFKBP-Cas9 for longer than 
4h led to aberrant parasite morphology (Serpeloni et al. 2016). Constitutive 
expression of Cas9 in Toxoplasma could not be achieved, unless the enzyme was 
expressed together with a decoy sgRNA (Sidik et al. 2016). A fitness advantage 
was later reported for parasites expressing Cas9 together with a sgRNA versus 
parasites expressing only Cas9 (Markus et al. 2019). Cas9 toxicity was proposed 
to be caused by endogenous RNA mediating Cas9 activity (Sidik et al. 2016) 
and/or by secondary non-targeted Cas9 nuclease activity in the absence of any 
sgRNA (Markus et al. 2019). Markus and co-workers hypothesized that the co-
expression of a sgRNA might sequester Cas9 enzymes, thus preventing undesired 
nuclease activity (Markus et al. 2019).  
As hypothesized at the beginning of this chapter, this problem was not observed 
with the split-Cas9 system. Activation of the system over a period of 48h without 
sgRNA did not have any noticeable effects on parasite morphology. The 
activated split-Cas9 system is less efficient than the wild-type Cas9 enzyme at 
inducing nucleotide insertions or deletions at the specific target site (Zetsche, 
Volz, and Zhang 2015). This reduced efficiency of the split-Cas9 system might 
explain the apparent lack of toxicity when activated without genome targeting 
sgRNA. I concluded from this, that expression of a decoy sgRNA, as proposed 
previously for constitutive Cas9 expression (Sidik et al. 2016; Markus et al. 
2019), is not necessary for the split-Cas9 system. 
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In the ddFKBP-Cas9 system, stable transfection of a sag1sgRNA caused 
accumulation of sag1-KO mutants in the parasite population without ddFKBP-
Cas9 activation (Dr Elena Jimenez-Ruiz, unpublished data). This level of 
background activity is not present in the split-Cas9 system, suggesting tighter 
regulation by Cas9 sub-unit separation. 
All in all, the split-Cas9 system is capable of reliably disrupting genes in 
Toxoplasma. The DNA damage caused by Cas9 activity is only apparent in the 1st 
lytic cycle. I therefore argue that phenotypic analysis of split-Cas9 mutants is 
possible in the 2nd lytic cycle. In addition, the obvious nature of the DNA damage 
allows for exclusion of this phenotype during analysis. It is of most importance to 
note, however, that the split-Cas9 system is not suitable for investigating 
nucleus replication or cell replication. Also, any experimental set up with the 
split-Cas9 system should include a control that allows for the estimation of how 
DNA damage affects the process that is being researched.  
Published research strongly indicates that Tgactin1, although critical for 
completion of the lytic life cycle, is not essential for intracellular growth and 
replication (Andenmatten et al. 2013; Egarter et al. 2014; Periz et al. 2017; 
Whitelaw et al. 2017). Lack of Tgactin1 affects vacuole organisation (Periz et al. 
2017). However, effects on overall nuclear integrity or parasite morphology, as 
described here for the DNA damage, have not been reported. The same is true 
for the actin depolymerisation factor (TgADF) (Mehta and Sibley 2011; Haase et 
al. 2015; Periz et al. 2017). Therefore, the split-Cas9 system should be 
applicable for investigating actin-related phenotypes or for screening 
approaches aiming at identifying novel actin binding proteins. I argue that the 
clear nature of the DNA damage phenotype should allow for its exclusion from 
phenotypic analysis. Noteworthy, Lacombe and co-workers recently suggested a 
negative impact of transient Cas9 expression on mitochondria morphology 
(Lacombe et al. 2019). This finding indicates that Cas9 expression might affect 
additional cellular processes, a phenomenon that requires further investigation 
in the future. In sum, subsequent confirmation of the gene-specific phenotype 
with other conditional systems such as the DiCre system  (Andenmatten et al. 
2013) is recommended when applying (split-)Cas9-based strategies.  
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4 Combining the split-Cas9 and actin-chromobody 
technology to investigate actin distribution and 
dynamics in Toxoplasma 
In the previous chapter, the split-Cas9 technology was established as molecular 
tool for targeted gene disruption in Toxoplasma. To investigate and visualize the 
impact of actin binding proteins on actin dynamics, combination of this 
conditional CRSIPR/Cas9 system with the actin-chromobody technology 
presented the next step of this study.  
Chromobodies are nanobodies which are derived from single-heavy chain 
antibodies found in Camels (Hamers-Casterman et al. 1993). These nanobodies 
can be fused to fluorescent proteins (Melak, Plessner, and Grosse 2017) and have 
been used to visualize actin filaments in a variety of organisms ranging from 
animal cells (Panza et al. 2015; Plessner et al. 2015) to plants (Rocchetti, 
Hawes, and Kriechbaumer 2014).  
Expression of anti-actin-chromobodies in Toxoplasma revealed an extensive actin 
network consisting of (probably short) F-actin bundles in intracellular parasites 
(Periz et al. 2017). This network connects parasites within the parasitophorous 
vacuole (PV) via intravacuolar filaments. Parasites also possess a highly dynamic 
actin accumulation centre anterior to the nucleus (also referred to as cytosolic 
actin centre [cAC]). Periz and co-workers demonstrated that these structures 
depend on actin and the actin treadmilling machinery. Loss of TgActin caused 
intravacuolar, filamentous structures to disappear while depletion of TgADF 
abolished actin dynamics in the cytoplasm. Furthermore, absence of TgADF 
resulted in strong actin accumulation at the basal and (to a lesser extent) at the 
apical pole.  
In the past, actin visualisation in Toxoplasma presented a challenge. Detection 
of actin with classical antibody staining was controversially discussed with 
regards to antibody specificity and background staining (Drewry & Sibley, 2015; 
Whitelaw et al., 2017). Other fluorogenic actin probes such as Lifeact (Riedl et 
al. 2008) could not be expressed in the parasite and, thus, were not useful in 
order to detect filamentous actin (F-actin) in Toxoplasma (Tardieux 2017; Periz 
et al. 2017).  
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The novel ability to visualize F-actin in fixed or live Toxoplasma cells presented 
an exciting opportunity to re-evaluate actin dynamics and to precisely dissect 
the function of known actin factors within this complex cytoskeletal network. In 
this chapter, I will demonstrate that different aspects of actin biology can be 
explored by combining split-Cas9 and the actin-chromobody technology in 
Toxoplasma.  
 
4.1 Disruption of Tgactin1 and Tgadf with the split-Cas9 
system 
To combine the split-Cas9 system with the chromobody technology, the actin-
chromobody fused to the fluorescent protein EmeraldFP (Cb-Emerald) (Periz et 
al. 2017) was randomly integrated into the genome of RHsCas9-Δhx parasites. 
RHsCas9-CbEmerald parasites were enriched in the transfected population by 
flow cytometry. Subsequent serial dilution resulted in a clonal RHsCas9-Δhx-
CbEmerald (referred to as RHsCas9-CbEmerald) line. This line displayed the actin 
network features previously described (Periz et al. 2017): long intravacuolar F-
actin network and actin accumulation anterior to the nucleus (Figure 4.1 A and 
C, wt panels).  
Next, I confirmed that the split-Cas9 system can be applied to investigate actin 
dynamics in Toxoplasma. For this purpose, an actin1sgRNA and adfsgRNA were 
transfected into the RHsCas9-CbEmerald to create the two lines RHsCas9-
CbEmerald-actin1sgRNA and RHsCas9-CbEmerald-adfsgRNA (Figure 4-3 A). Upon 
disruption of Tgactin1, parasites lost their actin structures as previously 
described (Periz et al. 2017) (Figure 4-1 A and Figure 4-3 B). In the absence of 
intravacuolar filaments and the cytosolic actin accumulation centre, parasites 
showed ubiquitous Cb-Emerald distribution in the cytoplasm. This most likely 
represents diffusion of unbound Cb-Emerald throughout parasite lacking actin 
structures. Disruption of Tgactin1 also resulted in apicoplast loss as previously 
described (Andenmatten et al. 2013; Egarter et al. 2014; Whitelaw et al. 2017). 
Of relevance, in non-induced parasites, apicoplasts localised to the actin 
accumulation centre in the cytosol (Figure 4-1 A, wt panels).  
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Figure 4-1: Disruption of Tgactin1 and Tgadf in RHsplit-Cas9 parasites 
expressing actin-chromobody-Emerald (Cb-Em or Cb) 
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Figure 4-1 continued: (A) and (B) IFA depicting the effect of Tgactin1 (RHsCas9-Cb-
actin1) or Tgadf (RHsCas9-Cb-adf) disruption on the actin network (Cb-Emerald) and 
apicoplast segregation (HSP60). To achieve gene disruption (KO), parasites were 
incubated with 50nM rapamycin for 1h. Parasites were fixed after 48h. Apicoplasts were 
stained with α-HSP60 by IFA. Nuclei were stained with DAPI. Scale bars are 5µm. (C) 
Images depicting collapsed t-stacks obtained from live microscopy for RHsCas9-Cb-adf 
parasites. Parasites were grown in the presence of absence of 50nM rapamycin for 1h, 
followed by growth for another 72h. Parasites were then mechanically lysed and 
inoculated for 24h prior to live microscopy. Scale bars are 5µm. See also Supplement 
Movie V1. 
 
 
Figure 4-2: Disruption of Tgsag1 in RHsplit-Cas9 parasites expressing actin-
chromobody-Emerald (RHsCas9-Cb-sag1-3) 
IFA depicts the effect of Tgsag1 disruption on the actin network (Cb-Emerald). To achieve 
gene disruption (KO), parasites were incubated with 50nM rapamycin for 1h. Parasites 
were fixed after 48h and stained with α-SAG1 by IFA. Nuclei were stained with DAPI. 
Scale bars are 5µm.  
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In smaller vacuoles (Figure 4-1 C) (Supplement Movie V1), disruption of Tgadf 
reproduced the published phenotype of actin accumulation at the basal and (to a 
lesser extent) at the apical pole together with loss of actin structures in the 
cytosol (Periz et al. 2017). Interestingly, the split-Cas9 system identified the 
accumulation of thick intravacuolar filaments as a characteristic feature of 
Tgadf disruption in larger vacuoles (Figure 4-1 A and B). Actin was almost 
exclusively observed in these filamentous structures which can span the entirety 
of the vacuole (Figure 4-1 B). As reported previously, parasites displayed an 
apicoplast replication defect upon loss of TgADF (Jacot, Daher, and Soldati-Favre 
2013; Haase et al. 2015). Disruption of the Tgadf and Tgactin1 genes upon split-
Cas9 activation was confirmed by sequencing (Figure 4-3 C). 
Finally, I wanted to exclude that Cas9-mediated gene disruption has a universal 
impact on the actin network by targeting the dispensable gene Tgsag1 (Kim and 
Boothroyd 1995; Lekutis et al. 2001).  For this purpose, the RHsCas9-CbEmerald-
sag1-3 strain was generated (Figure 4-3 A). Activation of split-Cas9 resulted in 
TgSAG1 loss on the parasite surface (Figure 4-2) strongly indicating Tgsag1 gene 
disruption. Loss of TgSAG1 did not affect overall actin distribution as parasites 
still displayed intravacuolar actin filaments and cytosolic actin accumulation. 
In summary, the disruption of the genes Tgactin1, Tgadf and Tgsag1 showed that 
the split-Cas9 system can be applied to depict different actin network 
phenotypes. Previously reported phenotypes with the DiCre (Andenmatten et al. 
2013) and TATi-1 (Meissner, Schlüter, and Soldati 2002) systems were 
successfully confirmed. 
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Figure 4-3: Confirmation of the strains RHsCas9-ActinChromobodyEmerald-
sag1sgRNA3 (RHsCas9-Cb-sag1-3), RHsCas9-ActinChromobodyEmerald-
actin1sgRNA (RHsCas9-Cb-actin1) and RHsCas9-ActinChromobodyEmerald-
adfsgRNA (RHsCas9-Cb-adf) 
(A) Analytical PCR confirming integration of indicated sgRNA-plasmids into the parasite 
genome. Integrated plasmids were amplified from the genome as described in Figure 3-2 
A. If more than one clonal line was obtained, the one used for further experiments in this 
study is highlighted. (B) and (C) Sequencing performed on the sgRNA cut side of 
RHsCas9-Cb-actin1-KO and RHsCas9-Cb-adf-KO parasites. For this purpose, cultures 
were induced with 50nM rapamycin for 1h. Parasites were grown for 48h prior to gDNA 
collection. The sgRNA cut site was amplified by PCR. Amplicons (I-IV) were cloned into 
the pGEM vector and sequenced. Green letters indicates sgRNA sequence. Red letters 
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represent nucleotide insertion in the mutant strain, causing a frame shift and, thus, the 
functional disruption of the indicated gene. Black arrows indicate the predicted cut side.  
 
4.2 Investigating the impact of Tgadf disruption on actin 
filament dynamics  
Upon loss of Tgadf gene function, actin appears to accumulate mostly in thick 
intravacuolar filamentous structures. I hypothesised that this phenomenon could 
be explained by the previously suggested involvement of TgADF in actin filament 
turnover (Mehta and Sibley 2010, 2011). Loss of TgADF might prevent the 
depolymerisation of actin filaments and, thus, the re-introduction of actin 
monomers into the available actin pool in Toxoplasma. As consequence, the 
enrichment of filamentous actin structures depletes free monomeric actin from 
the overall actin pool that is required for maintaining sites of highly dynamic 
actin, i.e. the cytosol.   
To test this idea, I was eager to address the impact of TgADF loss on the overall 
dynamics of filamentous actin structures in the parasites. One process that was 
associated with highly dynamic disassembly of F-actin structures was parasites 
egress (Periz et al. 2017). Upon the induction of egress with a calcium-
ionophore, but prior to parasite movement, the large intravacuolar actin 
filaments were disassembled in a rapid fashion. I argued that, if TgADF is indeed 
responsible for actin turnover, actin filament disassembly should be diminished 
in sCas9-adf-KO parasites.  
 
4.2.1 Analysis of egress behaviour in conditional sCas9 mutants 
Before analysing the role of TgADF in F-actin disassembly upon egress, it was 
critical to determine whether the split-Cas9 system is suitable for analysis of this 
process. For this purpose, it had to be excluded that Cas9-mediated DNA 
damage, which can lead to aberrant nuclei and overall cell morphology (see 
chapter 3), diminishes the parasites ability to egress. The egress of sCas9-sag1-3-
KO, sCas9-actin1-KO and sCas9-adf-KO parasites were measured and normalized 
to the respective non-induced wild-type lines (Figure 4-4 A and B). In addition, 
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abundance of DNA damage and the rate of gene disruption after split-Cas9 
activation were measured for all strains (Figure 4-4 C).  
 
Figure 4-4: Parasite egress after split-Cas9 mediated gene disruption 
(A) and (B) Induced (50nM rapamycin, 1h or 48h) and non-induced RHsCas9-CbEm 
parasites were grown for 48h. Egress was then induced by incubating parasites with 2µM 
A23187 for 5-8min. Egress percentage of the sCas9-KO parasites in (A) was normalized 
to the egress percentage of the respective sCas9-wt parasites depicted in (B). Egress 
percentage was obtained from three independent egress assays. Experiments were 
stopped for wt and KO populations at the same time, when the wt populations showed 
egress of about 80%. Time for egress in the individual wt vs KO experiments was as 
follows: sag1 – 8min, 8min, 8min; formin2 – 5min, 7min, 7min; adf – 8min, 8min, 5min; 
actin1 – 8min, 5min, 7min. For each condition 100 vacuoles were counted (total n=300). 
(C) The table gives information about the overall induction rate and DNA damage in the 
respective parasite populations at 48h after rapamycin induction (50nM, 1h).  Numbers 
were obtained from three independent experiments for each strain and condition. For 
each condition 100 vacuoles were counted (total n=300). For the formin2, adf and actin1 
sCas9 strains, one biological repeat was performed with a rapamycin incubation time of 
48h. For analysis of the RHsCas9-CbEm-formin2 strain, please refer to chapter 5.  
 
Disruption of the non-essential Tgsag1 gene (Kim and Boothroyd 1995; Lekutis et 
al. 2001) caused DNA damage in 55.67% (±3.79) of parasites. In comparison with 
the wt parental line, however, egress was reduced by only 5% (±1.1) in sCas9-
sag1-3KO parasites. IFA analysis confirmed that parasites were able to egress 
120 
 
despite displaying a DNA damage phenotype (Figure 4-5). In agreement with 
studies that reported Tgactin1 as critical for parasite egress (Egarter et al. 2014; 
Whitelaw et al. 2017), the sCas9-actin1-KO population showed an egress 
reduction of 80.8% (±5.4) at 48h post split-Cas9 activation. Disruption of Tgadf 
caused a reduction of egress by 47.5% (±6.1). This result can be seen as support 
for the  previously reported egress phenotype for TgADF depletion (Mehta and 
Sibley 2011). Mehta and Sibley showed that TgADFcKO parasites were slower to 
egress due to impaired motility. In their experiments, not all TgADFcKO 
parasites managed to egress at the 5-8min mark post egress induction, the cut-
off time I chose in my egress experiments. Together these data suggest that the 
split-Cas9 system is capable of reliably describing a wide range of egress 
phenotypes in parasites mutants.  
 
Figure 4-5: Depiction of egressed and intracellular RHsCas9-CbEm-sag1-3-
wt and RHsCas9-CbEm-sag1-3-KO parasites after A23187 treatment 
For this experiment, induced (50nM rapamycin, 1h) and non-induced RHsCas9-CbEm-
sag1 parasites were grown for 48h. Egress was then induced by incubating parasites with 
2µM A23187 for 8min. After fixation with 4%PFA, parasites were stained for TgSAG1 by 
IFA. (A) Depiction of sag1-wt and sag1-KO parasites that remained intracellular after 
A23187 treatment. For sag1-KO parasites, the top panel shows a healthy vacuole while 
the bottom panel represents DNA damage (aberrant morphology). (B) Depiction of 
egressed sag1-wt and sag1-KO parasites. For sag1-KO parasites, healthy parasites are 
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depicted in the top panel. The bottom panel shows egressed sag1-KO parasites 
representing DNA damage (asterisks). Scale bars are 5µm.  
 
4.2.2 Impact of Tgadf disruption on filament disassembly upon 
egress 
Next, the impact of Tgadf disruption on disassembly of the large intravacuolar 
filaments upon parasite egress was investigated. To this end, the abundance of 
large filamentous actin structures before and after egress in wild-type and 
mutant parasites were compared to each other. Fixed assays revealed that in a 
growing wild-type population, 73.3% (RHsCas9-CbEm-sag1-3) and 83.3% 
(RHsCas9-CbEm-adf) show intravacuolar filaments (Figure 4-6 and Figure 4-7).  
After treatment with calcium-ionophore (2µM A23187), these filamentous actin 
structures usually could not be detected anymore in the proximity of freshly 
egressed parasites or within still intracellular vacuoles (Figure 4-6- and 4-7). 
This was true for the majority of sCas9-sag1-wt, sCas9-sag1-KO and sCas9-adf-wt 
parasites (Figure 4-6). In sCas9-sag1-wt parasites only 4.6% (egressed) and 22% 
(intracellular) of parasites displayed intravacuolar filaments after calcium-
ionophore treatment. In the sCas9-sag1-ko population these numbers were 1.8% 
(egressed) and 8% (intracelluar). For sCas9-adf-wt, 21% (egressed) and 40% 
(intracellular) of parasites showed large intravacuolar filaments or their 
remainders. In total, sCas9-sag1-wt and sCas9-sag1-KO parasites show a strong 
reduction of intravacuolar filaments from 73.3% down to 4.6% (wt) and 1.8% (KO) 
upon egress.  In sCas9-adf-wt parasites they dropped from 83.3% to 21.3%. In 
striking contrast, the large majority of sCas9-adf-KO parasites still displayed 
large actin filaments throughout the vacuole and in close proximity to freshly 
egressed parasites (Figure 4-6 and 4-7). 79.3% of egressed parasites still showed 
large intravacuolar filaments. For intracellular parasites it was 94.4%.  
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Figure 4-6: Effect of A23187 treatment on intravaculaor filamentous actin 
structures in RHsCas9-CbEm-sag1-3-ko and RHsCas9-adf-ko parasites 
compared to wt parasites 
This figure depicts the abundance of large intravacuolar filamentous actin structures in 
sag1-wt/KO (A) and adf-wt/KO (B) parasites after A23187 treatment for 5-8min or no 
treatment. See Figure 4-4 for overall egress rates and Figure 4-7 for representative 
123 
 
images. Analysis is based on three independent experiments. For RHsCas9-CbEm-sag1-
3: no A23187/no Rapa: n=300; 2µM A23187/no Rapa: n=241 (egress), n= 
59(intracellular); 2µM A23187/50nM Rapa: n=225 (egress), n=75 (intracellular). For 
RHsCas9-CbEm-adf: no A23187/no Rapa: n=300; 2µM A23187/no Rapa: n= 230 
(egress), n= 70 (intracellular); 2µM A23187/50nM Rapa: n=121 (egress), n= 179 
(intracellular).  
In summary, RHsCas9-sag1-wt/KO and RHsCas9-adf-wt parasites showed loss of 
actin filaments upon egress induction, while RHsCas9-adf-KO parasites show no 
reduction in these structures compared to the non-treated intracellular wild-
type population. It would therefore appear that regulation of TgADF is critical 
for F-actin disassembly during parasite egress. Furthermore, disassembly of actin 
network seems to be associated with parasite egress, but not essential for this 
process to happen. In the past, actin sedimentation assays revealed that actin is 
more stable in parasites depleted of TgADF (Mehta and Sibley 2011). The here 
described phenotype in the RHsCas9-CbEm-adf-KO line visualized this previous 
finding within the parasite. 
124 
 
 
Figure 4-7: Depiction of egressed and intracellular RHsCas9-CbEm-adf-wt 
and RHsCas9-CbEm-adf-KO parasites after A23187 treatment 
For this experiment, induced (50nM rapamycin, 1h) and non-induced RHsCas9-CbEm-adf 
parasites were grown for 48h. Egress was then induced by incubating parasites with 2µM 
A23187 for 5-8min. After fixation with 4%PFA, parasites were stained for GAP45 by IFA. 
Images depict intracellular (A) and egressed (B) vacuoles with (+) or without (-) 
intravacuolar filamentous actin structures. See Figure 4-4 and 4-6 for corresponding 
numerical analysis. White arrows indicate the remains of intravacuolar filaments after 
parasite egress. Scale bars are 5µm.  
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4.3 Re-defining intracellular actin distribution and 
dynamics 
After performing analysis on intravacuolar actin structures that manifest outside 
the parasite body, I aimed at re-visiting actin distribution and dynamics within 
the parasite. A highly dynamic cytosolic actin accumulation centre had been 
described by Periz and colleagues (Periz et al. 2017). However, no further 
analysis of actin distribution or dynamics was performed. To further explore 
actin dynamics I applied kymograph analysis as described by Mangeol and co-
workers (Mangeol, Prevo, and Peterman 2016). For this purpose, live microscopy 
was performed on Cb-Emerald expressing parasites. I then conducted Kymograph 
analysis on the obtained movies to measure particle flow, representing actin 
flow alongside a chosen track. Fourier filtering allowed for the distinction 
between different flow directions. Furthermore, I used kymograph data for the 
generation of time-averaged local intensity profiles. These profiles depict Cb-
Emerald intensity, i.e. actin distribution, in live parasites over the entire 
duration of the movie. 
In wild-type parasites, time-averaged local intensity profiling showed the highest 
Cb-Emerald intensities at the two poles and anterior to the nucleus (Figure 4-8 
A and Figure 4-9 A) (Supplement Movie V1 and V2) (Appendix Figure 7-3). 
Disruption of Tgactin1 resulted in the absence of any directed actin distribution 
(Figure 4-8 B) (Supplement Movie V2). Loss of Tgadf function led to strong 
actin accumulation at the basal end (Figure 4-9 B) (Supplement Movie V1) 
(Appendix Figure 7-3). Thus, intensity profiling confirmed numerically the 
phenotypes described for these genes by IFA (Figure 4-1). Of relevance, 
distribution of GFP throughout the parasites differed distinctively from the Cb-
Emerald pattern (Figure 4-8 C) (Supplement Movie V3) (Appendix Figure 7-2).  
Time-lapsed video microscopy revealed that the cytosolic actin centre is highly 
dynamic and frequently interacts with the parasite periphery (Figure 4-10 B) 
(Supplement Movie V1). Wild-type parasites showed actin accumulation in the 
periphery as confirmed by intensity profile measurement and skeletonisation 
analysis (Figure 4-10A and Figure 4-11) (Supplement Movie V1 and V2). 
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Figure 4-8: Actin distribution in intracellular RHsCas9-CbEm-actin1 wt and 
KO parasites along the middle axis 
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Figure 4-8 continued: (A) and (B) Time-averaged intensity profiling along the parasites 
middle axis in RHsCas9-CbEm-actin1-wt and RHsCas9-CbEm-actin1-KO parasites. 
Parasites were incubated with or without 50nM rapamycin for 1h. After a growth period of 
72h, cultures were mechanically lysed and incubated on a fresh host cell monolayer for 
another 24h prior to live microscopy. (C) Time-averaged intensity profiling along the 
parasites middle axis for the RH-GFP line. Parasites were grown for 24h prior to live 
microscopy. At least 5 (actin1) or 10 (GFP) independent movies were produced and 
analysed for each condition. Movies are depicted as images representing collapsed t-
stacks. Intensity profiles depict Cb-Emerald or GFP intensity along the measured axis 
(yellow line) over the entire duration of the movie. As polarity is difficult to define for 
RHsCas9-actin1-KO parasites, the start point of the measurement is indicated with an 
asterisk. The figure shows representative images. Scale bars are 5µm. See also 
Supplement Movies V2 and V3, as well as Appendix Figure 7-2. Please note that live 
microscopy for the RHsCas9-CbEm-actin strain was performed by Dr Mario Del Rosario. 
 
Recently, a model of actin flux to the basal pole alongside the parasite 
periphery was proposed for extracellular Toxoplasma parasites (Tosetti et al. 
2019). As the periphery presents a place of high actin abundance in intracellular 
parasites, I was eager to investigate actin flow at this location. Kymograph 
analysis on wild-type parasites showed trajectories representing Cb-Emerald 
particle flow to the apical and the basal pole (Figure 4-12 A and B) 
(Supplement Movie V1 and V2) (Appendix Figure 7-1 and 7-3).This finding 
demonstrates bi-directional actin flow alongside the lateral axis of intracellular 
parasites. Strikingly, upon Tgactin1 disruption, kymographs did not display any 
obvious particle tracks (Figure 4-12 A) (Supplement Movie V2) (Appendix 
Figure 7-1). This interpretation is supported by the strong resemblance of 
sCas9-actin1-KO kymographs to measurements performed on the movie 
background (Figure 4-12 D) (Supplement Movie V2) (Appendix Figure 7-1). 
Disruption of Tgadf caused kymographs to depict strong accumulation of static 
actin at the basal end (Figure 4-12 B) (Supplement Movie V1) (Appendix 
Figure 7-3). Measurements performed on RH-GFP parasites resulted in more 
diffuse and, thus, highly distinguishable kymographs when compared to wild-
type Cb-Emerald kymographs (Figure 4-12 C) (Supplement Movie V3) 
(Appendix Figure 7-2). This strongly indicates that the kymograph analysis 
presented here is capable of specifically depicting actin dynamics. 
Data suggest that intracellular Toxoplasma parasites possess four sites of major 
actin abundance. These sites are the two poles, the cytosolic region anterior to 
the nucleus and the periphery. Bi-directional actin flow appears to occur at the 
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periphery. Based on these findings, I am proposing that cytosolic actin flow 
connects these different sites of actin accumulation.  
 
Figure 4-9: Actin distribution in intracellular RHsCas9-CbEm-adf wt and KO 
parasites along the middle axis 
(A) and (B) Time-averaged intensity profiling along the parasites middle axis in RHsCas9-
CbEm-adf-wt and RHsCas9-CbEm-adf-KO parasites. Parasites were incubated with or 
without 50nM rapamycin for 1h. After a growth period of 72h, cultures were mechanically 
lysed and incubated on a fresh host cell monolayer for another 24h prior to live 
microscopy. At least 10 independent movies were produced and analysed for each 
condition. Movies are depicted as images representing collapsed t-stacks. Intensity 
profiles depict Cb-Emerald intensity along the measured axis (yellow line) over the entire 
duration of the movie. The figure shows representative images. See also Supplement 
Movie V1 and Appendix Figure 7-3. Scale bars are 5µm.  
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Figure 4-10: Live microscopy and skeletonisation analysis investigating the 
interaction of the cytoplasmic actin pool and peripheral actin in the 
RHsCas9-CbEm-adf-wt line 
Parasites were grown for 72h. Cultures were then mechanically lysed and incubated on a 
fresh host cell monolayer for another 24h prior to live microscopy. (A) Skeletonisation 
analysis (right panel) for the depicted Cb-Emerald movie (left panel). The movie is 
depicted as collapsed t-stacks. (B) Live microscopy depicting the contact of the 
cytoplamsic actin pool with peripheral actin (white arrrows). At least 10 independent 
movies were produced and analysed. The figure shows representative images. Time is 
depicted as mm:ss. Scale bars are 5µm. See also Supplement Movie V1. 
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Figure 4-11: Actin distribution in intracellular RHsCas9-CbEm-actin1 wt and 
KO parasites along the horizontal axis 
(A) and (B) Time-averaged intensity profiling along the parasites horizontal axis in 
RHsCas9-CbEm-actin1-wt and RHsCas9-CbEm-actin1-KO parasites. Parasites were 
incubated with or without 50nM rapamycin for 1h. After a growth period of 72h, cultures 
were mechanically lysed and incubated on a fresh host cell monolayer for another 24h 
prior to live microscopy. Movies are depicted as images representing collapsed t-stacks. 
Intensity profiles depict Cb-Emerald intensity along the measured axis (yellow line) over 
the entire duration of the movie. The start point of each measurement is indicated with an 
asterisk. Scale bars are 5µm. See also Supplement Movie V2. Please note that live 
microscopy for the RHsCas9-CbEm-actin strain was performed by Dr Mario Del Rosario. 
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Figure 4-12: Kymograph analysis of peripheral actin flow in intracellular 
Toxoplasma parasites 
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Figure 4-12 continued: Kymograph analysis is shown for (A) RHsCas9-CbEm-actin1-
wt/KO, (B) RHsCas9-CbEm-adf-wt/KO and (C) RH-GFP parasites. (D) Kymograph 
analysis was performed on the movie background for RHsCas9-CbEm-actin1-KO. Particle 
movement alongside the periphery is depicted via three colour-coded kymographs. Red 
tracks represent particles moving to the basal end, green tracks show particle flow to the 
apical end and blue depicts static particles. The yellow line represents the area of 
kymograph measurement. Particle movement was measured from the apical (A) to the 
basal pole (B). As polarity is difficult to define for sCas9-actin1-KO parasites, the start 
point of the flow measurement is indicated with an asterisk. The same is true for the 
background measurement. Parasites were incubated with or without 50nM rapamycin for 
1h. After a growth period of 72h, cultures were mechanically lysed and incubated on a 
fresh host cell monolayer for another 24h prior to live microscopy. RH-GFP parasites were 
grown for 24h prior to live microscopy. Images represent videos as collapsed t-stacks. At 
least 5 (actin) or 10 (others) independent movies were produced and analysed for each 
depicted condition. The figure shows representative kymographs. Scale bars are 5µm. 
See also Supplement Movies V1, V2 and V3. Additional analysis can be found in 
Appendix Figures 7-1, 7-2 and 7-3. Please note that live microscopy for the RHsCas9-
CbEm-actin strain was performed by Dr Mario Del Rosario. 
 
4.4 Summary and conclusions 
In this chapter, the split-Cas9 system was combined with the actin chromobody 
technology (Periz et al. 2017) to investigate the actin network in Toxoplasma. By 
doing so, I was able to re-produce previously reported effects on the 
intracellular actin network for the genes Tgactin1 and Tgadf (Periz et al. 2017). 
The impact of these genes on parasite egress was also investigated with the 
split-Cas9 system. My findings support previous publications for Tgactin1 (Egarter 
et al. 2014; Whitelaw et al. 2017) and Tgadf (Mehta and Sibley 2011). Taken 
together, these data suggest that phenotypical analysis is possible for actin 
factors despite the occurrence of DNA damage upon Cas9 activity.  
Interestingly, the abundance of DNA damage within a population depended on 
the targeted gene. For example, the number of vacuoles displaying DNA damage 
after Tgadf disruption was twice as high as the number of vacuoles after 
Tgactin1 targeting. It would therefore appear that some genomic loci are more 
challenging to repair than others. When applying split-Cas9 for phenotypic 
characterisation, it remains crucial to include proper controls such as the 
RHsCas9-sag1 strain. Furthermore, one has to determine the applicability of the 
split-Cas9 system for each assay individually. 
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Due to successful confirmation of known actin phenotypes, I argued that the 
split-Cas9 system should be suitable for a phenotypical screening approach, 
aiming at identifying potentially novel actin binding proteins. While a 
CRISPR/Cas9-based screening approach previously addressed overall parasite 
fitness (Sidik et al. 2016), a screen allowing for immediate insights into actin 
dynamics or other well discriminated phenotypes would present a powerful tool 
for future phenotypic screens. Therefore a medium through-put screen was 
initiated during my PhD studies (refer to chapter 5, section 5.5). 
Disruption of Tgadf abolished intravacuolar filament disassembly upon parasite 
egress. In other organisms, ADF activity depends on its phosphorylation status 
(Mizuno 2013). ADF activity is inhibited by LIM kinase-dependent phosphorylation 
(Arber et al. 1998; Yang et al. 1998). The SSH phosphatase can mediate ADF 
dephosphorylation, thus leading to its re-activation (Niwa et al. 2002). It was 
also reported that SSH phosphatases can decrease LIM kinase activity by 
dephosphorylating the kinase itself (Soosairajah et al. 2005). Applying these 
findings to Toxoplasma biology, one could speculate that a calcium-dependent 
pathway might exist that mediates dephosphorylation of TgADF prior to egress. 
Activation of TgADF located to the large filamentous structures might explain 
their disassembly within seconds, as shown by Periz and co-workers (Periz et al. 
2017). More experiments would have to be conducted to support this hypothesis.  
Importantly, filament disassembly does not appear to be critical for successful 
parasite egress. I am therefore proposing that the disassembly process might 
serve the purpose of recycling actin by reintroducing monomeric actin to the 
cytosolic actin pool. Since actin was shown to be critical for parasite egress 
(Egarter et al. 2014; Whitelaw et al. 2017), increasing the overall actin 
concentration within the parasite might increase the chance for successful 
egress and subsequent host cell invasion. 
Overall actin distribution was re-defined for intracellular parasites by performing 
live microscopy and kymograph analysis. I identified four actin accumulation 
sites: the apical and basal end, the cytosolic region anterior to the nucleus and 
the periphery. In addition, bi-directional actin flow appears to connect these 
actin polymerisation centres with each other. Based on live microscopy 
presented in this chapter, I was hypothesising that the cytosolic actin 
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polymerisation centre is fuelling the lateral actin flow. To gather supporting 
evidence for this theory, I wanted to focus on identifying the actin factors 
responsible for this highly dynamic actin site.  
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5 Investigating the role of TgFormin2 within the 
intracellular actin network 
In chapter 4, I redefined actin distribution in intracellular Toxoplasma parasites. 
The split-Cas9 system successfully reproduced previously reported actin 
phenotypes for the genes Tgactin1 and Tgadf. In addition, four major actin 
accumulation sites were described: the two poles, the cytosolic region anterior 
to the nucleus and the periphery. The cytosolic actin centre (cAC) showed a 
highly dynamic nature and frequently interacted with the parasite periphery. 
Based on these observations, I hypothesised that the cAC is critical for the 
lateral actin flow in intracellular Toxoplasma parasites.  
To explore this hypothesis, it was critical to identify the actin binding protein 
responsible for maintaining the cAC. I argued that rapid actin nucleation and 
polymerisation must be mediating the highly dynamic nature of this distinct 
actin site. The Toxoplasma genome codes for a limited set of actin binding 
proteins (Baum et al. 2006). For example, Toxoplasma lacks key components of 
the Arp2/3 actin nucleation complex (Gordon and Sibley 2005), which is a major 
contributor to actin polymerisation in other eukaryotes (Gould and Machesky 
1999; Pollard and Beltzner 2002; Pollard 2007, 2016). Therefore, I reasoned that 
the remaining actin nucleation factors present in Toxoplasma, namely 
TgFormin1-3 (Baum et al. 2006; Gupta, Thiyagarajan, and Sahasrabuddhe 2015), 
could be involved in maintaining the cAC.  
The FH2 domains of TgFormin1 and 2 were reported to initiate nucleation of 
rabbit actin (Daher et al. 2010) and Toxoplasma actin (Skillman et al. 2012) in 
vitro. Initially, TgFormin1 and 2 were localised to the parasite periphery (Daher 
et al. 2010). A more recent study mentions that endogenously-tagged TgFormin1 
accumulates at the apical tip of the parasite, while endogenously-tagged 
TgFormin2 locates to the vicinity of the apicoplast (Jacot et al. 2016). No 
experimental evidence was provided to support this claim for TgFormin2. The 
TgFormin3 FH2 domain also nucleates rabbit actin and the enzyme was localised 
to the apical and the basal pole as well as around the mitochondrion (Daher et 
al. 2012). Overall, the localisation to the vicinity of the apicoplast made 
TgFormin2 the prime candidate for mediating the cytosolic actin centre. I 
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followed this line of reasoning as the apicoplast frequently co-localised with the 
cytosolic actin centre anterior to the nucleus (Figure 4-1 A, wt panels).  
It shall be mentioned that investigating the function of actin nucleation factors 
in vivo addresses a relevant conundrum of Toxoplasma actin biology. Although 
nucleation activity was shown for TgFormins in vitro (Daher et al. 2010, 2012; 
Skillman et al. 2012), an isodesmic polymerisation model was proposed as 
underlying mechanisms for actin filament formation in Toxoplasma (Skillman et 
al. 2013). According to this model, actin filaments assemble in a nucleation-
independent fashion rendering nucleation factors unnecessary. It was further 
suggested that polymerisation and depolymerisation rate of actin filaments 
happen at equal rates. The model was applied to explain the previously reported 
presence of short and unstable actin filaments in Toxoplasma (Sahoo et al. 
2006). It was recently proposed that Plasmodium actin kinetics behave similar to 
canonical actin in vitro (Kumpula et al. 2017). The observation that the 
depolymerisation rate for PfACT1 appeared faster than for canonical actins 
(Kumpula et al. 2017) was later explained by unique structural features in the 
PfACT1 molecule, promoting filament destabilisation and, consequently, 
depolymerisation (Kumpula et al. 2019). 
In this chapter, the tools established in chapter 4 will be used to investigate the 
function of the actin nucleation factor TgFormin2 within the complex actin 
network of Toxoplasma. I will demonstrate that the actin-chromobody 
technology presents a powerful tool for addressing actin dynamics in their 
natural environment, the parasite itself.  
 
5.1 Localisation and function of TgFormin2 within the 
actin network of intracellular Toxoplasma 
Literature available during the process of data generation for this thesis made 
conflicting reports regarding TgFormin2 localisation. According to one study, 
TgFormin2 accumulated mainly to the periphery for Toxoplasma (Daher et al. 
2010), while another reported the enzyme in close proximity to the apicoplast 
(Jacot et al. 2016). To clarify TgFormin2 localisation, TgFormin2 was 
endogenously-tagged with a c-terminal HA-tag (Figure 5-1 A). Correct 
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integration of the HA-tag into the parasite genome was confirmed by analytic 
PCR (Figure 5-1 B) and sequencing (Appendix Figure 7-6 A). In intracellular 
parasites, TgFormin2-HA accumulated in close proximity to the apicoplast 
(Figure 5-1 C and D). Transient expression of the actin-chromobody in 
TgFormin2-HA parasites revealed that TgFormin2 co-localises with cytosolic sites 
of actin accumulation (Figure 5-1-E).  
To explore TgFormin2 function, I generated the RHsCas9-CbEmerald-formin2 
strain which expressed a formin2-sgRNA together with the split-Cas9 system and 
the actin-chromobody. Analytic PCR confirmed integration of the sgRNA-plasmid 
into the parasite genome (Figure 5-2 A). Upon disruption of Tgformin2, 68% 
(±6.6) of parasites lost the cytosolic actin centre (cAC) at 48h post split-Cas9 
activation (1st lytic cycle) (Figure 5-3A and Figure 5-4 B). The untreated control 
population showed a baseline for cAC loss of 1.3% (±1.2). The disruption of 
Tgformin2 did not affect intravacuolar filament formation (Figure 5-3).  
138 
 
 
Figure 5-1: Investigation of TgFormin2 (FRM2) localisation in Toxoplasma 
(A) Cartoon depicting the insertion of an HA-tag at the 3´end of the Tgformin2 (frm2) 
gene. Arrows indicate primers used for analytic PCRs shown in (B). (B) Analytical PCR 
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confirming integration of the HA-tag into the parasite genome at the c-terminus of 
Tgformin2 (frm2). The recognition sites of the colour-coded primers (arrows) are shown in 
(A). (C) IFA depicting TgFRM2-HA localisation in Toxoplasma. Parasites were grown for 
24h and fixed with 4%PFA prior to IFA. Samples were stained with α-G2Trx (apicoplast) 
and α-HA (TgFRM2-HA). (D) Super-resolution microscopy confirming TgFRM2-HA 
localisation. Parasites were treated as described in (C). (E) Position of TgFRM2-HA within 
the actin network in intracellular Toxoplasma parasites. Samples were transiently 
transfected with the Cb-Emerald plasmid, inoculated for 48h and fixed with 4%PFA. 
Parasites were stained with α-HA (TgFRM2-HA) by IFA. The figure shows representative 
images. Nuclei were stained with DAPI. All scale bars are 5µm. Please note that the 
TgFRM2-HA strain was generated by Dr Mirko Singer. Experiments shown in this figure 
represent my own work. 
 
Tgformin2 disrupted parasites lacking the cAC anterior to the nucleus displayed 
an apicoplast segregation phenotype (Figure 5-3). Two types of phenotypes 
were observed. Some vacuoles contained parasites simply being devoid of 
apicoplasts (Figure 5-3 A, middle panel). In other vacuoles, the lack of 
apicoplasts within the parasites was associated with the accumulation of 
apicoplast material to distinct locations within the vacuole (Figure 5-3 A and B). 
Most likely, apicoplasts accumulated outside the parasite bodies, i.e. the 
residual body or bodies, as Tgformin2 disrupted parasites often egressed without 
containing an apicoplast (Figure 5-4 A). The apicoplasts were left behind 
outside the parasites upon egress. Of relevance, overall egress was not 
significantly affected by Tgformin2 disruption (Figure 4-4 A and B). 
Quantification of the apicoplast phenotype in parasites lacking the cAC was 
performed to provide a more detailed overview. After 48h post Cas9 activation 
(1st lytic cycle), 59.7% (±5) of vacuoles depicted parasites devoid of the 
apicoplast without accumulation of apicoplast material to a specific location 
(Figure 5-4 C). Accumulation of apicoplasts in the residual body was observed in 
31.7% (±5.7) of vacuoles. In the 2nd lytic cycle (96h), apicoplast mislocalisation 
to the residual body was detected in 75% (±4.4) of vacuoles, while 24% (±5.3) of 
vacuoles contained parasites lacking the apicoplast without noticeable 
relocation to the residual body. In the non-treated control population, 11% (±1) 
(1st lytic cycle) and 12.3% (±1.6) (2nd lytic cycle) of vacuoles contained parasites 
lacking the apicoplast. Accumulation of apicoplasts within residual bodies of 
vacuoles was never observed in the control populations. Noteworthy, only 
vacuoles without any signs of DNA damage were included in the phenotypic 
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analysis (Figure 4-4 C). Disruption of the Tgformin2 gene was confirmed by 
sequencing at 48h post induction (Figure 5-2 B).  
 
Figure 5-2: Confirmation of the strains RHsCas9-ActinChromobodyEmerald-
DrpAsgRNA (RHsCas9-Cb-DrpA), RHsCas9-ActinChromobodyEmerald-
formin2sgRNA (RHsCas9-Cb-formin2) and RHsCas9-ActinChromobody-
Emerald-profilinsgRNA (RHsCas9-Cb-profilin) 
(A) Analytical PCR confirming integration of indicated sgRNA-plasmids into the parasite 
genome. Integrated plasmids were amplified from the genome as described in Figure 3-2 
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A. (B) Sequencing performed on the sgRNA cut side of RHsCas9-Cb-formin2-KO. For this 
purpose, cultures were induced with 50nM rapamycin for 1h. Parasites were grown for 
48h prior to gDNA collection. The sgRNA cut site was amplified by PCR. Amplicons (I, II) 
were cloned into the pGEM vector and sequenced. Green letters indicates sgRNA 
sequence. Red letters represent nucleotide insertion in the mutant strain, causing a frame 
shift and, thus, the functional knock-out of the indicated gene. Black arrows indicate the 
predicted cut side. Please note that the analytical PCR (A) was performed by Dana 
Aghabi under my supervision. 
 
In summary, data presented here strongly indicate that the nucleation factor 
TgFormin2 is critical for maintaining the cytosolic actin centre (cAC) in 
intracellular parasites. TgFormin2 localisation to the vicinity of the apicoplast 
and to actin accumulation centres supports this finding. The previously reported 
TgFormin2 localisation by Jacot and co-workers (Jacot et al. 2016) was 
confirmed. TgFormin2 driven actin nucleation appears to be essential for 
apicoplast inheritance. The process of apicoplast inheritance had been linked to 
TgFormin2 previously by overexpressing the TgFormin2 FH2 domain in 
Toxoplasma (Jacot, Daher, and Soldati-Favre 2013). Most interestingly, 
conditional disruption of Tgformin2 with the split-Cas9 system caused the 
apicoplast mislocalisation to the residual body. The importance of actin 
dynamcis on apicoplast inheritance is well documented in Toxoplasma 
(Andenmatten et al. 2013; Jacot, Daher, and Soldati-Favre 2013; Haase et al. 
2015; Whitelaw et al. 2017). However, massive accumulation of apicoplast 
material outside the parasite upon Tgformin2 disruption presents a unique 
feature among actin-related apicoplast phenotypes.  
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Figure 5-3: Disruption of Tgformin2 in RHsplit-Cas9 parasites expressing 
actin-chromobody-Emerald (Cb-Em or Cb) 
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Figure   5-3   continued: IFA depicts the effect of Tgformin2 (RHsCas9-Cb-formin2) 
disruption on the actin network (Cb-Emerald) and apicoplast segregation (HSP60). 
Tgformin2-wt parasites showed normal apicoplast numbers and localisation (normal), 
while Tgformin2-KO parasites depicted apicoplast loss (loss) or the accumulation of 
apicoplast material in the residual body (RB) (in RB). Quantification of these phenotypes 
can be found in Figure 5-4. (A) To achieve gene disruption (KO), parasites were 
incubated with 50nM rapamycin for 1h. Parasites were fixed after 48h with 4%PFA (1st 
lytic cycle). (B) Parasites were treated with 50nM rapamycin for 1h (KO). Parasites were 
grown for 48h, mechanically lysed and inoculated again for another 48h prior to fixing 
with 4%PFA (2nd lytic cycle). Apicoplasts were stained with α-HSP60 by IFA. Nuclei were 
stained with DAPI. Scale bars are 5µm.  
 
Figure 5-4: Disruption of Tgformin2 in RHsplit-Cas9 parasites expressing 
actin-chromobody-Emerald (Cb-Em or Cb) 
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(A) IFA depicting natural egress of RHsCas9-CbEm-formin2-KO parasites. To achieve 
gene disruption (KO), parasites were incubated with 50nM rapamycin for 1h. Parasites 
were fixed after 48h with 4%PFA and stained with α-HSP60 (apicoplast) by IFA. Scale bar 
is 5µm. (B) Quantification of IFA depicted in Figure 5-3 A. The graph quantifies the loss of 
the cytosolic actin centre (cAC) anterior to the nucleus in rapamycin-treated (50nM) and 
untreated populations of the RHsCas9-CbEm-formin2 strain. For this experiment, 
parasites were stained by IFA after 48h of growth (see Figure 5-3 A). (C) Quantification of 
the different apicoplast phenotypes depicted in the IFAs in Figure 5-3 A and B. RHsCas9-
CbEm-formin2-wt parasites showing the natural cytosolic actin centre (cAC) anterior to the 
nucleus were compared to RHsCas9-CbEm-formin2-KO parasites lacking the cAC. For 
both conditions, parasites of the 1st and the 2nd lytic cycle were investigated. Parasites 
were treated as described in Figure 5-3 A and B. Quantifications presented in (B) and (C) 
were obtained from three independent experiments for each condition. For each condition 
100 vacuoles were counted (total n=300).  
 
5.2 Confirmation of TgFormin2 function with the DiCre 
system 
The effect of Tgformin2 disruption with split-Cas9 presented a complete novelty 
with regards to actin dynamics in intracellular parasites. To ensure that the DNA 
damage observed in some parasites after split-Cas9 activation (see chapter 3) 
did not cause the observed phenotype, I decided to validate the function of 
TgFormin2 using the DiCre system (Andenmatten et al. 2013) as an independent 
conditional approach. Due to its mode of action, the DiCre system allows gene 
excision without causing a double-stranded DNA break. As demonstrated for 
TgMec17 (see chapter 3, Figure 3-9 and Figure 3-10), no underlying effects are 
to be expected upon gene excision.  
For this purpose, the Tgformin2 gene was flanked with two loxP sites and, at the 
same time, c-terminally-tagged with yfp to generate the DiCre-formin2-YFPloxP 
strain (Figure 5-5 A). Genome modifications and gene excision upon DiCre 
activation via rapamycin were confirmed via analytic PCRs (Figure 5-5 B). 
Sequencing analysis revealed in-frame integration of the yfp-tag into the 
genome (Appendix Figure 7-6 B).  
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Figure 5-5: Generation and verification of the DiCre-formin2-YFPloxP strain 
(A) Cartoon depicting the strategy of flanking the Tgformin2 gene with two loxP sites 
and, at the same time, inserting a YFP-tag at the 3´end of the gene. Upon rapamycin 
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treatment, the endogenous Tgformin2 locus is excised. Arrows indicate primers used for 
analytic PCRs shown in (B). (B) Analytical PCR confirming integration of the loxP sites 
and the YFP-tag into the parasite genome. PCRs 1 and 2 confirm 5’ and 3’ integration, 
respectively. To confirm the excision of the Tgformin2 (frm2) gene upon rapamycin 
treatment, parasites were inoculated with (+) or without (-) 50nM rapamycin. Samples 
of gDNA were collected after 48h. Excision of Tgfrm2 was confirmed by PCR 4. The 
amplification of the 3’ integration product in PCR 3 indicates incomplete gene excision 
in the rapamycin-induced frm2-YFPloxP population. The recognition sites of the colour-
coded primers (arrows) are shown in (A). Please note that the DiCre-formin2-YFPloxP 
strain was generated by Dr Mirko Singer. Experiments shown in this figure represents my 
own work. 
 
Localisation of TgFormin2 to the vicinity of the apicoplast was confirmed by 
detecting TgFormin2-YFP with an anti-YFP antibody (Figure 5-6 A, top panel). 
Interestingly, the YFP signal was not detectable without antibody use (Figure 5-
7), probably suggesting low expression levels for TgFormin2. Closer examination 
revealed that 30% of TgFormin2-YFP signal partially overlaps with the apicoplast 
(Figure 5-8). In other cases, TgFormin2 was found adjacent to the apicoplast 
with (58%) or without (12%) being in contact with the apicoplast periphery. 
Taken together, this quantification suggests that TgFormin2 preferentially 
accumulates in close proximity to the apicoplast in intracellular parasites.  
Rapamycin treatment resulted in loss of TgFormin2-YFP in 35.7% (±3.8%) of 
parasites as determined by IFA (Figure 5-6 A). The same two types of apicoplast 
phenotypes as for the split-Cas9 system (Figure 5-3 and Figure 5-4) were 
observed upon excision of Tgformin2-YFP with the DiCre system (Figure 5-6). In 
23.3% (±3.8) of vacuoles, some parasites were devoid of the apicoplast without 
accumulation of apicoplast material to a specific location within the vacuole 
(Figure 5-6 A and B). Lack of apicoplasts within the parasites was associated 
with the accumulation of apicoplast material to the residual body in 41.3% (±3.1) 
of vacuoles. In the untreated control population, 1% (±0) of parasites showed an 
apicoplast segregation phenotype. No apicoplast material was detectable in the 
residual body in the control population. In addition, TgFormin2-YFP excision 
resulted in loss of the cAC anterior to the nucleus when parasites were 
transiently transfected with the actin-chromobody-emerald (Figure 5-9).  
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Figure 5-6: Effect of Tgformin2 (frm2) excision with the DiCre system on 
apicoplast segregation and position 
148 
 
Figure 5-6 continued: (A) IFA depicting apicoplast fate in DiCre-frm2-YFPloxP and 
DiCre-frm2-KO parasites. DiCre-frm2-YFPloxP parasites showed normal apicoplast 
numbers and localisation (normal). The DiCre-frm2-KO population depicted normal 
apicoplast numbers (normal), apicoplast loss (loss) or the accumulation of apicoplast 
material in the residual body (RB) (in RB). DiCre-frm2-YFPloxP and DiCre-frm2-KO 
parasites were grown for 48h without or with 50nM rapamycin, respectively. After fixation 
with 4%PFA, apicoplasts were stained with α-Atrx-1 and Formin2-YFP was detected with 
α-YFP by IFA. Nuclei were stained with DAPI. Scale bars are 5µm. (B) Quantification of 
apicoplast phenotypes observed in IFA as presented in (A). Numbers were obtained from 
three independent experiments for each condition. For each condition 100 vacuoles were 
counted (total n=300).  
 
Figure 5-7: IFA attempting detection of TgFormin2-YFP (TgFRM2-YFP) 
without α-YFP antibody 
DiCre-frm2-YFPloxP and DiCre-frm2-KO parasites were grown for 72h without or with 
50nM rapamycin, respectively. After fixation with 4%PFA, apicoplasts were stained with α-
HSP60 by IFA. Nuclei were stained with DAPI. The YFP channel shows background 
fluorescence. In the DiCre-frm2-YFPloxP population, YFP-tagged TgFRM2 was not 
detectable in the absence of an YFP-antibody. The figure shows representative images. 
Scale bars are 5µm.  
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I was also interested in examining whether actin dynamics mediated by 
TgFormin2 were involved in the replication and localisation of other organelles. 
While parasites displayed the characteristic apicoplast phenotypes after 
TgFormin2-YFP excision, parasites did not show any defect in mitochondria 
replication and morphology (Figure 5-10 A). Some rhoptry material accumulated 
in the residual body upon Tgformin2 loss (Figure 5-10 B). However, further 
studies will have to be conducted to elucidate the role of actin dynamics in 
rhoptry biogenesis and overall morphology.  
In summary, the DiCre system confirmed TgFormin2 function in intracellular 
Toxoplasma parasites. Localisation studies with YFP-tagged TgFormin2 stressed 
the close proximity between the nucleation factor and the apicoplast in 
intracellular parasites.  I decided to further investigate this phenomenon in the 
next section.  
 
Figure 5-8: IFA depicting localisation of TgFormin-YFP in relation to the 
apicoplast in DiCre-frm2-YFPloxP parasites 
Parasites were grown for 48h and fixed with 4%PFA. Apicoplasts were stained with α-
Atrx-1 and TgFormin2-YFP was detected with α-YFP. Three different types of positioning 
were identified for TgFormin2-YFP. In 30% of parasites, TgFormin2 and the apicoplast 
partially co-localise (1). In 58% of parasites, there is overlap in the periphery of TgFormin2 
accumulation site and the apicoplast (2). Other parasites (12%) show TgFormin2 in close 
proximity to the apicoplast without signal overlap (3). Quantification is based on n=142 
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parasites from 22 independent vacuoles. This figure shows representative images. Scale 
bar is 5µm. 
 
Figure 5-9: Transient expression of the actin-chromobody-emerald (Cb-
Emerald/CbEm) in DiCre-frm2-YFPloxP and DiCre-frm2-KO parasites 
Parasites were transiently transfected with the Cb-Emerald plasmid. Subsequently, the 
samples were grown with or without 50nM Rapamycin and fixed after 48h or 72h with 
4%PFA. Apicoplasts were stained with α-HSP60 by IFA. Nuclei were stained with DAPI. 
The figure shows representative images. Scale bars are 5µm.  
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Figure 5-10: IFA depicting the effect of Tgformin2 depletion with the DiCre 
system on morphology and positioning of mitochondria and rhoptries 
(A) and (B) Parasites were grown with or without 50nM Rapamycin for 48h and fixed with 
4%PFA. Apicoplasts were stained with α-HSP60 or α-Atrx1 by IFA. Rhoptries were 
visualized with α-Rop2,4. Mitochondria were stained with α-TOM40. Nuclei were stained 
with DAPI. The figure shows representative images. Scale bars are 5µm.  
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5.3 The role of the apicoplast in maintenance of actin 
dynamics 
Bioinformatic studies performed by Dr Jonathan Wilkes at the Wellcome Centre 
for Integrative Parasitology (Glasgow, UK) revealed that TgFormin2 contains a 
PTEN-C2-like domain (Stortz et al. 2019). The PTEN-C2 domain was reported to 
be involved in membrane recruitment (Das, Dixon, and Cho 2003). Interestingly, 
the PTEN domain mediates localisation of formin homology 5 (FH5) to the 
chloroplast in rice (Zhang et al. 2011). Since most TgFormin2 appeared to be in 
contact with the apicoplast (Figure 5-8), I hypothesised that the apicoplast 
might act as an anchoring point for TgFormin2. This would mean that the 
apicoplast would not only be important for correct TgFormin2 localisation, but, 
indirectly, also for maintaining the cAC. I argued that the role of the apicoplast 
in TgFormin2 recruitment and cAC maintenance could easily be addressed by 
depleting the apicoplast from parasites.  
To deplete Toxoplasma parasites of the apicoplast, the gene TgdrpA was 
disrupted with the split-Cas9 system. TgDrpA had been described previously as 
critical for the apicoplast segregation process by mediating apicoplast fission 
(van Dooren et al. 2009). Conditional expression of a dominant negative TgDrpA 
mutant rendered the parasites unable to segregate their apicoplasts. This 
resulted in apicopast loss in parasites during intracellular growth. I argued that 
the disruption of TgdrpA presented a reliable tool for assessing the impact of the 
apicoplast loss on the cAC anterior to the nucleus. 
For this purpose, I introduced the drpAsgRNA into the RHsCas9-CbEm parental 
strain to generate the line RHsCas9-CbEm-drpAsgRNA. Integration of the 
drpAsgRNA was confirmed by analytical PCR (Figure 5-2 A). Disruption of TgDrpA 
via split-Cas9 resulted in parasites devoid of the apicoplast (Figure 5-11). In 
addition, apicoplasts appeared elongated, most likely due to the lack of 
apicoplast fission in the absence of functional TgDrpA (van Dooren et al. 2009). 
Interestingly, parasites lacking an apicoplast still displayed the cAC anterior to 
the nucleus showing that the apicoplast is not essential for cAC maintenance. 
Conditional disruption of TgFormin2 function via the split-Cas9 or the DiCre 
system caused the cAC to disappear (Figure 5-3 and Figure 5-8), suggesting that 
there are no compensatory functions for maintaining the cAC in Toxoplasma. 
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Hence, the presence of the cAC indirectly suggests correct TgFormin2 
localisation and function in the absence of an apicoplast. It was recently 
reported that TgFormin2 co-localises with the Golgi apparatus in non-dividing 
parasites and that depletion of the apicoplast does not impact TgFormin2 
localisation (Tosetti et al. 2019). These findings make an exclusive role for the 
apicoplast in TgFormin2 recruitment in non-dividing parasites highly unlikely. 
The function of the PTEN-C2 domain remains to be elucidated. One could 
speculate that the PTEN-C2-like domain mediates TgFormin2 localisation and 
traffic to the apical region of the parasites independent from the apicoplast. I 
am further hypothesising that this domain might be involved in re-located 
TgFormin2 to the edges of the dividing apicoplast (Tosetti et al. 2019). Further 
investigation is required to determine the biological relevance of the PTEN-C2-
like domain.  
 
Figure 5-11: Disruption of TgDrpA in RHsplit-Cas9 parasites expressing 
actin-chromobody-Emerald (Cb-Em or Cb) 
IFA depicts the effect of TgDrpA (RHsCas9-Cb-DrpA) disruption on the actin network (Cb-
Emerald) and apicoplast segregation (HSP60). To achieve gene disruption (KO), 
parasites were incubated with 50nM rapamycin for 1h. Parasites were fixed after 48h with 
4%PFA. Apicoplasts were stained with α-HSP60 by IFA. Nuclei were stained with DAPI. 
The figure shows representative images. Scale bars are 5µm.  
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5.4 The effect of the cytosolic actin centre on overall 
actin dynamics in intracellular Toxoplasma 
Two independent systems identified TgFormin2 as nucleation factor critical for 
maintaining the cytosolic actin centre (cAC) anterior to the nucleus. Upon loss 
TgFormin2 function, the cAC, but not the intravacuolar filaments, is lost in 
intracellular parasites (Figure 5-3 and Figure 5-9). This phenotype was 
described by IFA and confirmed by time-averaged local intensity profiling 
(Figure 5-12 and Appendix Figure 7-4) (Supplement Movie V4).  
To analyse the effect of cAC loss on actin distribution and dynamics within 
parasites, I performed live microscopy on RHsCas9-CbEm-formin2-wt and 
RHsCas9-CbEm-formin2-KO parasites. Non-treated RHsCas9-CbEm-formin2-wt 
parasites displayed a highly dynamic cytosolic actin centre (cAC) that interacted 
with the parasite periphery (Figure 5-13) (Supplement Movie V4). Collapsed t-
stack images and skeletonisation analysis confirmed that actin accumulated at 
four accumulation sites: the two poles, the cytosolic actin centre (cAC) anterior 
to the nucleus and the parasite periphery (Figure 5-14) (Supplement Movie V4). 
Upon Tgformin2 disruption, parasites lost the cAC (Figure 5-14) (Supplement 
Movie V4). In addition the actin signal in the periphery appeared strongly 
reduced. Actin polymerisation outside the parasite bodies, i.e. the residual body 
was not affected. Actin accumulation was still detectable at the apical tip in 
some parasites.  
Kymograph analysis in formin2-wt parasites showed particle trajectories to the 
apical and basal pole indicating bi-directional actin flow along the periphery 
(Figure 5-15 and Appendix Figure 7-5) (Supplement Movie V4). Kymographs of 
RH-sCas9-CbEm-formin2-KO parasites appeared overall more diffuse, although 
some tracks could still be observed. This is most likely due to residual actin in 
the periphery and perhaps due to actin polymerisation mediated by TgFormin1 
located at the apical tip (Jacot et al. 2016). 
In summary, these data indicate that the TgFormin2-mediated cytosolic actin 
centre (cAC) majorly contributes to actin distribution and dynamics within 
intracellular parasites. Upon cAC loss, actin abundance was highly reduced in 
the parasite periphery. Peripheral actin flow also appeared affected, with 
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kymographs showing less clear trajectories.  This strongly indicates that the 
highly dynamic cAC does indeed fuel lateral, bi-directional actin flow in 
intracellular Toxoplasma. In conclusion, actin nucleation mediated by TgFormin2 
appears to be required for the maintenance of intracellular actin dynamics.   
 
Figure 5-12: Actin distribution in intracellular RHsCas9-CbEm-formin2 wt 
and KO parasites along the middle axis 
(A) and (B) Time-averaged intensity profiling along the parasites middle axis in RHsCas9-
CbEm-formin2-wt and RHsCas9-CbEm-formin2-KO parasites. Parasites were incubated 
with or without 50nM rapamycin for 1h. After a growth period of 72h, cultures were 
mechanically lysed and incubated on a fresh host cell monolayer for another 24h prior to 
live microscopy. At least 10 independent movies were produced and analysed for each 
condition. Movies are depicted as images representing collapsed t-stacks. Intensity 
profiles depict Cb-Emerald intensity along the measured axis (yellow line) over the entire 
duration of the movie. The figure shows representative images. Scale bars are 5µm. 
Please see also Appendix Figure 7-4 and Supplement Movie V4. 
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Figure 5-13: Live microscopy analysis investigating the interaction of the 
cytoplasmic actin pool and peripheral actin in the RHsCas9-CbEm-formin2-
wt line 
Parasites were grown for 72h. Cultures were then mechanically lysed and incubated on 
a fresh host cell monolayer for another 24h prior to live microscopy.Images depcit the 
contact of the cytoplamsic actin pool with periheral actin (white arrows). At least 10 
independent movies were produced and analysed. The figure shows representative 
images. Time is depicted as mm:ss. Scale bars are 5µm. Please see also Supplement 
Movie V4. 
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Figure 5-14: Skeletonisation analysis investigating actin distribution in 
RHsCas9-CbEm-formin2-wt and RHsCas9-CbEm-formin2-KO parasites 
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(A) and (B) RHsCas9-CbEm-formin2-wt parasites were cultured under normal conditions. 
RHsCas9-CbEm-formin2-KO parasites were treated with 50nM rapamycin for 1h. After a 
growth period of 72h, cultures were mechanically lysed and incubated on a fresh host cell 
monolayer for another 24h prior to live microscopy. Movies are shown with their 
respective skeletonisation analyses. Movies are depicted as collapsed t-stacks. At least 
10 independent movies were produced and analysed for each depicted condition. The 
figure shows representative movies and skeletonisation. Scale bars are 5µm. Please see 
also Supplement Movie V4. 
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Figure 5-15: Kymograph analysis of peripheral actin flow in intracellular 
RHsCas9-CbEm-formin2-wt and KO parasites 
160 
 
Particle movement alongside the periphery is depicted via three colour-coded 
kymographs. Red tracks represent particles moving to the basal end, green tracks show 
particle flow to the apical end and blue depicts static particles. The yellow line represents 
the area of kymograph measurement. Particle movement was measured from the apical 
(A) to the basal pole (B). Parasites were incubated with or without 50nM rapamycin for 1h. 
After a growth period of 72h, cultures were mechanically lysed and incubated on a fresh 
host cell monolayer for another 24h prior to live microscopy. Images represent videos as 
collapsed t-stacks. At least 10 independent movies were produced and analysed for each 
depicted condition. The figure shows representative kymographs. Scale bars are 5µm. 
Please see also Appendix Figure 7-5 and Supplement Movie V4. 
 
5.5 Summary, conclusions and on-going work 
In this chapter, I addressed TgFormin2 localisation and function within the 
Toxoplasma actin network. TgFormin2 was important for apicoplast inheritance 
and positioning as well as the maintenance of the cytosolic actin centre (cAC) 
anterior to the nucleus. The cAC appeared critical for overall actin distribution 
and flow in intracellular parasites, indicating that actin dynamics within 
intracellular parasites pre-dominantly depend on TgFormin2-driven actin 
nucleation.  
Most recently, during writing of this thesis, Tosetti and co-workers published 
their investigation of the three actin nucleation factors in Toxoplasma, namely 
TgFormin1, 2 and 3 (Tosetti et al. 2019). According to this study, TgFormin3 
localises to the basal pole and the residual body mediating actin nucleation 
outside the parasite body during intracellular growth. Actin nucleation by 
TgFormin1 does not majorly contribute to intracellular actin dynamics. Instead, 
TgFormin1 was reported to be critical for motility, invasion and egress of 
extracellular parasites. Results presented by Tosetti and colleagues regarding 
TgFormin2 stand in strong agreement with data presented here. It can be 
concluded that TgFormins fulfil non-overlapping roles during different stages of 
the asexual lytic cycle in Toxoplasma. 
TgFormin1-mediated actin nucleation was described to be critical for 
maintaining actin flow in extracellular parasites (Tosetti et al. 2019). According 
to live microscopy studies of moving and non-moving extracellular parasites, 
actin appears to accumulate at the basal end of the parasite, indicating actin 
flow from the apical to the basal pole. Tosetti and co-workers suggest that actin 
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translocation to the basal pole happens along the parasite periphery (Tosetti et 
al. 2019). This peripheral flow seems to be MyosinA-dependent and, thus, to be 
mediated by the actomyosin system (Tosetti et al. 2019). Data presented here 
provide experimental evidence that the parasite periphery represents a site of 
increased actin abundance during intracellular growth. Actin flow appears bi-
directional alongside the periphery in intracellular parasites and is fuelled by 
TgFormin2-mediated actin polymerisation in the cytosolic region anterior to the 
nucleus. It remains to be elucidated whether intracellular actin flow happens in 
a MyosinA–dependent fashion.  
During the process of the submitting this thesis, Hunt and co-workers reported 
TgCAP to be critical for maintaining the cAC (Hunt et al. 2019). This finding 
potentially indicates an interaction between TgCAP and TgFormin2. In 
Plasmodium, PfCAP was found to be capable of exchanging ADP to ATP on rabbit 
actin monomers in vitro (Makkonen et al. 2013). Exploring the nature of the 
potential interaction between TgCAP and TgFormin2 presents and exciting 
opportunity for future research efforts. 
Previously, actin polymerisation in Toxoplasma had been proposed to occur in an 
isodesmic fashion (Skillman et al. 2013). The model was applied to explain the 
previously reported presence of short and unstable actin filaments in 
Toxoplasma (Sahoo et al. 2006). Both studies were based on in vitro experiments 
with recombinant Toxoplasma actin. The model was also used to explain the 
limited set of actin nucleation factors (Baum et al. 2006), most prominently the 
lack of the Arps2/3 complex (Gordon and Sibley 2005), as the isodesmic model 
suggested nucleation-independent actin polymerisation (Skillman et al. 2013). 
The recent observation of a filamentous actin network in vivo (Periz et al. 2017) 
was the first direct experimental evidence to indicate the presence of actin 
factors that would allow for the formation of long filamentous actin structures in 
Toxoplasma. Data presented here and by others (Tosetti et al. 2019) clearly 
show that actin nucleation factors play a critical role in maintaining actin 
structures and dynamics in vivo. In combination, these data sets strongly 
indicate that Toxoplasma actin polymerisation relies heavily on actin nucleation 
factors. This raises the question about the relevance of the isodemic 
polymerisation model (Skillman et al. 2013) for actin dynamics in vivo. It is 
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important to note that data presented here do not directly disprove the 
isodesmic model for actin polymerisation. However, the functional requirement 
for such a unique polymerisation mechanism for eukaryotic actin still needs to 
be defined in vivo.  
The split-Cas9 system was capable of accurately describing the features unique 
to TgFormin2 loss of function. This was clearly demonstrated by the 
reproduction of the phenotypic characteristics with the DiCre system (this study) 
and with a clonal Tgformin2 knock-out line (Tosetti et al. 2019). Upon rapamycin 
induction, the split-Cas9 system achieved a higher rate of Tgformin2 loss of 
function (68% (±6.6)) than the DiCre system (35.7% (±3.8%)). I am speculating 
that the long DNA sequence between the two loxP sites (ca. 19,000bps) might 
act as a physical hindrance to Cre-recombinase functionality. The distance 
between the two loxP sites might be too large for the Cre-recombinase to act at 
its full potential. During the course of this thesis, numerous phenotypes were 
reproduced with the split-Cas9 system. In addition, the system was also capable 
of reliably investigating the biological novelty of the Formin2 phenotype. I 
therefore propose this system as a reliable tool for the investigation of actin 
dynamics in intracellular Toxoplasma. 
I reasoned that the split-Cas9 system was well suited for the purpose of 
screening for novel actin factors. The system can be exploited for phenotypic 
screening due to its inducible nature. Phenotypic screening capacity presents a 
novelty in Toxoplasma research since the use of constitutively expressed Cas9 
can only be used for measuring overall parasite fitness (Sidik et al. 2016). I was 
therefore eager to initiate a medium throughput phenotypical screening 
approach for novel apicomplexan actin factors. At the same time, this approach 
also aimed at addressing the impact on apicoplast replication. Apicoplast 
replication is linked to actin dynamics (Andenmatten et al. 2013; Jacot, Daher, 
and Soldati-Favre 2013; Haase et al. 2015; Whitelaw et al. 2017) and could 
therefore act as valuable indicator for overall actin function within the parasite.  
For this purpose, I designed a library consisting of sgRNAs targeting about 320 
apicomplexan-specific genes in total. The selected genes did not code for any 
signal peptide since I suspected actin binding proteins to be cytosolic. The 
screen was performed by Janessa Grech and Dr Elena Jimenez-Ruiz at the LMU 
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Munich (Germany). About 20 gene candidates were identified with a potential 
role in apicoplast biology and/or actin network dynamics. Careful validation of 
these candidates is subject to on-going research at the moment.   
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6 Discussion 
Actin is a highly abundant structural protein in eukaryotes that is critical for 
several cellular processes, including cytokinesis, cargo trafficking and cellular 
motility (Baum et al. 2006; Pollard and Cooper 2009). In Toxoplasma biology, the 
investigation of actin dynamics and functions presents a major research focus. 
Actin plays a key function in parasite egress, motility and invasion (Dobrowolski 
and Sibley 1996; Drewry and Sibley 2015; Egarter et al. 2014; Whitelaw et al. 
2017). Actin was also reported to be involved in apicoplast inheritance 
(Andenmatten et al. 2013; Whitelaw et al. 2017) and dense granule trafficking 
(Heaslip, Nelson, and Warshaw 2016; Whitelaw et al. 2017). Overall, actin is 
critical for the completion of the lytic cycle and, thus, parasite survival 
(Andenmatten et al. 2013; Egarter et al. 2014). Of relevance, despite numerous 
functions of actin during the lytic cycle, intracellular morphology and replication 
rate in culture appear to be largely unaffected by the lack of actin (Egarter et 
al. 2014; Periz et al. 2017). Noteworthy, depletion of TgACT1 results in 
asynchronous replication (Periz et al. 2017). 
Recently, actin structures were successfully visualised by exploiting actin-
chromobodies in Toxoplasma, revealing an extensive actin network within the 
parasitophorous vacuole (PV) (Periz et al. 2017). This network connects 
individual parasites with each other and appears important for vesicle trafficking 
between individual parasites within the PV (Periz et al. 2017). In addition, highly 
dynamic actin structures accumulate anterior to the nucleus in individual 
parasites (Periz et al. 2017). This thesis aimed at exploiting actin visualisation to 
investigate actin dynamics in vivo in unprecedented detail. For this purpose, the 
actin-chromobody was combined with the split-Cas9 technology (Zetsche, Volz, 
and Zhang 2015) to enable rapid gene disruption in Toxoplasma.  
In this study, I established the split-Cas9 system as a conditional tool for gene 
disruption in Toxoplasma (refer to chapters 3, 4 and 5). Despite the appearance 
of DNA damage-related phenotypes immediately after split-Cas9 activation, the 
system is capable of efficiently disrupting genes of interest. However, the gene-
specific phenotype must be distinguishable from the unspecific DNA damage 
phenotype to avoid misinterpretation of results. Gene-specific phenotypes were 
reproduced for a variety of genes, including Tggap40 (Harding et al. 2016) 
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(chapter 3), Tgmec17 (Varberg et al. 2016) (chapter 3) and TgdrpA (van Dooren 
et al. 2009) (chapter 5). Importantly, combination of the split-Cas9 system with 
the actin-chromobody technology reproduced the previously reported actin 
network phenotypes for the genes Tgactin1 and Tgadf (Periz et al. 2017) 
(chapter 4). Furthermore, Tgadf gene disruption strongly indicated that TgADF 
presents an important factor in the disassembly of the intravacuolar F-actin 
filaments prior to parasite egress from the host cell.  
The actin-chromobody enabled live microscopy and kymograph analysis 
investigating actin dynamics in intracellular parasites. By doing so, I re-defined 
four actin accumulation sites in intracellular Toxoplasma parasites: the apical 
and basal end, the cytosolic region anterior to the nucleus (cAC) and the 
periphery (chapter 4). These actin polymerisation centres appeared to be 
connected by bi-directional actin flow alongside the parasite periphery.  The 
split-Cas9 system revealed TgFormin2 as critical for maintaining the cAC 
(chapter 5). Since cAc loss severely affected actin distribution and peripheral 
actin flow, I concluded that actin dynamics within intracellular parasites pre-
dominantly depend on TgFormin2-driven actin nucleation. Furthermore, 
TgFormin2 appeared to be important for apicoplast inheritance and positioning 
(chapter 5). The split-Cas9-mediated TgFormin2 phenotype was confirmed by 
excising the Tgformin2 gene with the DiCre system. Results for TgFormin2 
obtained in this study stand in strong agreement with observations made by 
Tosetti and co-workers (Tosetti et al. 2019). 
 
6.1 Application of CRISPR/Cas9 strategies in Toxoplasma 
The type II CRISPR/Cas9 system was successfully applied for genome editing in 
various organisms, including human cells (Jinek et al. 2013; Mali et al. 2013), 
woody plants (Fan et al. 2015), beetles (Gilles, Schinko, and Averof 2015) and 
rabbits (Yan et al. 2014). CRISPR/Cas9 has also positively impacted genome 
modification efforts in trypanosomatids (Lander and Chiurillo 2019). In 
Toxoplasma, CRISPR/Cas9 was shown to be effective for single target gene 
disruption and site-specific insertions (Shen et al. 2014; Sidik et al. 2014). 
Nevertheless, phenotypic analysis based on CRISPR/Cas9 faces challenges in 
Toxoplasma.  
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Several studies reported that prolonged or constitutive Cas9 expression can 
negatively impact Toxoplasma morphology and/or fitness (Serpeloni et al. 2016; 
Sidik et al. 2016; Markus et al. 2019). This challenge was overcome by expressing 
Cas9 together with a sgRNA (Sidik et al. 2016). It was argued that Cas9 toxicity is 
caused by endogenous RNA mediating Cas9 activity (Sidik et al. 2016) and/or by 
secondary non-targeted Cas9 nuclease activity in the absence of any sgRNA 
(Markus et al. 2019). It was suggested that co-expression of a sgRNA might 
sequester Cas9 enzymes, thus preventing undesired nuclease activity (Markus et 
al. 2019). Interestingly, in contrast to the conditional ddFKBP-Cas9 system 
(Serpeloni et al. 2016), prolonged split-Cas9 activation did not result in aberrant 
parasite morphology. Most likely, this is because of the reduced efficiency of 
split-Cas9 in comparison to the wild-type Cas9 enzyme (Zetsche, Volz, and Zhang 
2015). Despite its reduced efficiency, the split-Cas9 system still achieved high 
gene disruption rates of over 95% in induced populations. Potentially, less 
efficient Cas9 variants could be constitutively expressed in Toxoplasma without 
the need for a decoy sgRNA. 
A previous report indicates a negative impact of transiently transfected of Cas9-
sgRNA plasmid on parasite fitness as measured by plaque assay immediately 
after transfection (Sidik et al. 2014). The effect was observed in RH parasites 
and, to a greater extent, in RHΔku80 parasites. Sidik and co-workers 
hypothesised that DNA damage caused by Cas9 could be responsible for this 
decrease in fitness, especially in the RHΔku80 strain. Data presented here shows 
that DNA damage presents a universal outcome of Cas9 activity and strongly 
impacts parasite and nuclear morphology. Therefore, in agreement with the 
hypothesis proposed by Sidik and co-workers (Sidik et al. 2014), I conclude that 
the repair of the Cas9-mediated DSB presents a bottleneck for parasite recovery 
(Figure 6-1).  
Because of this, my data urge caution when phenotypic analysis is performed 
immediately after Cas9 activity. For instance, it was suggested that TgMec17 is 
important for parasite replication based on transient Cas9 experiments (Varberg 
et al. 2016). However, the proposed impact of TgMec17 depletion on nuclear 
replication was only reproducible with the split-Cas9 system, but not with the 
DiCre system. I am therefore proposing that replication defect is not TgMec17 
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specific, but rather represents the effect of Cas9-mediated DNA damage in the 
1st lytic cycle of parasites.  
 
Figure 6-1: Schematic depiction of the DNA damage bottle neck that a 
Toxoplasma population has to overcome after Cas9 activity 
Cas9-mediated double-stranded DNA breaks cause a DNA damage phenotype within the 
1st lytic cycle after Cas9 activity. The DNA damage phenotype is lost in the 2nd lytic cycle, 
most likely due to the incapability of DNA damage parasites to re-invade. The schematic 
exemplarily depicts the results obtained for the Tgsag1 gene during this study. Parasites 
expressing TgSAG1 on their surface are outlined in red. Parasites lacking TgSAG1 are 
shown without red outline.  
 
Independent disruptions of the same gene usually produced similar levels of DNA 
damage abundance. Interestingly, however, the overall abundance of DNA 
damage within the 1st generation of a population can vary strongly when 
different genes are targeted by Cas9. For example, disruption of sag1 caused a 
DNA phenotype in 55.67% (±3.79) of parasites, while the number for actin1 
disruption was only 30% (±2.65). Potentially, different genomic loci are more 
accessible to the DNA repair machinery. Transcriptional pressure might also 
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impact the rate of successful DSB repair.  Whether these speculation hold true, 
however, remains to be elucidated.  
In mammalian cells, the usual DNA repair outcome after Cas9-mediated DNA 
cleavage was reported to be insertions or deletions (indels) of maximal 20bp 
(Koike-Yusa et al. 2014; Tan et al. 2015; van Overbeek et al. 2016). However, 
Kosicki and co-workers showed that large deletions ranging from 250bp to 6kb 
can occur after Cas9 mediated DNA cleavage (Kosicki, Tomberg, and Bradley 
2018). The indels observed for the targeted genes in my study (Tgsag1, 
Tgmec17, Tgactin1, Tgadf and Tgformin2) support previous reports in 
mammalian cells. While most indels are short insertions or deletions, Cas9-
mediated cleavage of the formin2 gene resulted in a large deletion (over 150bp) 
at the targeted locus. My findings stand also in agreement with previous reports 
in Toxoplasma. While smaller indels seem to appear more frequently in this 
organism (Shen et al. 2014; Sidik et al. 2014; Serpeloni et al. 2016), larger 
insertions over 100bp have been reported (Sidik et al. 2014). Overall, it would 
appear that Toxoplasma tends to show similar DNA repair outcomes to 
mammalian cells. 
In the context of CRISPR/Cas9-mediated genome targeting in mammalian cells, 
it has been reported that a variety of additional on-target DNA modifications, 
including inversions, can occur outside the cut site (Kosicki, Tomberg, and 
Bradley 2018). It would therefore appear that the CRISPR/Cas9 system has the 
potential to cause substantial genome rearrangements with unpredictable 
impact on the organism. Whether this is also true for Toxoplasma remains 
unclear. However, due to the similar DNA repair behaviour so far, it seems likely 
that similar events could also occur. In addition to the DNA damage phenotype, 
this possibility presents another reason to evaluate phenotypes thoroughly when 
applying CRSIPR/Cas9.  
Nevertheless, I argue that a conditional CRISPR/Cas9 system might be more 
robust with regards to proper phenotype depiction than, for example, clonal 
lines. In an induced split-Cas9 Toxoplasma population, different genomic 
modifications (indels) will be responsible for target gene disruption in different 
parasites. Since large genome rearrangements do not present the majority of 
DNA repair events (Kosicki, Tomberg, and Bradley 2018), truthful phenotypic 
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description should be possible by quantitative analysis of the entire induced 
population. A high induction rate as described for the split-Cas9 system is 
certainly beneficial in this endeavour. 
At this point it should be mentioned that target sites in the human genome 
appear to be repaired in a non-random fashion (van Overbeek et al. 2016; 
Chakrabarti et al. 2019). This means that certain type of indels preferentially 
occur at a given target site after DNA repair. A large scale study investigating 
over 1,000 target sites in the human genome, however, reported that not all 
target sites display highly preferred indels (Chakrabarti et al. 2019). While some 
target sites appear to possess one preferred sequence alteration, other sites lack 
a clear preference with DNA repair resulting in various indels. Target sites of the 
induced split-Cas9 populations for the genes Tgadf, Tgactin1 and Tgformin2 
showed different indels after gene disruption. I therefore propose that these 
populations should display their respective phenotype due to a variety of indels 
making the phenotypic analyses more robust. For Tgmec17 and Tgsag1, several 
gRNAs were applied for target gene disruption. This presents another way to 
increase the number of indels and minimize the chance of incorrect phenotypic 
analysis due to on-target genome rearrangements.  
The CRISPR/Cas9 technology enables genome wide screens in mammalian cells 
(Shalem et al. 2014; Wang et al. 2014; Jiang et al. 2019; Korkmaz et al. 2019). In 
Toxoplasma, a genome-wide CRISPR/Cas9 screen identified novel fitness-
conferring genes (Sidik et al. 2016; Sidik, Huet, and Lourido 2018). The 
relevance of this screen for the overall scientific advancement in apicomplexan 
biology cannot be overstated. Nevertheless, the application of a constitutively 
expressed Cas9 enzyme allowed only for the assessment of overall parasite 
fitness. This leaves phenotypic screens to be achieved in the future. Due to its 
conditional nature, the split-Cas9 system is generally well suited for such an 
approach. While the underlying Cas9-mediated DNA damage limits its 
application, I argue that the split-Cas9 system is capable of supporting a 
phenotypic screen for novel actin factors.  
First of all, research strongly indicates that Tgactin1, although critical for 
completion of the lytic life cycle, is not essential for intracellular growth and 
replication (Andenmatten et al. 2013; Egarter et al. 2014; Periz et al. 2017; 
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Whitelaw et al. 2017). In agreement with this, detrimental effects on nuclear 
integrity or parasite morphology, as described here for the DNA damage 
phenotype, have not been reported. The same is true for the actin 
depolymerisation factor (TgADF) (Mehta and Sibley 2011; Haase et al. 2015; 
Periz et al. 2017). 
Secondly, this thesis shows that the split-Cas9 system was able to reproduce 
previously published actin phenotypes with the actin-chromobody for the genes 
Tgactin1 and Tgadf (Periz et al. 2017). In addition, the split-Cas9 enabled 
phenotypic description resulting from the disruption of the Tgformin2 gene. The 
validity of the described characteristics was confirmed by DiCre system 
(Andenmatten et al. 2013) and by an independent study (Tosetti et al. 2019). It 
should also be mentioned that the various actin phenotypes are easily 
distinguished, indicating that Cas9 activity does not interfere with the true 
nature of the phenotype. A medium-throughput screen is on-going at the 
moment, aiming at identifying novel actin binding proteins.  
In summary, split-Cas9 extends the molecular toolbox that researchers have at 
their disposal for exploring Toxoplasma biology. Since the successful repair of 
Cas9-mediated DSB presents a significant obstacle, some parasites display a DNA 
damage phenotype after split-Cas9 activation. This limits the potential 
applications for this system. For instance, the system is not suitable for 
investigating nuclear or cellular replication. However, other biological questions 
addressing actin and apicoplast biology can be addressed applying this 
technology. In this context, vacuoles displaying an obvious DNA damage 
phenotype can easily be excluded from the analysis. Although the split-Cas9 
system can be utilised for targeted gene characterisation approaches, I am 
hypothesising that the technique is most powerful in the context of phenotypic 
screening.  
Due to the Cas9 mode of action, DSBs within genome cannot be avoided when 
aiming at gene control on the genetic level. One alternative approach, however, 
that would circumvent the challenges caused by DNA damage in Toxoplasma is 
the use of RNA-cleaving CRISPR/Cas systems. RNA cleavage would control gene 
expression on the transcriptional level. Type II CRISPR/Cas9 system from 
Streptococcus pyogenes can be programmed to target and cleave ssRNA 
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(O’Connell et al. 2014). It can also be exploited to target RNA nucleases to RNA 
molecules (Batra et al. 2017). In addition, Cas9 enzymes from other species 
were reported to target RNA as well as type III and VI CRSIPR/Cas systems (Wang 
et al. 2019).  
In the type VI CRISPR/Cas13a system, a single crRNA is sufficient to promote 
Cas13a-mediated ssRNA cleavage (Abudayyeh et al. 2016). However, Abudayyeh 
and colleagues observed collateral cleavage of standby RNAs upon Cas13a-
mediated target RNA cleavage. It was suggested that this phenomenon is 
responsible for the observed growth rate inhibition in bacteria expressing RFP, 
Cas13a and a RFP-targeting crRNA  (Abudayyeh et al. 2016). Intriguingly, when 
Cas13a was expressed in mammalian and plant cells for targeted transcript 
knockdown, no signs of collateral RNA cleavage were observed (Abudayyeh et al. 
2017). Collateral RNA cleavage was also reported for Cas13b (Smargon et al. 
2017) and Cas13d nucleases (Konermann et al. 2018). 
The fact that Cas13 can be targeted to RNA molecules by only one crRNA 
(Abudayyeh et al. 2016) should make expression of all necessary components 
achievable in Toxoplasma. Of course, the potential for collateral RNA cleavage 
would have to be addressed carefully. Nevertheless, exploiting CRISPR/Cas 
system for transcriptome modification in Toxoplasma presents an exciting 
outlook.   
 
6.2 Actin dynamics in Toxoplasma  
Visualisation of the in vivo actin network in Toxoplasma (Periz et al. 2017) can 
be considered a milestone in apicomplexan biology. Initial experiments 
performed by Periz and colleagues revealed that individual parasites are 
connected by a filamentous actin network. Vesicular trafficking between 
individual parasites within the PV was proposed to occur along actin filaments 
(Periz et al. 2017). The actin network appears dynamic with intravacuolar 
filaments being dis- and reassembled during parasite replication (Periz et al. 
2017). In addition, highly dynamic actin structures accumulate anterior to the 
nucleus in individual parasites (Periz et al. 2017). 
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Time-lapse microscopy was used in this thesis to further define actin dynamics in 
intracellular parasites. Actin accumulates at the apical and basal end of the 
parasite, the cytosolic region anterior to the nucleus and the periphery. 
Intriguingly, the cytosolic actin centre (cAC) anterior to the nucleus is highly 
dynamic and frequently interacts with peripheral actin. Overall, actin 
accumulation sites seem to be connected by bi-directional actin flow along the 
parasite periphery, as shown by kymograph analysis. I would therefore argue 
that intracellular parasites possess a dynamically connected actin network that 
spans their whole body (Figure 6-2). While filamentous actin structures enable 
vesicle trafficking between individual parasites (Periz et al. 2017), the 
intracellular actin network might mediate cargo transport within parasites.  
For instance, dense granule trafficking was reported to rely on actin and TgMyoF 
(Heaslip, Nelson, and Warshaw 2016; Whitelaw et al. 2017). Unsurprisingly, the 
distribution pattern of TgMyoF in intracellular parasites (Jacot, Daher, and 
Soldati-Favre 2013; Tosetti et al. 2019) appears similar to the actin distribution 
described by Periz et al. (Periz et al. 2017) and this thesis. TgMyoF is present in 
the same region as the cytosolic actin centre (cAC), localising to the area of the 
apcioplast and TgFormin2 (Jacot, Daher, and Soldati-Favre 2013; Tosetti et al. 
2019). In addition, TgMyoF can be found in the parasite periphery (Jacot, Daher, 
and Soldati-Favre 2013; Tosetti et al. 2019). 
Peripheral, bi-directional actin flow was also observed in resting extracellular 
parasites (Del Rosario et al. 2019). Interestingly, this actin flow did not depend 
on MyoA, a core component of the acto-myosin motor complex (Frénal, 
Dubremetz, et al. 2017). Whether bi-directional actin flow in intracellular 
parasites is MyoA independent remains to be seen. Other myosins could be 
responsible for peripheral actin translocation in intra- and extracellular 
parasites. TgMyoG was reported to localise to the parasite periphery (Frénal, 
Jacot, et al. 2017), while TgMyoL showed a ubiquitous distribution throughout 
the cytoplasm (Frénal, Jacot, et al. 2017). Hence, both myosins could represent 
reasonable candidates for maintaining the actin flow. Due to its similar 
distribution pattern to actin (Jacot, Daher, and Soldati-Favre 2013; Tosetti et al. 
2019), the same is true for TgMyoF. Interestingly, actin translocation appears 
MyoA dependent upon calcium stimulation (Del Rosario et al. 2019; Tosetti et al. 
2019). This might indicate that different signalling pathways in Toxoplasma 
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exploit different cellular factors to mediate actin translocation.  In addition, the 
reportedly fast turnover of apicomplexan filaments (Sahoo et al. 2006; Skillman 
et al. 2011; Kumpula et al. 2017, 2019)  might also contribute to directed actin 
translocation.  
 
Figure 6-2: Schematic depicting a model for actin flow in extracellular 
(gliding) and intracellular Toxoplasma parasites 
Actin accumulates at the basal pole of extracellular parasites due to a TgFormin1-
mediated actin flow. In intracellular parasites, the cytosolic actin centre (cAC) anterior to 
the nucleus fuels the bi-directional actin flow. TgFormins2 promotes cAC dynamics and is, 
thus, mainly responsible for maintaining actin dynamics in individual, intracellular 
parasites. Actin accumulation at the apical and basal pole in intracellular parasites is most 
likely supported by the other TgFormins. TgFormin1 and 3 were found to localise to the 
apical and the basal pole, respectively. Reprinted from eLife (Stortz et al. 2019) under the  
Creative Commons Attribution 4.0 International License. 
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6.3 In vivo Functions of Formins in Toxoplasma  
In vivo actin dynamics differ substantially from what can be observed in vitro 
(Pollard 2016). To efficiently control all aspects of actin assembly and 
disassembly, eukaryotic cells exploit a vast number of actin binding proteins 
(ABPs) (Pollard 2016). Processes that are heavily controlled by ABPs include de 
novo actin filament synthesis and actin treadmilling. In comparison to other 
eukaryotes, apicomplexan parasites encode for a limited set of ABPs (Baum et 
al. 2006). Strikingly, Formins are the only known actin nucleators in Toxoplasma 
and Plasmodium as spire (Baum et al. 2006) and the Arp2/3 complex (Gordon 
and Sibley 2005) are absent.  
This thesis and a recent report by Tosetti and colleagues (Tosetti et al. 2019) 
elucidate the non-overlapping functions of TgFormins in vivo. Strikingly, actin 
flow appears to depend on different Formins in extracellular and intracellular 
Toxoplasma parasites (Figure 6-2). Actin translocation to the basal end was 
reported to power motility in extracellular parasites and depends on TgFormin1 
(Tosetti et al. 2019). In intracellular parasites, however, peripheral actin flow 
and overall actin distribution within individual parasites appear to be mainly 
mediated by TgFormin2 as described in this thesis. A similar function was 
reported for PfFormin2 in intracellular Plasmodium falciparum blood stages 
(Stortz et al. 2019). Actin structures within the PV, but outside individual 
parasites, rely on TgFormin3 (Tosetti et al. 2019). 
Noteworthy, it was reported that resting extracellular parasites depict similar 
actin distribution to intracellular parasites, including bi-directional actin flow in 
the periphery (Del Rosario et al. 2019).  Gliding motility appears to promote and 
require rearrangements of overall actin flow in a MyoA-dependent fashion (Del 
Rosario et al. 2019; Tosetti et al. 2019). This is supported by two independent 
studies that observed actin accumulation at the poles in extracellular parasites 
upon motility induction (Del Rosario et al. 2019; Tosetti et al. 2019).  
In summary, TgFormin2 and 3 act mainly during intracellular growth, while 
TgFormin1 is crucial for gliding in extracellular parasites. I am hypothesising that 
Toxoplasma employs distinct mechanisms when directing actin flow during a 
resting or moving state. The exact molecular nature of these mechanisms, 
especially for intracellular parasites, will be the focus of future studies.  
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Proper actin dynamics are crucial for apicoplast replication and inheritance in 
Toxoplasma as depletion of actin causes apicoplast loss (Andenmatten et al. 
2013; Whitelaw et al. 2017). The ABPs TgFormin2 (Jacot, Daher, and Soldati-
Favre 2013; Tosetti et al. 2019), TgADF (Jacot, Daher, and Soldati-Favre 2013; 
Haase et al. 2015) and TgProfilin (Jacot, Daher, and Soldati-Favre 2013) are 
critical for apicoplast segregation as they maintain actin dynamics. It was 
suggested that TgMyoF and TgFormin2 act together to mediate proper apicoplast 
inheritance (Tosetti et al. 2019). A comparative study investigating the role of 
Formin2 in apicoplast inheritance in Toxoplasma and Plasmodium proposed that 
MyoF pulls the replicating apicoplast into the newly forming daughter cells along 
Formin2-mediated actin cables (Stortz et al. 2019). 
Interestingly, TgFormin2 knock-out lines are viable in culture (Tosetti et al. 
2019). In TgFormin2 knock-out populations, about 40% of parasites show normal 
apcioplast segregation while 60% of vacuoles show at least partial apicoplast loss 
(Tosetti et al. 2019). I made highly similar observations when excising TgFormin2 
conditionally via the DiCre system. Unsurprisingly, about 90% of parasites lacking 
the cAC after split-Cas9-mediated Tgformin2 disruption showed impaired 
apicoplast inheritance with up to 75% of vacuoles showing apicoplasts 
mislocalised to the residual body. This solidifies the current understanding that 
apicoplast segregation and correct positioning depends on TgFormin2-mediated 
actin polymerisation. As mentioned above, the importance of actin dynamics on 
apicoplast inheritance is well documented in Toxoplasma (Andenmatten et al. 
2013; Jacot, Daher, and Soldati-Favre 2013; Haase et al. 2015; Whitelaw et al. 
2017). Nevertheless, the massive and most prominent accumulation of apicoplast 
material in the residual body presents a characteristic feature of the TgFormin2 
phenotype. As of now, it remains unclear when and how the apicoplast 
mislocalise to the residual body during parasite replication. Potentially, the lack 
of TgFormin2-promoted actin filaments renders the parasites unable to pull the 
apicoplast into the newly forming daughter cells via TgMyoF. As a result, 
apicoplast accumulate outside of the parasite, i.e. the residual body. Live 
microscopy investigating parasite and apicoplast replication in TgFormin2 
depleted parasites (over several rounds of replication) should present a suitable 
method to address this question in the future.  
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In parasites lacking the apicoplast, the cAC was still present indicating a normal 
localisation and function of TgFormin2. This hypothesis is supported by findings 
showing localisation of TgFormin2 to the apical region of parasites lacking the 
apicoplast (Tosetti et al. 2019). Furthermore, Tosetti and colleagues reported 
co-localisation of TgFormin2 and the Golgi apparatus. Collectively, these 
observations might indicate anchorage of TgFormin2 to the Golgi apparatus or to 
both, the apicoplast and the Golgi apparatus. Based on IFA data presented by 
Tosetti and co-workers, it might be reasonable to assume that the close 
proximity of TgFormin2 and the apicoplast in non-dividing parasites could be the 
result of the close proximity between the Golgi and the apicoplast. Further 
experiments will be required to fully determine the nature of TgFormin2 
localisation in dividing and non-dividing parasites.  
Based on the results from in vitro sedimentation assays, actin polymerisation 
was proposed to occur in an isodesmic fashion with actin polymerisation 
occurring independently from a critical concentration in Toxoplasma (Skillman et 
al. 2013). According to this model, actin assembly and disassembly happen at 
the same rate. Thus, the kinetically unfavourable actin nucleation prior to 
filament elongation would not present a rate limiting step. It was argued by 
Skillman and colleagues that F-actin formation could therefore happen 
independently from nucleation-promoting factors. In addition, the model was 
applied to explain the previously reported presence of short and unstable actin 
filaments in Toxoplasma (Sahoo et al. 2006). 
Kumpula and co-workers challenged the reliability of actin sedimentation assays 
for analysing apicomplexan actin kinetics (Kumpula et al. 2017). They argued 
that the short length of apicomplexan actin oligomers could prevent their 
sedimentation. Pyrene fluorescence assays suggested kinetics for PfACT1 similar 
to canonical actin with F-actin formation depending on nucleation (Kumpula et 
al. 2017). Of relevance, the same study revealed that PfACT1 has a higher 
depolymerisation rate than canonical actin. Subsequently, crystallography 
studies revealed that unique structural features in the PfACT1 molecule promote 
filament destabilisation and, eventually, depolymerisation (Kumpula et al. 
2019). For instance, within the PfACT1 molecule, the interaction between the A-
loop and the Plasmodium-specific residue Lys270 enables a conformational stage 
that promotes actin filament fragmentation (Kumpula et al. 2019). Collectively, 
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these data indicate that the instability of apicomplexan F-actin can be explained 
by structural features not found in canonical actin. 
Originally, the isodemsic model was believed to offer an explanation for the 
limited set of actin nucleation factors (Baum et al. 2006), most prominently the 
lack of the Arp2/3 complex (Gordon and Sibley 2005). However, findings 
presented by myself and Tosetti et al. (Tosetti et al. 2019)  clearly show the 
critical function of TgFormins in maintaining actin dynamics. Very similar 
observation have been made in Plasmodium (Stortz et al. 2019). Collectively, 
these data support canonical actin kinetics depending on nucleation in the 
apicomplexan Plasmodium and Toxoplasma parasites. At this point of time, all in 
vitro and in vivo observations can be explained by the canonical understanding 
of actin dynamics. Although the isodesmic model (Skillman et al. 2013) has not 
been disproven directly, it does not offer exclusive explanations for any of the 
published actin-related phenotypes in vivo (Periz et al. 2017; Whitelaw et al. 
2017; Del Rosario et al. 2019; Stortz et al. 2019; Tosetti et al. 2019). 
 
6.4  In vivo Functions of TgADF in Toxoplasma 
Periz and colleagues presented time-lapse microscopy depicting rapid 
disassembly of intravacuolar actin filaments prior to parasite egress in a calcium 
dependent manner (Periz et al. 2017). Follow-up experiments performed here 
indicated that the actin depolymerisation factor (TgADF) is important for 
intravacuolar filament disassembly prior to parasite egress. 
TgADF displays a ubiquitous distribution throughout the parasite cytoplasm 
(Allen et al. 1997; Mehta and Sibley 2011; Haase et al. 2015). The inducible 
nature of the filament disassembly prior to egress (Periz et al. 2017) might 
suggest a signalling cascade as underlying activation mechanism. This would 
require a controlled activation of TgADF activity to enable rapid and site-specific 
actin filament disassembly. In other organisms, ADF activity depends on its 
phosphorylation status (Mizuno 2013). ADF activity is inhibited by LIM kinase-
dependent phosphorylation (Arber et al. 1998; Yang et al. 1998). The SSH 
phosphatase can mediate ADF dephosphorylation, thus leading to its re-
activation (Niwa et al. 2002). I therefore speculate that a calcium-dependent 
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pathway might exist that mediates TgADF activation prior to egress by 
modulating the enzyme’s phosphorylation status. Studies with TgADF 
phosphorylation mutants might be able to provide clarification about the exact 
underlying mechanism.  
Interestingly, in vitro sedimentation assays with rabbit actin suggested that 
TgADF does not stably associate with F-actin (Mehta and Sibley 2010). In the 
same study, TgADF also displayed a weaker severing activity than the canonical 
yeast cofilin and appeared to prevent F-actin assembly mainly by sequestering 
monomeric G-actin. Of relevance, the severing activity was measured on rabbit 
actin for both enzymes. The observation that TgADF appears responsible for the 
rapid breakdown of already existing filaments in vivo would suggest that TgADF-
mediated filament severing has relevance for actin dynamics. It was proposed 
that amino acid residues on the Toxoplasma actin monomer surface differ from 
conventional actin and that these differences contribute to filament instability 
(Sahoo et al. 2006; Skillman et al. 2011). Potentially, the weaker severing 
activity of TgADF is sufficient to mediate filament breakdown due to the more 
instable nature of Toxoplasma F-actin. The intravacuolar network was also 
reported to dis- and reassemble when intracellular parasites replicate (Periz et 
al. 2017). It is reasonable to hypothesis that TgADF might also be involved in 
mediating the network disassembly during replication.  
Noteworthy, filament disassembly is not an essential requirement for successful 
parasite egress. Potentially, the disassembly process might serve the purpose of 
recycling actin by reintroducing monomeric actin to the cytosolic actin pool. 
Actin was shown to be critical for parasite egress (Egarter et al. 2014; Whitelaw 
et al. 2017). Therefore, increasing the overall actin concentration within the 
parasite might benefit successful egress. Overall, experiments performed on 
TgADF and TgFormin2 emphasize that the actin-chromobody technology (Periz et 
al. 2017) is a powerful tool for investigating relevant actin processes in vivo. 
 
179 
 
6.5 Outlook on TgProfilin function and concluding 
remarks 
This study sets a solid foundation for future projects exploring actin kinetics in 
Toxoplasma. Unsurprisingly, TgFormin2 and TgADF appear to be key players in 
maintaining actin dynamics in Toxoplasma. The in vivo function of TgProfilin 
within the actin network, however, still requires investigation. In vitro assays 
suggest fundamental differences in the mode of action between Toxoplasma and 
yeast Profilin. TgProfilin inhibits TgFormin-mediated actin polymerisation 
(Skillman et al. 2012) while yeast Profilin enhances Formin-mediated F-actin 
assembly (Sagot et al. 2002). In yeast, Profilin is required for Formin-mediated 
formation of actin cables in vitro (Evangelista et al. 2002).  
 
Figure 6-3: Disruption of TgProfilin in RHsplit-Cas9 parasites expressing 
actin-chromobody-Emerald (Cb-Em or Cb) 
IFA depicts the effect of Tgprofilin (RHsCas9-Cb-Profilin) disruption on the actin network 
(Cb-Emerald). To achieve gene disruption, parasites were incubated with 50nM 
rapamycin for 1h. Parasites were fixed after 48h with 4%PFA. The figure shows 
representative images. Scale bars are 5µm. White arrows exemplarily indicate circular 
actin structures. Analytical PCR was performed to confirm the integration of the profilin-
sgRNA-plasmid into the parasite genome (Figure 5-2). 
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Preliminary data suggest that split-Cas9-mediated Tgprofilin disruption does not 
abolish TgFormin-mediated actin polymerisation in Toxoplasma (Figure 6-3). It 
would seem that intravacuolar filaments can appear more prominent after 
TgProfilin disruption. In addition, some parasites show circular actin structures 
that appear predominantly around the nucleus. Collectively, appearance of more 
prominent actin structures could suggest that the loss of TgProfilin increases 
actin polymerisation. Circular actin structures around the nucleus might 
represent increased TgFormin2-mediated actin polymerisation abolishing the 
dynamic nature of the cAC anterior to the nucleus. These in vivo observations 
would support a role for TgProfilin in actin sequestering as proposed in vitro by 
Skillman and colleagues (Skillman et al. 2012). TgProfilin might regulate actin 
filament formation by limiting the G-actin pool available for filament assembly. 
Future experiments will be performed to validate these prelimanry findings and 
to further characterise TgProfilin function in vivo.  
In conclusion, the actin-chromobody technology initiated a new era of actin 
research in apicomplexan parasites. With the obstacle of actin visualisation 
overcome in Toxoplasma (Periz et al. 2017) and Plasmodium (Stortz et al. 2019), 
actin studies in vivo now present an exciting opportunity to expand our 
knowledge on this abundant structural protein. The first steps were made in this 
endeavour by investigating the in vivo functions of Formins in apicomplexans 
(Stortz et al. 2019; Tosetti et al. 2019) and TgCAP in Toxoplasma (Hunt et al. 
2019). Moreover, novel functions for actin during host cell invasion (Del Rosario 
et al. 2019) and organelle recycling during intracellular replication (Periz et al. 
2019). To identify novel ABPs in Toxoplasma, screening approaches exploiting 
the split-Cas9 system are currently on-going in the Meissner laboratory (LMU 
Munich).  
The data presented in this thesis significantly contributed to our understanding 
of actin dynamics in Toxoplasma. Kymograph analysis gave detailed insights into 
overall actin dynamics in intracellular parasites. Furthermore, the ABPs TgADF 
and TgFormin2 were investigated for their function within the actin network in 
vivo. The split-Cas9 system will allow for phenotypic screening to further unravel 
the mechanics underlying actin dynamics in Toxoplasma.  
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7 Appendix 
 
Figure 7-1: Kymograph analysis of peripheral actin flow in intracellular 
RHsCas9-CbEm-actin1-wt and KO parasites 
(A) Kymograph analysis RHsCas9-CbEm-actin1-wt (sCas9-actin1-wt) and RHsCas9-
CbEm-actin1-KO (sCas9-actin1-KO). (B) Kymograph analysis RHsCas9-CbEm-actin1-KO 
(sCas9-actin1-KO) and movie background. Particle movement alongside the periphery or 
the movie background is depicted via three colour-coded kymographs. Red tracks 
represent particles moving to the basal end, green tracks show particle flow to the apical 
end and blue depicts static particles. The yellow line represents the area of kymograph 
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measurement. Particle movement was measured from the apical (A) to the basal pole (B). 
As polarity is difficult to define for sCas9-actin1-KO parasites, the start point of the flow 
measurement is indicated with an asterisk. The same is true for the background 
measurement. Parasites were incubated with or without 50nM rapamycin for 1h. After a 
growth period of 72h, cultures were mechanically lysed and incubated on a fresh host cell 
monolayer for another 24h prior to live microscopy. Images represent videos as collapsed 
t-stacks. At least 5 independent movies were produced and analysed for each depicted 
condition. The figure shows representative kymographs. Scale bars are 5µm. Please see 
also Figure 4-12 and Supplement Movie V2. Please note that live microscopy for the 
RHsCas9-CbEm-actin strain was performed by Dr Mario Del Rosario. 
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Figure 7-2: Actin distribution and kymograph analysis in intracellular RH-
GFP parasites 
184 
 
Figure 7-2 continued: (A) Time-averaged intensity profiling along the parasites middle 
axis in RH-GFP parasites. Intensity profiles depict Cb-Emerald intensity along the 
measured axis (yellow line) over the entire duration of the movie. (B) Particle movement 
alongside the periphery is depicted via three colour-coded kymographs. Red tracks 
represent particles moving to the basal end, green tracks show particle flow to the apical 
end and blue depicts static particles. The yellow line represents the area of kymograph 
measurement. Particle movement was measured from the apical (A) to the basal pole (B). 
For all analyses, RH-GFP parasites were grown for 24h prior to live microscopy. At least 
10 independent movies were produced and analysed for each condition. Movies are 
depicted as images representing collapsed t-stacks. The figure shows representative 
images. Scale bars are 5µm. Please see also Figure 4-8 and Figure 4-12 and 
Supplement Movie V3. 
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Figure 7-3: Actin distribution and kymograph analysis in intracellular 
RHsCas9-CbEm-adf wt and KO parasites 
(A) Time-averaged intensity profiling along the parasites middle axis in RHsCas9-CbEm-
adf-wt and RHsCas9-CbEm-adf-KO parasites. Intensity profiles depict Cb-Emerald 
intensity along the measured axis (yellow line) over the entire duration of the movie. (B) 
Particle movement alongside the periphery is depicted via three colour-coded 
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kymographs. Red tracks represent particles moving to the basal end, green tracks show 
particle flow to the apical end and blue depicts static particles. The yellow line represents 
the area of kymograph measurement. Particle movement was measured from the apical 
(A) to the basal pole (B). For all analyses, parasites were incubated with or without 50nM 
rapamycin for 1h. After a growth period of 72h, cultures were mechanically lysed and 
incubated on a fresh host cell monolayer for another 24h prior to live microscopy. At least 
10 independent movies were produced and analysed for each condition. Movies are 
depicted as images representing collapsed t-stacks. The figure shows representative 
images. Scale bars are 5µm. Please see also Figure 4-9 and Figure 4-12 and 
Supplement Movie V1. 
 
Figure 7-4: Actin distribution in intracellular RHsCas9-CbEm-formin2 wt and 
KO parasites along the middle axis 
(A) and (B) Time-averaged intensity profiling along the parasites middle axis in RHsCas9-
CbEm-formin2-wt and RHsCas9-CbEm-formin2-KO parasites. Parasites were incubated 
with or without 50nM rapamycin for 1h. After a growth period of 72h, cultures were 
mechanically lysed and incubated on a fresh host cell monolayer for another 24h prior to 
live microscopy. At least 10 independent movies were produced and analysed for each 
condition. Movies are depicted as images representing collapsed t-stacks. Intensity 
profiles depict Cb-Emerald intensity along the measured axis (yellow line) over the entire 
duration of the movie. The figure shows representative images. Scale bars are 5µm. 
Please see also Figure 5-12 and Supplement Movie V4. 
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Figure 7-5: Kymograph analysis of peripheral actin flow in intracellular 
RHsCas9-CbEm-formin2-wt and KO parasites 
Particle movement alongside the periphery is depicted via three colour-coded 
kymographs. Red tracks represent particles moving to the basal end, green tracks show 
particle flow to the apical end and blue depicts static particles. The yellow line represents 
the area of kymograph measurement. Particle movement was measured from the apical 
(A) to the basal pole (B). Parasites were incubated with or without 50nM rapamycin for 1h. 
After a growth period of 72h, cultures were mechanically lysed and incubated on a fresh 
host cell monolayer for another 24h prior to live microscopy. Images represent videos as 
collapsed t-stacks. At least 10 independent movies were produced and analysed for each 
depicted condition. The figure shows representative kymographs. Scale bars are 5µm. 
Please see also Figure 5-15 and Supplement Movie V4. 
 
 
 
 
 
 
 
188 
 
 
Figure 7-6 Sequencing of the formin2-HA and DiCre-formin2-YFPloxP lines 
confirming in-frame positioning of the HA and YFP-tag at the c-terminus  
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The top rows show the predicted DNA sequence in case of in-frame tag positioning for the 
lines formin2-HA (A) and DiCre-formin2-YFPloxP (B). The bottom row depicts the actual 
DNA sequence present in the two lines. Noteworthy, the nucleotide substitution in the 
linker sequence of the formin2-HA line (A) does not change the amino acid sequence. 
Colour coding: yellow: linker sequence, red: stop codon, orange: loxP sequence, green: 
3xHA tag (A) or YFP tag (B), blue: Tgformin2 sequence. Sequencing was performed by 
Eurofins (GATC services, LightRun Tubes). Please note that preparations for sequencing 
were performed by Dr Mirko Singer. 
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